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PREFACE
Media attention to Hepatitis C virus (HCV) has begun to increase over the last 
several years.  HCV is a blood borne pathogen that can culminate in chronic and severe 
liver disease.1  Only recently, Newsweek ran a cover story about the disease: “Hepatitis: 
The Insidious Spread of a Killer Virus” (Cowley 2002).  Recent ads, paid for by Roche 
Pharmaceutical, show a man with a bruised face and the words, “If Hep C Was Attacking 
Your Face Instead of Your Liver, You’d Do Something About It.”  HCV is often called 
the “silent killer” because of the asymptomatic nature of the disease and the public 
silence surrounding it.  Many persons are unfamiliar with HCV although there are an
estimated 5 million Americans infected with HCV (Erickson 2006).      
Despite the lack of direct sociological inquiries regarding HCV, attention to 
health has a longstanding tradition within the discipline (Bird et al. 2000).  Social 
scientists have shown the correlations between social and cultural factors and experiences 
with health and illness (Albrecht and Levy 1991; Bury 1991; Cockerham 2001; Kelly and 
Field 1996; Link and Phelan 1995).  As the average life span has increased, so has the 
number of Americans living with chronic illness, leading to scholarly interest in illness 
experience (Albrecht and Levy 1991).  A chronic illness can be defined as an illness that 
often does not have a severe acute onset, early symptoms may be difficult to recognize, 
the course of the illness is variable, and finally, the outcome of the illness is uncertain 
(Bury 2000).  Sociologists have developed a rich body of research concerning illness 
experience with a wide variety of diseases including epilepsy, mental illness, HIV and 
cancer (Charmaz 1991; Fife and Wright 2000; Goffman 1961; Link 1987; Schneider and 
1
 See Appendix 1 on page 26 for a detailed description of HCV. 
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Conrad 1983).  Research on illness experience has generally focused on subjective 
meanings associated with illness including notions of stigma, coping actions including 
patients’ interactions with others, and more recently, the effects of social structure on the 
illness experience (Pierret 2003).  The bulk of this research focuses on well known 
chronic illnesses (see Joachim and Acorn 2000 as an exception).  
Although HCV is not rare in prevalence, it is relatively unknown to the public and 
unexamined in medical sociology.  The focus on HCV offers a unique window into lay 
response to illness that does not have cultural spotlight characteristics of diseases such as 
cancer, HIV/AIDS, and depression.  In essence, I assess the efficacy of applying current 
understandings of chronic illness experience to an illness lacking in cultural imagery.  It 
is unclear based on prior research whether the existing discourse on chronic illness 
experience is sufficient to explain the experiences of individuals living with a potentially 
stigmatized illness that is culturally shrouded.   I specifically discuss how persons with 
HCV navigate their illness careers including their disclosure practices, reactions from 
others, and the meanings they give to their experiences.  
More broadly, I explore how social structure affects micro-level processes and 
interactions.  No studies have specifically examined the effects of race, class, and gender 
and how these dynamics affect the experience of having HCV.  Thus, this research 
addresses how a culturally invisible chronic illness is experienced with attention to 
locating individuals within the broader social structure.  Chronic illness is just one major 
life-changing event that individuals may experience in their lifetime.  The emergent 
research concepts apply to processes individuals undergo in an array of life-changing 
events.  This study adds to the existing discourse on stigma and how social structure
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affects stigma.  My research strengthens social psychological understandings of how 
issues of race and ethnicity affect meaning making processes.  Thus, while my 
dissertation clearly speaks to the sub-areas of medical sociology and deviance, the study 
also contributes to knowledge about stratification, in terms of how inequality is 
distributed and how public discourse or lack thereof affects experiences of illness.  
In the following chapters, I present the existing literature regarding illness 
experience, my methodological approach, my analyses and conclude with final thoughts.  
In Chapter 1, I detail what is known regarding the illness career.  I outline what is known
about biographical disruption experienced with chronic illness.  Chapter 1 addresses the 
literature about disclosure and stigmatization.  The pertinence of race, class, and gender 
to illness experience is highlighted.  I also include a discussion of what is missing in 
existing discourse, and how HCV can extend our current conceptualization of illness 
experience.  In Chapter 2, I describe my methodology of in-depth interviewing.  This 
chapter addresses experiences at the recruitment sites, the interview experience, and the 
respondents. I also explain my approach to data analysis including the incorporation of 
undergraduate research assistants and qualitative data analysis software.  The chapter 
addresses reflexivity with regards to various aspects of the research process, ethical 
issues in the research, and study limitations. 
In Chapters 3, 4, and 5, I present analyses of the data.  Each chapter incorporates 
data analysis and the relationship to existing theory and literature.  Chapter 3 addresses 
issues of disclosure.  Respondents offered a variety of reasons for disclosing health status 
and for not disclosing.  The reasons were either because of a concern for others or a 
concern for self. People had different levels of disclosure, which are related to 
ix
race/ethnicity as well as other factors.  After the discussion of disclosure, I turn to the 
reactions from others in Chapter 4.  People did engage in deprecatory self-labeling or felt 
stigma.  Some respondents did report acts of enacted stigma, while others were unaware 
that HCV was stigmatized.  Again, race/ethnicity is related to stigmatization. People also 
had no reactions to disclosure of their health status and positive reactions which involved 
various kinds of support.  Respondents devised a variety of ways to cope with stigma 
including information control, condemning the condemners and collective action. 
Chapter 5 examines the diagnostic experience and respondents’ reactions.  People had 
various levels of knowledge of HCV which were stratified by race/ethnicity.   
Respondents made sense of having HCV through abstract conceptualizations of their 
illness, HIV/AIDS discourse and through faith.
Chapter 6 summarizes patterns in the data and offers concluding thoughts.  The 
global theme of race/ethnicity and inequality is discussed with attention to theoretical and 
empirical research.  I conclude with a discussion of the contributions of this research to 
sociological discourse along with suggestions for future research.   
xAlicia E. Suarez
“So How Did You Get That?”: Experiences of Individuals Living with
Hepatitis C Virus (HCV)
Living with a chronic illness is challenging at both the individual and societal
levels.  How do individuals with Hepatitis C Virus (HCV), a culturally invisible disease, 
experience their illness?  This dissertation examines the illness careers of 53 men and 
women with HCV through in-depth interviews.  I explore how individuals experience
their illness through an extension of the concept of biographical disruption. This concept 
is further developed by incorporating disclosure patterns of health status and experiences 
with stigmatization.  This research addresses how people make sense of their illness on 
an individual level while still locating individuals within the larger social structure.
Three main findings emerge from this study.  First, individuals disclose their health status
at various levels with some people practicing quite open disclosure and others 
maintaining a veil of secrecy.  Whites disclose their HCV status more openly than do 
racial or ethnic minorities.  Reasons for revealing or hiding their illness are couched in 
terms of concern for others or a concern for self.  Second, not all persons with HCV 
believe that there is any stigma associated with the disease or have experienced any 
stigmatization.  Again, race plays a role with Whites reporting more experiences with 
stigmatization.  Individuals employ numerous coping mechanisms to deal with 
stigmatization.  People with HCV do experience other reactions to disclosure besides 
stigmatization including social support from family, friends, and in the workplace.  Third,
persons with HCV make sense of having the disease through a variety of processes.  
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Experiences with diagnosis are diverse including respondents’ initial reactions.  
Knowledge about the disease is stratified along racial lines but not by social class or 
gender with Whites having more accurate information about HCV.  Over half of the 
sample turned to HIV/AIDS discourse to give meaning to their illness because of the lack 
of available imagery on HCV.  Persons conceptualize their illnes in different fashions 
with some relying on their faith to cope.  These findings underscore how race shapes the 
illness experience of persons with HCV and propose ways to eliminate further 
inequalities. 
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1CHAPTER 1: CHRONIC ILLNESS EXPERIENCE AND HCV
Biographical disruption involves the combined effects of disabling symptoms and 
the cultural imagery surrounding chronic illness (Bury 2000).  It entails three features.  
First, the onset and problem of recognition of the disease is a disturbance in individuals’ 
lives (Bury 1982).  Secondly, persons may experience uncertainty regarding not only 
their health, but their sense of self.  Thirdly, biographical disruption involves mobilizing 
resources to deal with the illness.      
To extend our understanding of biographical disruption, I focus on individuals 
with Hepatitis C virus (HCV).2  This research broadens the concept of biographical 
disruption by including disclosure patterns and reactions to disclosure.  Individuals with 
chronic illness must decide whether to disclose their health status.  Choosing whom to 
tell, when and why, has consequences, including possible stigmatization.  Disclosure may 
also affect notions of self and interactions with others.  HCV provides an interesting case 
as it is not like other illnesses that have ample cultural imagery (Bury 1982).
In this chapter, I address existing theoretical and empirical literature regarding 
disclosure patterns, stigmatization, and sociological conceptions of illness.  The 
discussion is organized in line with how people with HCV experience their illness.  
People make decisions regarding disclosure and experience reactions to their disclosures.  
These behaviors and interactions affect how they conceptualize their illness.  Illness
experience can also be shaped by race, class, and gender. 
2
 See Appendix 1 on page 26 for a detailed description of HCV. 
2DISCLOSURE
Similar to HIV, HCV is an unpredictable disease in terms of long-term 
consequences and fluctuations in active symptoms.  HIV positive individuals must gain a 
sense of control over their lives to overcome feelings of uncertainty, although some 
choose uncertainty over a bleak reality (Weitz 1989).  This uncertainty may also be a 
defining characteristic of persons with HCV.  Persons may choose to live in secrecy 
rather than face their illness.  Some research has found that persons with HCV are 
reluctant to disclose because of fear of discrimination (Glacken et al. 2001).  Part of this 
secrecy may manifest itself through lack of disclosure to others, yet secrecy often leads to 
more stress and negative effects on health (Paxton 2002).  Thus, the individual is faced 
with the dilemma: to tell or not to tell.  To not tell may result in strained social 
interactions and demoralization. However, to disclose may result in actual rejection.         
Persons disclose their illness status for a variety of reasons.  Preventive telling is 
one way to thwart a potential rejection once the illness is known about.  Passing and 
withdrawal may become too difficult or impossible because of the physiological 
manifestation of the illness.  Tewksbury and McGaughey (1997) discuss how the stage of 
HIV affects the management of stigma. Persons in the early stages of the disease often 
pass as healthy by using selective disclosure (Tewksbury and McGaughey 1997).  
Individuals with HCV may not have to employ selective disclosure because of the lack of 
cultural knowledge about the disease. Conversely, HCV positive individuals may be less 
likely to embrace the identity of being HCV positive because of these same reasons. 
Persons with HIV who embrace their identity often feel a sense of purpose, an option 
3which may not be viable for HCV positive individuals (Tewksbury and McGaughey 
1997).  
 Lee and Craft (2002) argue that disclosure is centered on one theme: maintaining
pre-existing relationships and identities.  They found that persons with genital herpes 
disclosed to persons who they felt already accepted them.  Persons revealed their status 
when the nature of the relationship demanded disclosure.  The need to self-verify 
personal identities supersedes the fear of rejection in some situations (Lee and Craft 
2002).  By disclosing, individuals can reject public definitions of the illness and further 
validate their self-identities (Lee and Craft 2002) Others discuss how individuals 
sometimes disclose for seemingly unapparent reasons (Kelly 1991).  Kelly (1991) found 
that persons sometimes revealed their health status to gain sympathy, explain 
unsatisfactory role performance, to manipulate others, and to get attention.  These 
disclosures, however, may lead to social ridicule and rejection as others tire of persons 
occupying the sick role, especially once well (Kelly 1991).    
Medical personnel may indeed fall into the category of persons or relationships 
described above, where the nature of the relationship demands disclosure.  Healthcare 
workers know more about HCV than the general public.  It is important to inquire into 
acts of disclosure with a group of individuals (medical personnel) who are familiar with 
HCV. An extensive body of research has documented the stigmatization of HIV patients 
by physicians (Brown et al. 2003; Kelly et al. 1987).  Some research on HCV also finds 
stigmatization of HCV patients in healthcare settings (Zickmund et al. 2003).
It is unclear how the existing discourse concerning disclosure will apply to a 
disease without the same cultural visibility.  Thus, this research examines several issues 
4regarding disclosure: What motivates people with HCV to disclose? What reasons do 
persons with HCV give for not disclosing?  What affects disclosure practices for persons 
with HCV?  
STIGMA AND LABELING THEORY
Goffman’s (1963) classic work on stigma has had tremendous impact on 
numerous areas within sociology.   The stigma concept grew out of a symbolic 
interactionist approach and was embraced by those advocating labeling theory and more 
recently, modified labeling theory (Best 2004; Link 1987).  Labeling theory generally 
proposes that persons who experience a negative social reaction to their behavior and/or 
identities will experience numerous obstacles in society and may further accept their 
deviant label, leading to secondary deviance, that is deviance that follows from accepting 
the deviant label (Becker 1963; Lemert 1962).  Labeling theorists were generally 
concerned with power dynamics, in terms of who was defining behavior as deviant (Best 
2004).   Critics have argued that labeling theory is a passive process whereby persons 
simply accept and embrace a negative label attached to them by more powerful others 
(Glassner 1982; Gove 1980). 
While labeling theory lost eminence in studies of deviance and crime, modified 
labeling theory emerged within medical sociology as a fruitful theoretical approach (Best 
2004).  Modified labeling theory offers a more complex portrayal of individual reaction 
to labeling that allows for agency and negotiation (Lee and Craft 2002).  Link (1987) 
discusses how persons have expectations of what it means to be a mental patient.  Upon 
diagnosis, persons must then reevaluate these expectations as now they apply on a more 
personal level (Link 1987).  Persons may engage in what is called felt stigma defined by 
5Jacoby (1994) as, “Shame associated (with being epileptic) and the fear of enacted 
stigma” (270).  Expectations of rejection may actually elicit a negative reaction through 
strained social interactions (Link 1987).  Individuals who are especially likely to label 
themselves as stigmatized are those who feel they have not lived up to some type of 
societal expectation or norms in which they believe (Greil 1991).  People who feel 
stigmatized may be hurt by comments made by people who do not even know about their 
illness status nor are referring to the particular illness (Greil 1991).  Some researchers 
argue that felt stigma is more damaging than enacted stigma (Greil 1991; Scambler and 
Hopkins 1990).  
Numerous social scientists have examined the relationship between stigma and 
disease (Brown et al. 2003; Conrad and Schneider 1992; Goffman 1963; Kelly et al. 
1987; Link and Phelan 2001).  For this research, Link and Phelan’s (2001) definition of 
stigma will be used: “Stigma exists when elements of labeling, stereotyping, separation, 
status loss, and discrimination occur together in a power situation that allows them” (Link 
and Phelan 2001).  Stigma decreases individual’s life chance in a diverse array of areas 
including housing, employment, health, and quality of life itself (Link and Phelan 2001).  
Persons may experience social rejection, social isolation, and a negative sense of self 
(Fife and Wright 2000).  These factors have been studied in relation to a variety of 
diseases (especially mental illnesses), but diseases that are all generally known to the 
public (AIDS, cancer, tuberculosis, herpes).  Few studies examine rare or more invisible 
diseases and the relationship with stigma (Joachim and Acorn 2003) .  
  Many chronic illnesses are what Goffman (1963) calls discreditable stigmas; 
they are not immediately apparent in interactions and the individual must therefore 
6manage information.  Some ways to cope with stigma are passing, withdrawal, and 
preventive telling (Lee and Craft 2002).  Passing simply means concealing information 
about one’s stigma.  Passing may become problematic for the individual in that they may 
learn to identify with the persons who make disparaging remarks about those with the 
stigma they possess, which could lead to self-deprecation (Goffman 1963).  This may be 
less likely with HCV because of the state of public discourse surrounding the illness.  On 
the other hand, people may simply feel it is unnecessary to reveal their illness status to 
others when the roles involved in those relationships are unrelated to their illness identity 
(Lee and Craft 2002)
Withdrawal involves putting physical or social distance between those who are 
“wise” to the stigma and the “unwise”(Goffman 1963).  Managing the worlds of those 
who know and do not know may become onerous.  Finally, individuals often may begin 
to disclose at a more frequent rate, depending on the stage of their illness career (Lee and 
Craft 2002). Persons may choose to not discuss having HCV because of the ambiguity 
surrounding the disease in the general public.   With preventive telling, individuals with 
HCV may attempt to deal with others’ fear (of a virus they do not know) and also to 
educate others.  How the individual constructs the disease to others will undoubtedly 
have an effect on other’s reactions.  
STIGMA AND HCV
Yet, it remains to be seen what kind of reactions persons with HCV receive from 
others in light of the current public discourse about the disease.  Persons with HCV may 
not be stigmatized based on the aforementioned definition.  The supposition that HCV is
a stigmatized disease is feasible considering the linkage to intravenous drug use.  In fact, 
7the disease is often thought of as the ‘junkie’s disease’ (Krug and Hepworth 1999).   
Certainly, diseases that are seen as linked to behavior and in some ways preventable are 
often highly stigmatized (Schulte 2002).  Vietnamese immigrants in the 1970’s 
experienced discrimination in housing and schooling when the high prevalence of 
Hepatitis B in this population was discovered (Gilmore and Somerville 1994).  Thus, 
stigma associated with other types of Hepatitis may affect beliefs about HCV.  However, 
it is important to locate the actual state of public discourse concerning HCV as the 
discussion of stigma is predicated on there being cultural imagery available.
Knowledge concerning hepatitis and the liver is poor in the United States.
According to the American Liver Foundation, more than 1 in 4 U.S. adults did not know 
the liver was the primary organ affected by hepatitis (Orr 2006).  In addition, the vast 
majority of U.S. adults erroneously believe that alcohol abuse is the leading cause of liver 
disease (Orr 2006).  The American Gastroenterological Association commissioned an 
online survey conducted during 2003 as part of the “Be Hep C S.M.A.R.T.” (Shattering 
Myths and Reinforcing Truths) campaign (AGA 2003). 3  Findings reflect the lack of 
knowledge among the general public.  Slightly more than half of the general public 
believes HCV is a serious health threat compared to the vast majority of HCV sufferers, 
specialists, and primary care physicians (AGA 2003).  Less than half of those surveyed
are familiar or very familiar with HCV although more than half know that HCV can 
result in liver damage.  Nearly one in three persons thinks that HCV can be spread 
through fecal contaminated food or water and does not know that HCV can be spread 
3
 The sample was 1229 members of the public not infected with HCV, 493 HCV sufferers, 198 primary 
care physicians (PCP), and 217 specialists (gastroenterologists and hepatologists).  The sample was 
weighted by age, sex, race, education, and number of adults in household to reflect actual proportions in the 
population, although it was not a probability sample AGA. 2003. "Stigma of Hepatitis C Stops Americans 
from Getting Tested." Bethesda, MD: American Gastroenterological Association..  
8through any contact with infected blood (AGA 2003).  One in five Americans thinks 
there is a vaccine for HCV (as do 15% of HCV sufferers).  Approximately one third of
Americans are unaware that there are prescription treatments for HCV (less than 1 in 5 
persons with HCV are unaware of this.)  Finally, 38% of the public is unsure about any of 
the symptoms of HCV(AGA 2003).     
Evaluating levels of knowledge concerning HCV among intravenous drug users 
(IDUs) is a further reflection of public awareness as IDUs are at such high risks for 
infection and would presumably have more awareness.  Heimer and colleagues (2002) 
studied 493 IDUs in inner city neighborhoods in Chicago, IL, Hartford, CT, and Oakland, 
CA to assess HIV and hepatitis knowledge, in addition to injection related risk factors.4
The hepatitis knowledge addressed awareness of both HBV and HCV. 
Overall, there was significant difference between hepatitis knowledge and HIV 
knowledge (Heimer et al. 2002).  Respondents were almost three times more likely to 
answer, “don’t know” to items in the hepatitis scale compared to HIV.  Less than half of 
the sample knew there was no vaccine for HCV and could correctly answer items 
concerning the transmission of hepatitis through dried blood.  About half of the sample 
knew that persons with hepatitis could be recognized by disease symptoms. Finally, half 
of the respondents “correctly” knew that there is no cure for HCV (Heimer et al. 2002: 
1282).5  Factors predicting awareness of hepatitis included a history of HBV or HCV, 
HBV vaccinations, or having been in drug treatment (Heimer et al. 2002).  
4
 The sample consisted of both males and females with a mean age of 41 and had similar levels of 
education, income, and drug use histories.  Over ¾ of the sample was either African-American or Hispanic.  
In addition, over ¾ had been in a substance abuse program at some time and over half described their 
health as fair or poor. In short, these were not young neophytes, but chronic IDUs.  
5
 These researchers state that respondents, “…knew correctly that there is no cure for hepatitis C” (Heimer 
et al. 2002: 1282).  However, others, including most specialists, disagree that HCV cannot be cured (AGA 
2003).  
9Heimer and colleagues (2002) research suggests that IDUs obtain information 
about hepatitis from various types of healthcare facilities.  Because this population and 
other non-drug using low income and minority groups have lower rates of healthcare 
utilization, their potential for hepatitis knowledge may be less than other groups who 
have more interactions with healthcare workers.  However, only slightly more than half 
of primary care physicians ask their patients about risk factors and only 3% include 
testing for HCV as part of standard check-ups (AGA 2003). Thus, those with greater 
health care access, who are less at risk for HCV, are not necessarily getting information 
either.
In direct relation to HCV and stigma, almost 1 in 3 of the non-infected public 
believes that HCV mostly affects drug addicts and others with unhealthy lifestyles (AGA 
2003).  However, individuals may engage in a process of “imaginative rehearsal” of how 
others may respond to them (Link 1987).  Persons with HCV may be aware of the 
stereotypes and sentiments associated with persons with HIV/AIDS. For example, some 
researchers have found that 1 in 5 Americans believe that persons who got AIDS through 
sex or drug use “have gotten what they deserve” (Herek et al. 2002).  Likewise, Herek 
and colleagues (2002) report that nearly half of Americans agreed that persons with 
AIDS are responsible for their illness.  Individuals with HCV, especially those with a 
history of drug use, may fear similar reactions if their illness was revealed to others thus 
experiencing felt stigma (Brown et al. 2003).  The AGA suggests that HCV is simply not 
as stigmatized as sufferers might think.  Another explanation for the discrepancy in what 
sufferers versus the public believe could simply be the lack of correct information about 
HCV among the public.  In other words, if the public properly understood HCV, they
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might indeed have a more stigmatized view of both the disease and people infected with 
it.
Based on the preceding discussion, this research addresses the following points:  
What do people know about HCV prior to diagnosis? Do they think HCV is a stigmatized 
disease?  Do people engage in felt stigma?  Do persons experience enacted stigma?
How do they cope with the fear of stigmatization and/or experiences with stigmatization?
SOCIAL SUPPORT
There exists a strong link between social relationships and health and morbidity
(Turner and Marino 1994). Persons with strong social support experience less 
depression, cope better with stressful life events and have lower rates of overall morbidity 
(Ross and Mirowsky 1989; Wethington and Kessler 1986).  Individuals who have 
strained social relationships report worse physical health (Marmot 1998).  Evaluating the 
relational content is especially relevant when trying to understand how persons 
experience a chronic illness, as they often need practical help.   
Through disclosing health status an individual can access direct social support 
from others.  Upon disclosure, if the persons have a negative affect towards HCV as 
some do towards HIV, the afflicted individual may receive little to no social support  
(Brown et al. 2003).  Mobilization of resources is an aspect of biographical disruption 
according to Bury (1982). Being involved in religious activities or organizations may 
serve as one resource (House et al. 1988).  The presence of symptoms and stage of the 
illness may affect the ability to access resources.  Garnering resources and actions people 
take to minimize effects of illness are referred to as their strategy (Bury 1991).   
Strategies change over time and by context.  People may exploit the enactment of the 
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“sick role” and lose social support especially if they have had success with treatments or 
surgeries (Bury 1991).  However, accessing social support is not restricted to either 
negative or positive reactions from others.  Bury (1982) points out that persons may 
diminish their interactions with others because of actual physical limitations,
embarrassment, or fear about limitations.  Indeed, withdrawal from social situations and 
social isolation are features of chronic illness.  
In order to evaluate social support for persons with HCV, this research asks:  Do 
people with HCV receive social support as a result of disclosure?  What affects the 
likelihood of receiving support?
SOCIOLOGICAL CONCEPTIONS OF ILLNESS 
COPING
Persons with chronic illness often develop an illness concept.  An illness concept 
is “understood to comprise interpretations, explanations, and predictions with regard to 
one’s health status” (Schussler 1992).   Individual’s illness concepts and subsequent 
illness accounts will affect their levels and use of social support (Schussler 1992).  
Schussler (1992) found that illness concepts, as well as a feeling of internal versus 
external control over illness, are related to ability to cope with illness.  Bury defines 
coping as “the processes whereby the individual learns how to tolerate or put up with the 
effects of illness” (Bury 1991)  Persons who see their illness as a challenge or something 
of value and who feel like they have some control over their illness tend to cope more 
favorably with their illness as well as have less depression (Schussler 1992).   Whites, 
those with higher levels of education, younger people and non-Catholics are more likely 
to feel in control of their lives (Ross and Mirowsky 1989).  Persons who conceptualize 
12
their illness as an enemy, punishment, or as relief are more likely to cope less effectively 
and more likely to experience depression (Schussler 1992).  Finally, there is an 
association between complete denial of illness status or lack of any denial and experience 
with symptoms (Schussler 1992) .  
Two ways to approach the meaning of illness are a problems or consequences 
approach and meaning as significance approach (Bury 2000).  Research using a problems 
approach investigates patients’ difficulty or ease dealing with practical and material 
problems, including disruptive symptoms, treatment regimens, family, work, and daily 
activities (Bury 1991; Bury 2000).  However, the meaning of illness as significance is 
directly related to the previous approach.  Having a chronic illness inevitably affects the 
physical body in a variety of ways, be it physical appearance or performance, thus 
affecting personal identity (Bury 2000; Kelly and Field 1996). The significance is also 
related to the connotations associated with the illness or symptoms. The significance of 
illness is not static and changes with the life course.  Context is important in 
understanding how persons give meaning to their illness.  
Despite the lack of discourse concerning HCV, persons with HCV will eventually 
have to make sense of the illness both to themselves and to others.   Bury (1991) employs 
the concept of style that refers to presentation of self or the performance aspects of 
illness.   A person’s style refers to how they respond to and present features of their 
illness and treatment. Style is affected by beliefs about the self and the body (Bury 1991).  
Individuals offer accounts about their health status, meaning that people actively 
construct their views about illness and health in relation to their own unique position in 
the world (Popay et al. 1998; Radley and Billig 1996).  An account, in the original 
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conception by Scott and Lyman, is defined as “a statement made by a social actor to 
explain unanticipated or untoward behavior" (Scott and Lyman 1968).  While the concept 
of an account used to be limited to explaining deviance, it has been expanded to 
incorporate more social phenomenon.   Williams (1984) describes a similar phenomenon 
as narrative reconstruction.  Narrative reconstructions are “attempts to account for and 
repair breaks in the social order” (Williams 1984).  Kelly (1991) conceptualizes accounts 
as “vocabularies of motive or coping” (122).  Any time a person offers a health account, 
they are constructing their illness through interactions with another.  Thus, persons’ 
illness accounts are not static and the accounts given to others may actually change 
depending on who they are interacting with and their reaction.  An account is simply the 
telling of the illness concept.       
 People often feel the need to legitimize their situation through the accounts or 
reconstructions given.  Thus, the accounts of persons with HCV may be especially 
interesting as they may be educating others about the disease through their account. Their 
discussion of the disease may be more or less accurate in order to protect perhaps the 
other’s reaction to the illness, lest it be stigmatizing.  The larger, structural consequences
of these educational interactions may have disastrous consequences if misinformation is 
continuously given in acts of disclosure.    
Several questions emerge regarding coping and HCV:  How do people with HCV 
conceptualize their illness?  What factors influence style?  Do people vary their illness 
accounts for different audiences?  
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DIAGNOSIS, UNCERTAINTY, AND KNOWLEDGE
In regards to HCV, persons may experience symptoms before they are aware of 
their infection. Or in contrast, persons may feel perfectly fine and suddenly be diagnosed 
with HCV.  Biographical disruption begins, according to Bury (1982), as soon as a 
person experiences symptoms, seeks help and/or is diagnosed with HCV.
The process of diagnosis is crucial in understanding how persons first reacted to 
their disease.  People’s experiences of illness are shaped by their interactions with their 
doctors (and others) as well as influenced by race, class, and gender (Brown 1995).  
Individuals with HCV are especially vulnerable to being affected by the actual diagnostic 
experience, as this may be the first time they have even heard of the disease.  Persons 
with HCV most likely do not have any expectations or understandings about what it 
means to have HCV and thus do not have a readily available conception of what their 
experience means.  
Another aspect of biographical disruption involves the emerging disability and 
problem of uncertainty (Bury 1982).  While some sociologists discuss the labeling of 
illness as problematic, Bury (1982) argues that the diagnosis can be a relief for 
individuals in that their symptoms are legitimized and that medical intervention becomes 
available. In addition, patients may conceptualize disease as an outside force, yet still 
have the contrary experience of having the illness infiltrate their lives.  Not all persons 
with HCV experience active symptoms and even for those who have experienced 
symptoms, there may be times when they have no symptoms.  Actual physical 
experiences of symptoms affects how individuals conceptualize the disease (Albrecht and 
Levy 1991).  The course of the illness will also impact how an individual conceptualizes 
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the illness over time (Bury 1991).  Experiences with intensive treatment regimens is
disruptive to previous activities and social roles and leads to the illness as a master status 
(Greil 1991).  Thus persons who have undergone treatment for HCV may be more likely 
to incorporate having HCV into their identity.  
The problem of uncertainty involves the unpredictable course of the illness and 
also medical discourse.  Younger persons with milder symptoms are often more 
interested in instrumental styles of intervention and for information about tests and 
treatments (Bury 1991).  Older patients with more severe symptoms are more concerned 
about the broader implications of their illness and how to communicate these concerns 
with physicians (Bury 1991).  Chronically ill people realize medical knowledge is limited 
and often combine medical knowledge with their own biographical experiences.   Bury 
notes that, “moral concerns and scientific-based knowledge overlap” (Bury 1982).  Thus, 
persons do not passively accept expert knowledge, but reinterpret this knowledge along 
with lay experience.  Chronically ill individuals often explain causation through reference 
to the self, the body, and society (Williams 1984).  Thus instead of persons being 
disillusioned with medical knowledge, they appropriate it.  Medicine can be both a relief 
and a constraint in making sense of illness.
The lack of cultural imagery about HCV leads to several questions regarding 
diagnosis, uncertainty, and knowledge:  How do people with HCV come to be diagnosed?  
What are their reactions to diagnosis?  Do people with HCV experience uncertainty?  
What do people with HCV know about their disease?  What are the implications of their 
knowledge about HCV?
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RACE, CLASS, AND GENDER AS MEDIATORS OF ILLNESS EXPERIENCE
The previous discussion focused on various aspects of illness experience.  When
studying illness experience, however, it is crucial to situate individuals within the larger 
social structure.  In order to understand different persons’ experience with HCV, there 
must be an appreciation of individuals’ position in society.  
IMPORTANCE OF STUDYING RACE, CLASS, GENDER AND HCV
Attention to race, class, and gender is especially important as medical researchers 
have noted differences by race and gender in rates of chronic HCV and responsiveness to 
treatment.  Blacks have disproportionately high rates of HCV compared to Whites in the 
US with Blacks accounting for 22% of the HCV population (Alter et al. 1998; Palmer 
2006).   The disease progresses more quickly in men and among Blacks (Palmer 2006; 
Reddy 2002).  In terms of treatment, women and Whites in general respond better to 
treatment (Reddy 2002).  Blacks, however, are less likely to receive treatment once 
diagnosed (Palmer 2006). Blacks with HCV have a slightly higher history of intravenous 
drug use (36%) compared to Whites (28%) and Hispanics (23%) which may affect 
experience with the illness (Lepe et al. 2006).  Thus, the need to investigate the actual 
social experiences is paramount to understand these differences by socio-demographics.  
Of course, race, class, and gender are not homogenous categories.  Indeed, there 
will be variation within and across each group and overlapping influences based on race 
and class, for example, on gender.  My intention is not to reify these categories, but to 
explore how these social statuses do and do not affect lived experiences with HCV, all 
the while realizing the varied and intricate embodiment of these categories.  
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 Researchers should not assume that having HCV is especially salient for all 
persons or that this unifies these persons as a group. Some researchers criticize much 
existing research on stigma and disease as being too individualistic and overly simplistic 
in the quest for causality (Link and Phelan 2001; Parker and Aggleton 2003).  The danger 
in these typical conceptualizations lies in the outcomes for intervention as being too 
narrowly focused and not addressing the larger processes of stratification, as is much of 
the research on AIDS stigma.  For example, in a review of interventions to address AIDS 
stigma, Brown and colleagues (2003) suggest that contact with people living with 
HIV/AIDS (PLHA) appears to be the best approach currently.  However, none of the 
reviewed studies evaluate how PLHA are also stigmatized or not based on race, class, and 
gender and not just their health status.  Thus, the proposed interventions also ignore the 
larger implications of social stratification.  In other words, the experience of having HCV 
will be mediated by an individual’s status and the associated benefits or costs of those 
statuses.  By addressing these structural effects and their manifestation on an individual 
level, subsequent interventions in prevention methods or care of HCV individuals may be 
attuned to these dimensions.
RACE, ETHNICITY AND HEALTH
The relationship between race/ethnicity and health has been well established by 
numerous researchers (Krieger 2000).  Rates of infant mortality, for example, vary 
greatly for Black versus White Americans (LaVeist 1993)  Blacks have an infant 
mortality rate roughly twice that of Whites in the US although this varies dramatically by 
city (LaVeist 1993).  Native Americans and some Hispanic groups also have higher 
infant mortality rates (Smaje 2000).  Black Americans are more likely to suffer heart 
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problems and high blood pressure than White Americans (Krieger and Bassett 1986).  
Mortality rates are higher in general for Blacks than Whites in the US and Hispanics in 
younger age groups also have higher mortality rates (Smaje 2000).  
Historically, these differences were explained through a genetic model, while 
more recently, most researchers recognize the socially constructed nature of race and 
ethnicity (Krieger 2000).  Some have argued that researchers should stop studying race 
and ethnicity as it reifies difference and is a socially constructed and unscientific category 
(Stolley 1999).  Of course, many concepts studied by sociologists are socially constructed 
and others argue that race and ethnicity will not stop affecting health just because they 
are not studied (Krieger 2000).  Race and ethnicity affect lived experiences as they are 
schemas for orienting individuals in the social world (Smaje 2000).  
 In addition, race and ethnicity cannot be reduced solely to social class, as 
morbidity and mortality rates cut across class lines in terms of race and ethnicity as 
discrimination affects all minority persons (Krieger 2000) (although this is contested, see 
(Robert and House 2000; Smaje 2000).  There is an interaction with race and class in that 
among poor people, Blacks and Hispanics are considerably more likely to live in high 
poverty areas (Robert and House 2000).  Other facets of race/ethnicity that impact health 
are lifestyle and social capital (Smaje 2000).  Lifestyle factors include levels of exercise, 
diet, smoking, alcohol and drug usage, and high risk sexual or leisure activities (Smaje 
2000). Of course, community context affects the ability to engage or not in lifestyle 
choices. Social capital refers to coping resources, such as social networks for social 
support and community institutions (Smaje 2000). Different racial and ethnic groups have 
varying norms about familial support and collective action.  Race/ethnicity may affect 
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health care utilization rates although see Schnittker, Pescosolido, and Croghan (2005) 
(Smaje 2000). Blacks are less likely to receive preventative care and are more likely to 
report low levels of satisfaction with health services (Smaje 2000).  Finally, race and 
ethnicity have been found to affect the management of stigma for HIV positive 
individuals (Tewksbury and McGaughey 1997).  
This research thus addresses the following issues regarding race/ethnicity and 
illness experience with HCV:  Does race/ethnicity affect disclosure patterns?  Does 
race/ethnicity influence reactions to disclosures, including stigmatization?  Are coping 
patterns or knowledge about HCV impacted by race/ethnicity?  
SOCIAL CLASS AND HEALTH
There are health disparities independent of race based on social status (Marmot 
1998; Mirowsky et al. 2000; Robert and House 2000).  This disparity does not just apply 
to those in lower socioeconomic groups, but applies across the hierarchy, although there 
are diminishing returns in higher socioeconomic groups (Marmot 1998; Robert and 
House 2000).   Mirowsky and colleagues (2000) see social status as being composed of 
education levels, work status, occupational prestige and economic status.  They argue 
these components cannot be reduced to one measure but should be evaluated and 
analyzed independently (Mirowsky et al. 2000).  It is clear that persons with lower 
education, lower income, lower status occupations, and less wealth have higher rates of 
morbidity and mortality (Marmot 1998; Mirowsky et al. 2000; Robert and House 2000).  
Socioeconomic status has a large effect on health for infants, less of an effect for 
adolescents, a slightly larger effect for younger adults increasing through adulthood and 
then again dropping in old age (Marmot 1998; Robert and House 2000).  Access to 
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medical care may help explain some of the differences although this is debated within the 
field (Robert and House 2000).  
Marmot and colleagues (1998) found that education levels predicted health based 
on a multi-level measurement.  Education, like socio-economic status, has a gradient 
effect on health (Marmot 1998).  Education is also related to lifestyle factors with the 
more highly educated engaging in more healthy behaviors such as exercise and good diet 
habits (Mirowsky et al. 2000)  Educated individuals are less likely to be unemployed, 
they are more likely to work full-time, more likely to be autonomous at work, have 
higher incomes, feel more in control of their lives, and have higher levels of social 
support (Mirowsky et al. 2000).  
 Employment affects health in that the unemployed experience higher rates of 
morbidity and mortality (Mirowsky et al. 2000).  Work conditions, such as less 
controlling environments and more rewarding work, are related to health (Mirowsky et al. 
2000).  Bury (1982) discusses how social class and occupation affect the ability to 
compensate for disability through resources acquisition.  Higher prestige jobs are more 
flexible and persons can easily take time off to keep medical appointments or to attend to 
symptoms of their illness (Anderson 1991).  In addition, the way that people 
conceptualize and talk about their illness and bodies may be affected by employment and 
work conditions.  Anderson (1991) reports how middle class women were able to adapt 
their work experiences to manage their illness, while working-class women could not.   
Income literally affects the ability to engage in prescribed self-care in that some persons 
simply do not have the financial resources either to purchase necessary medical 
equipment or for transportation to and from medical appointments (Anderson 1991).
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  Bury (1991) notes how class affects style in that middle class people 
conceptualize the body and the self in more abstract terms, while working class define the 
body more in pragmatic terms.  Blair (1993) also found that working class persons 
described how they felt more in terms of physically located experiences compared to 
middle class who discussed mental states more (Blair 1993).  Middle class respondents in 
Blair’s study (1993) were generally more verbally engaged.  Smaje (2000) also notes that 
racial minorities may define health in more functional terms and with attention to effects 
on day-to-day life, rather than biologically.  Although, Anderson (1991) found that what 
appeared to be ethnic differences in illness experience were in fact class differences 
(Anderson 1991).  
A sense of control may be one of the strongest effects of social status on health 
(Mirowsky et al. 2000).  As previously mentioned, a sense of control is related to illness 
concept.  Those with higher education, better employment conditions, and good 
economic status feel more in control of their lives (Mirowsky et al. 2000).  Education 
fosters not only a sense of control, but helps foster sharpened analytic and problem 
solving skills.  Middle class individuals, who conceptualize their experiences more so in 
terms of mental rather than physical states and solutions, feel more in control (Blair 
1993).    
Thus, those with higher social statuses have more resources to gain information 
concerning illness.  Middle and upper class individuals are more likely to seek out a more 
complex understanding of the disease from their physician, while the lower class patients 
may ask fewer questions (Anderson 1991).  Lareau (2003) has found that lower class 
individuals have a decidedly different interaction style in institutional settings including 
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interactions with physicians.  This may be in part from a lack of sense of control of one’s 
life whereby one is less motivated to actively try to solve problems (Mirowsky et al. 
2000).    Middle class persons often ask more questions and feel more of a sense of 
entitlement to appropriate care (Anderson 1991; Lareau 2003).   In addition, some 
individuals may be more adept at appropriating medical knowledge and jargon.  Arksey 
(1994) discusses how sufferers of Repetitive Strain Injury (RSI) become familiar with 
different theories of causation and treatment for their illness. However, she does not 
discuss whether the access and acquisition of this knowledge is equally distributed across 
sufferers (Arksey 1994). 
Social class and illness experience with HCV are examined along several 
dimensions:  Are disclosure patterns affected by social class?  Is there a relationship 
between social class and reactions to disclosure or experiences with stigmatization? 
Does social class influence coping patterns or knowledge about HCV?
GENDER AND HEALTH
Gender also has profound effects on health.  While men have higher mortality 
rates and rates of chronic conditions, women have higher morbidity rates especially acute 
conditions (Rieker and Bird 2000; Verbrugge 1989).  This difference can partially be 
explained by biological differences between men and women but also through social and 
cultural factors (Lane and Cibula 2000; Rieker and Bird 2000)  Women visit doctors 
more, have more disability days than men, and use prescription and non-prescription 
drugs more (Rieker and Bird 2000; Verbrugge 1989).  Race interacts with gender in 
numerous ways in effects on health (Rieker and Bird 2000).  Non-white women report 
worse physical health than white women, although this pattern of self-reported health 
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differences is not seen in men (Marmot 1998).  Some explanations for higher morbidity 
risk for women are their lower levels of paid employment, more emotional stress, feeling 
more vulnerable to illness, fewer time constraints, and less physical activity than men 
(Verbrugge 1989).  Men’s mortality is partially linked to male engagement in high-risk 
behaviors such types of work and leisure activity (Lane and Cibula 2000).  Men are also 
more likely to drink and use illicit drugs (Lane and Cibula 2000; Rieker and Bird 2000).  
In terms of distress and psychological health, women are more likely to experience 
depression and men to have substance abuse problems (Rieker and Bird 2000).     
For some aspects of HCV, biological factors related to sex may be affecting 
health outcomes.   However, in terms of dealing with the illness, the social aspects of 
gender are monumental in explaining the illness experience.  Bury (1991) notes how 
gender may affect the coping process as women may worry more about their illness.  
Illness accounts may be affected by beliefs about gender in terms of explaining not being 
in the workforce or having to be cared for by others (Radley and Billig 1996).   
Illness experience with HCV may be especially affected by gender even more so 
if the assumed mode of transmission is from IV drug usage.  Women, in general, are 
often seen as deviant simply for not being men (Schur 1984).   Drug use is seen as 
deviant for both men and women, however, as women are all ready devalued, female 
drug addicts are “double deviants”.  Women who contracted HCV through drug use may 
be even more condemned for violating traditional gender norms concerning substance 
use.  Apart from drug use, women and men, in general, who violate gender norms are 
labeled as deviant (Schur 1984).  Thus, men and women who cannot perform roles 
associated with their gender because of their illness (such as wage earning or child care) 
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may experience heightened stigmatization.  Other researchers have found that 
management of stigma for HIV positive individuals is affected by route of transmission, 
race, gender, and sexual orientation of the individual (Tewksbury and McGaughey 1997)
(although see Lee 2002 for an exception).   Of course, labeling from others may lead to 
integration of these ideas into their illness account.           
Gender, especially in conjunction with assumed mode of transmission, may also 
have an affect on level of social support received from others (although see (Thoits 
1995).  Some have reported that HIV positive men have more social support than HIV 
positive women especially if the women contracted the virus through drug use 
(Lichtenstein et al. 2002).  Women often are providers of social support to family and 
friends and may have difficulty receiving social support (Anderson 1991).  However,
women are more likely to join support groups than men (Rieker and Bird 2000).
Research on gender and health leads to several issues regarding gender and illness 
experience with HCV: Do women disclose more or less than men? Are reactions to 
disclosure or experiences with stigmatization different for men and women?  Do women 
cope with HCV more or less effectively than men?  Do women have more knowledge 
about HCV?
CONCLUSION
The goal of this research is to examine illness experience with a culturally 
invisible disease, HCV.  I build upon the idea of biographical disruption by also 
addressing issues of disclosure and stigmatization.  In addition, I address how social 
structure impacts illness experience.  The use of in-depth interviews allows for rich, 
textual data while a diverse sample gives insight into social structure.  
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In the following chapters, I present the methodological approach, patterns in the 
data, and concluding remarks. In Chapter 2, I discuss recruitment sites, the respondents, 
the interviews, issues of reflexivity, and limitations of the research. In Chapters 3, 4, and 
5 contain analyses of the data.  I begin with respondents’ experiences with disclosure in 
Chapter 3.   Chapter 4 addresses reactions to disclosures of health status including social 
support and stigmatization.  Chapter 5 assesses how respondents made sense of having 
HCV in light of their experiences with disclosure and stigmatization.  In Chapter 6, I 
highlight the theme of race and inequality, address contributions to existing discourse, 
and suggest implications for future research.
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APPENDIX 1
DESCRIPTION OF HCV 
Hepatitis is a general term that refers to inflammation of the liver.  Hepatitis may 
be caused by numerous sources including drugs, toxic chemicals, and viruses.  There are 
several strains or types of hepatitis viruses, such as hepatitis A, hepatitis B, hepatitis C, 
hepatitis D, and hepatitis E, that are related only in that they affect the liver.  The 
numerous types of hepatitis have different etiology, an array of consequences, and 
varying treatment protocols.  Currently, there are vaccines for both hepatitis A and B.  
Hepatitis C has been more recently discovered compared to hepatitis A and B and there is 
currently no vaccine available. 
RATES AND PREVALENCE OF HCV
Hepatitis C virus (HCV) is a blood borne pathogen that leads to chronic infection 
in 80-85% of infected persons (Franciscus and Highleyman 2003).  Worldwide, it is 
estimated that over 170 million people or 3% of the world’s population have been 
infected with HCV (Reddy 2002).  The Centers for Disease Control estimate that 3.9 
million Americans or 1.8% of the population is infected with HCV, the most common 
blood borne infection in the United States, although only 2.7 million may have chronic 
infection and 70% of these persons may be unaware they are infected (AGA 2003).  More 
recently, others estimate that over 5 million Americans are infected (Erickson 2006).  
Approximately 25, 000 people are infected each year 
(http://www.cdc.gov/ncidod/diseases/hepatitis/c/fact.htm).   Persons aged 30-49 years old 
have the highest rates of infection in the US (Reddy 2002) (although others state that 
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persons 40-59 have the highest rates of HCV-http://grants.nih.gov/grants/guide/rfa-
files/RFA-DK-03-011.html).  Seventy percent of persons with HCV will develop chronic 
liver disease at some point in their life 
(http://www.cdc.gov/ncidod/diseases/hepatitis/c/fact.htm).  Currently, 40% of chronic 
liver disease in the United States is related to HCV (Reddy 2002).  There are an estimated 
8,000-10,00 deaths a year in the US from complications associated with HCV, although 
this number is expected to triple in the next ten to twenty years (Franciscus and 
Highleyman 2003).  According to Erickson (2006) the number of deaths per year from 
HCV, have exceeded deaths from HIV/AIDS since 2000. 
TRANSMISSION
HCV is spread through exposure to infected blood.  Parenteral transmission 
(outside of the intestines) of HCV is 10-fold more efficient than HIV(Thorpe et al. 2002).   
Intravenous drug users (IDUs) are at especially high risk for new infection.  It is 
estimated that 60% of current transmissions are through IV drug use 
(http://www.hepnet.com/hepc/aasld00/alter.html).  The Centers for Disease Control 
(CDC) estimates that within 5 years of initial IV drug use, 90% of most IDUs have 
contracted the virus (Alter et al. 1998).   Young IDUs are infected with HCV at four 
times the rate of HIV (Alter et al. 1998).  Prior to routine screening of blood and blood 
products in 1992, transfusions were the most common method of transmission 
(Franciscus and Highleyman 2003; Reddy 2002).  Transfusions accounted for 20% to 
40% of all infections up until the last fifteen years, although now they account for less 
than 5% of infections (http://www.hepnet.com/hepc/aasld00/alter.html ).     Sexual 
transmission is rare (1-3%) with an estimated transmission rate of 1.5% between long-
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term, heterosexual partners where one individual has HCV although risks such as 
sexually transmitted infections (STI) or drug abuse may raise the chances (Franciscus and 
Highleyman 2003; Reddy 2002).  Having multiple sexual partners, anal sex, working in 
the sex industry, and having contact with a sex worker have been cited as possible means 
of sexual transmission but is unclear how these sexual practices could increase rates of 
transmission (AGA 2003; Highleyman 2002). Needle-stick exposure in health-care 
settings and mother-to-infant transmission are also means of transmission although the 
rates are not high with less than 10% of needle-sticks resulting in HCV and 5%-6% of 
mothers passing HCV to their children (Franciscus and Highleyman 2003; Reddy 2002).  
Evidence is inconclusive regarding tattooing and body piercing in the US as a means of 
transmission (Alter et al. 1998).  Finally, there are individuals with HCV where no 
recognized source of infection can be identified 
(http://www.hepnet.com/hepc/aasld00/alter.html).
EFFECTS OF HCV
After exposure to HCV, the incubation period is generally 6-7 weeks and acute 
infection is asymptomatic in 60% to 70% of patients (Reddy 2002).  Many persons will 
have few to no symptoms for the first twenty years after infection, thus accounting for the 
many persons who are unaware they are infected (Franciscus and Highleyman 2003).  
The virus attacks cells in the liver leading to chronic inflammation of cellular tissue in the 
liver and eventual fibrosis or a hardening of the liver tissue, which may result in cirrhosis 
(Franciscus and Highleyman 2003; Reddy 2002).   Cirrhosis may lead to hepatocellular 
carcinoma and/or liver failure.  Factors that affect the rapid progression of the disease 
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include alcohol use, over forty years old at time of infection, male sex, and severe 
histology at time of initial diagnosis (Reddy 2002).  
Histology is measured by levels of ALT (alanine aminotransferase) and AST 
(aspartate aminotransferase), which are both liver enzymes (Franciscus and Highleyman 
2003).  High levels of ALT are often the impetus for testing persons for HCV, although 
ALT levels will fluctuate over the course of the disease (Reddy 2002).  After proper 
testing and diagnosis, many physicians eventually recommend a liver biopsy to determine 
inflammation levels and fibrosis of the liver 
(http://digestive.niddk.nih.gov/ddiseases/pubs/chronichepc/index.htm#E).  In addition, 
specialists will determine which of the six genotypes of the virus the patient has as well 
as viral load (Reddy 2002).  Symptoms experienced by some with chronic infection 
include nausea, chronic fatigue, mood swings, loss of appetite, muscle or joint pain, 
headaches, indigestion, depression, “brain fog”, and abdominal pain (Franciscus and 
Highleyman 2003).     
TREATMENT
 Treatment is available with the goal of staving off progression of the disease, 
although it is not recommended for all persons with HCV as there are some factors that 
are known to affect responsiveness to treatment (Reddy 2002).  Treatment usually 
consists of a combination of pegylated alpha interferon and ribavirin for a period of 24 or 
48 weeks (http://digestive.niddk.nih.gov/ddiseases/pubs/chronichepc/index.htm#H).  This 
regimen often reduces ALT levels and detection of HCV antibodies in the blood 
(http://digestive.niddk.nih.gov/ddiseases/pubs/chronichepc/index.htm#H).   65% of 
specialists do believe treatment can cure people, meaning the virus can no longer be 
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detected in the blood for a sustained period of time (AGA 2003).  However, response 
rates are currently around 50% depending on virus genotype, viral load, and several other 
factors, including race, sex, and age (with women, younger people, and Whites more 
responsive to treatment) (Reddy 2002).  In addition, side effects may be severe, including 
fatigue, muscle aches, headaches, nausea and vomiting, low-grade fever, weight-loss, 
irritability, depression, and reversible hair loss 
(http://digestive.niddk.nih.gov/ddiseases/pubs/chronichepc/index.htm#H).  Some patients 
quit treatment because of the debilitating side effects (AGA 2003).   
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CHAPTER 2: METHODOLOGICAL APPROACH
In-depth interviewing is the most appropriate methodology in terms of my 
research questions, similar to much of the research on illness experience (Morse 2001).
Methodologically, in-depth interviewing allows for the uncovering of taken for granted 
assumptions that are not easily voiced by individuals (Johnson 2002).   In addition, 
allowing persons with HCV to express their “narratives,” helps alleviate the tension 
between agency and structure as people give narratives to make sense of their place in 
society (Popay et al. 1998).  This methodology allows for a deeper, rich assessment of the 
multiple perspectives and experiences of the diverse group of individuals with HCV.
This chapter addresses issues pertaining to qualitative research including 
experiences and challenges with recruitment and the interview experience itself. I 
describe the sample which consists of white and racial and ethnic minority men and 
women of varying social economic backgrounds, allowing for comparisons across class, 
gender and racial lines. My approach to data analysis includes my use of undergraduate 
research assistants and ATLAS.ti. I address reflexivity regarding my interactions with 
healthcare providers and respondents.  Reflexivity is also outlined with regards to the 
process of data analysis and ethical issues inherent in this type of research.  Finally, I 
describe the limitations of the study.
ENTRY AND EXPERIENCES IN RECRUITMENT SITES
The data collection took place in Baton Rouge, Louisiana and surrounding areas 
during the summer of 2004.  Baton Rouge is a city with nearly a quarter of a million 
inhabitants and has slightly more African-American (50.02%) than White citizens 
(45.7%) (U.S. Census Bureau 2000).   This location allowed for a diverse research 
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sample.  The over-representation of African-Americans is important as this group is 
disproportionately affected by chronic HCV infection (Alter et al. 1998).  I chose Baton 
Rouge because of my familiarity with it and personal contacts there. 
I worked with Dr. Cassidy, an Associate Professor of Medicine at Louisiana State 
University because of the diversity of his patients.  Dr. Cassidy has clinics at a local
charity hospital affiliated with Louisiana State University that served as one recruitment 
site.  The majority of Dr. Cassidy’s patients utilizing the public clinic are poor or working 
class.  As a comparison group, recruitment also came from Dr. Cassidy’s private practice. 
This allowed for a more relatively privileged group of individuals (these persons can 
either afford private health care and/or have health coverage) to be included in the sample 
as well. 
PRIVATE PRACTICE
The private practice ran efficiently and smoothly.  Each Thursday when patients 
were seen, the nurses asked if they were interested in the study and gave them a Study 
Information Sheet. The Study Information Sheets introduced the study, detailed the 
benefits and risks of participation in the research, described confidentiality, and provided
my contact information.6 Willing patients filled out a Consent Form Sheet with their 
name and phone number on which the nurse wrote their race/ethnicity and gender to help 
me with my sampling.7 I generally called people either the same day they had seen Dr. 
Cassidy or the next day so that it would be fresh in their mind although many forgot they 
had filled out the form and for some, it took a good bit of explaining who I was before 
they remembered.   
6
 See Methodological Appendix on page 205. 
7
 See Methodological Appendix on page 205. 
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PUBLIC CLINIC
The atmosphere at the public clinic was much more chaotic than the private 
practice.  While the nurses at the private clinic recruited for me, my presence and active 
recruiting was very necessary at the public clinic.  This clinic was very rushed and over 
100 patients were seen in a number of hours.  The residents vied for Dr. Cassidy’s 
attention because they had to go over the charts with him before a patient was released.  I 
introduced myself to the residents on my first day and tried to briefly explain to them my 
research.  There were different residents in rotation there and I shortened my request over 
time to just asking them if their patient(s) had HCV or not as most were uninterested in 
my research.  I quickly learned that the residents were overworked and mostly 
unconcerned with helping me recruit for my research.  I had to be pro-active in asking 
them constantly if they were seeing someone with HCV as they never volunteered the 
information. Once I had established that the patient had HCV, I entered the exam room, 
gave patients a Study Information Sheet, and asked if they were interested in 
participating.  People then completed the Consent Form Sheet providing their name and 
contact information. 
My time spent at the public clinic was invaluable for gaining some appreciation of 
what it was like to receive healthcare there.  Warr (2004) discusses the insight researchers 
can gain from situating research in the lived environments of participants (Warr 2004).  I 
was able to see rushed nature of the encounters at the public clinic and how there was 
little continuity in care for the patients as they often had a new resident hurriedly reading 
their chart.   For example, one respondent, Rick, commented, “Matter fact every time I go 
to that Hepatitis clinic I got to see a different intern every month.  You know, they don't 
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really do anything about my case except for the few minutes they look at the file.” From 
my experience at the clinic, I could better understand how he felt this way.  
 I also was privy to backstage behavior by staff that helped me appreciate how 
some of the staff conceptualized at least some of the patients (Goffman 1959) .  One 
nurse discussed with me a “non-compliant” patient who was a young, Black woman.  The 
nurse felt she was not honest because she had sought out another doctor to help with her 
lack of appetite.  The nurse stressed that she had told this woman that lack of appetite 
could be a consequence of the treatment and was aggravated that the woman saw another 
physician as he prescribed steroids that were contra-indicated with HCV treatment.  The 
patient claimed to have only taken one or two pills but the nurse did not believe her.  The 
nurse was angry that a patient taking such expensive treatment would possibly ruin it 
through her non-compliance. 
 I met this patient when trying to solicit her to participate in the study.  Upon 
entering the exam room and introducing myself, she asked me if having HCV meant she 
would get AIDS, too. She said people had told her that and that she never felt sick and 
didn’t really understand what Hepatitis C even was.  Although my research does not 
specifically address doctor and patient interactions, it is clear that the way health care 
staff conceptualizes patients affects their interactions.  While the nurse saw the young 
woman in this example as non-compliant, my brief experience with her reflected her lack 
of knowledge and fear rather than willful non-compliance.  This woman had such a lack 
of understanding of even having HCV that it is not surprising she was not more careful in 
terms of receiving health care from other physicians which might interfere with her HCV 
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treatment.  Thus, future research should perhaps focus more on doctor-patient 
interactions to help broaden our understanding of patient’s experience of HCV.   
OUTSIDE RECRUITMENT
Accessing persons with HCV who may or may not be under the care of a 
physician is important in attempting to sample a wide array of persons with HCV. Before 
arriving in Louisiana, I intended to recruit from Narcotics Anonymous meetings in Baton 
Rouge and a HCV organization in New Orleans.  I called the leader of the HCV 
organization once I was in Louisiana and learned that there was no longer a support 
group affiliated with the organization.  I found another support group in a suburb of New 
Orleans. 
I attended one meeting of the support group to solicit respondents and was 
welcomed by the group.  I provided Study Information Sheets to all attendants at the 
meeting.  There were fifteen people there besides me, all of whom were White, including 
a drug representative, a nursing student, two partners of people with HCV and the 
facilitator’s child. Numerous people mentioned how they got HCV and at least two said 
through IV drugs.  There were a few stories shared about stigmatizing experiences or 
diagnosis stories.  After everyone went around the table, the meeting became a free for all 
in terms of people just asking questions and receiving answers.  Numerous people 
mentioned the stage of fibrosis of their liver as well as their viral loads.  Viral loads have 
a dubious status as far as clinical meaning but seemed very salient to these persons.  The 
pharmaceutical representative answered a few questions from people and the facilitator 
spoke a great deal as well.  After the meeting, I gathered contact information from people 
for interviews.  
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In addition, I did interview several respondents that I found through my informal 
social networks.  None of these persons were formally under the care of a physician, thus 
I would not have found them through my formal recruitment sites.  Two of these persons 
were quite secretive about having HCV and their interviews were especially useful in 
understanding persons who do not readily disclose. 
CHALLENGES IN RECRUITMENT
I did experience some difficulties in the recruitment process.  Being introduced by 
the nurses at the private practice seemed to give more validity to my request and many 
people gladly gave me their names and numbers.  For example, I had six interviews 
scheduled the day after my first time spent at the private practice.  A drawback of these 
introductions may have been an association of me with the healthcare providers perhaps 
skewing the respondent’s perceptions of me and coloring our interactions as they may 
have thought I was reporting back to the providers.  I did re-introduce myself at each 
interview and emphasized that I was a sociologist from Indiana University and not 
affiliated with any health care provider in an effort to prevent misunderstandings. The 
initial experiences at the private clinic were a good segue into recruiting at the public 
clinic.     
I spent Tuesday mornings at the public clinic recruiting respondents8.  I learned to 
blend in to the busy environment and stay out of the nurses’ way.  I brought cookies and 
donuts on different occasions to remind staff that I was there and needed their assistance.  
8
 On a number of occasions I walked into an exam room only to find out that the patient was incarcerated 
and in an orange jumpsuit with a guard.  I did not have IRB approval to interview individuals who were 
incarcerated.  I learned to ask nurses and residents if the patient was an inmate before entering the room. 
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As a whole, patients at the public clinic tended to be more skeptical than those at the 
private clinic although some at the public clinic were almost the opposite in terms of 
obsequiousness I think because they thought I was a doctor or associated with their health 
care.  I received many names and numbers through the public clinic but had more trouble 
scheduling interviews with this population than the private clinic.  I mentioned this to Dr. 
Cassidy who pushed me to interview respondents while they were at the clinic.  I tried 
this as will be described in detail later, but did not feel this was a good environment for 
the interview.  Instead, I tried to schedule interviews while collecting names and numbers 
and then I just called to remind people of the interview.  This method did work somewhat 
better although many people just wanted me to call to set it up rather than commit then.  
Regarding Narcotics Anonymous, I had planned to arrive at Narcotics 
Anonymous meeting locations before the meeting time and ask the chairperson if I may 
leave Study Information Sheets on display.  I would not attend the meetings and 
interested persons would have to contact me.  My goal was to recruit at least ten people 
outside of the health care system and I was fairly successful with recruiting through the 
support group.  I thus dropped Narcotics Anonymous meetings as a recruitment site.  
Although I might have gotten a different perspective from persons there who were unlike 
those who went to a support group for HCV, I was doubtful that this method of 
recruitment would prove fruitful.
RESEARCH PARTICIPANTS 
This research focuses on male and female adults eighteen and over who have 
HCV.  Persons under 18 are currently not eligible for combination therapy treatment for 
HCV, according to the National Digestive Diseases Information Clearinghouse 
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(http://digestive.niddk.nih.gov/ddiseases/pubs/chronichepc/index.htm#E). Thus, the 
experiences of minors may be fundamentally different than adults, as they do not have 
the same options available.  I interviewed any eligible adult who may or may not have 
gone through treatment in the past as well as persons who were undergoing treatment.   
Many individuals are co-infected with HCV and HIV, however this group was not 
eligible, as their experiences with HCV will be affected by their HIV status.  This co-
morbidity is increasingly common and important. This research will complement the 
abundant discourse on HIV to better understand the plight of those with both HIV and 
HCV.  
Based on these methodological considerations, my goal was to interview 20 
respondents from the public clinic and 20 respondents from the private practice.  At both 
of these two locations, I hoped to interview five white women, five minority women, five 
white men, and five minority men. This design allows for clear comparisons across race, 
class, and gender. I also anticipated interviewing 10 respondents from outside the health 
care system within which I was recruiting.  
Because I had the three different recruitment sites, I obtained a fairly diverse 
group of respondents as can be seen in the Research Participants Demographics Table.9
My sample is reflective of the sampling goals.  The research participants are 53 men and 
women ranging from age 22 to 70 with a mean age of 48.  Thirty-four persons were 
White.  Sixteen respondents were African-American and 3 respondents were Asian one 
of whom was Middle Eastern.10  Years of education among the respondents ranged from 
5 to 20 years with a mean of 12.5 years.  The average household income was $32,000 a 
9
 See Appendix 2 on page 63. 
10
 At times, I refer to the minority respondents as “Black” because Blacks comprise the bulk of this group. 
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year.11  Respondents from the private practice had the highest average household income 
of $42,000 a year.  The ten persons recruited who were not under the care of Dr. Cassidy 
had an average household income of $36,000 a year. The persons recruited through the 
public clinic had the lowest average household income of $21,000 a year.    
Qualitative research often determines sample size through theoretical saturation.  
Theoretical saturation refers to the point during data collection (and analysis) when there 
are no new themes in the data in regards to the emergent categories seen through data 
analysis (Strauss and Corbin 1998).  After forty or so interviews, I originally thought I 
had a good sense of the recurrent themes in the data.  However, I was surprised when 
new themes emerged fairly late in the data collection process concerning conceptions of 
HCV and HIV.  After being able to explore this new thread, I felt that I had reached 
theoretical saturation as I was not collecting any surprising data from subsequent 
interviews.   
IN-DEPTH INTERVIEWS
While the interviews were flexible or semi -structured, I did use an Interview 
Guide based on my research questions.12  Johnson (2001) notes that researchers should 
have a protocol of questions as a starting point for the in-depth interview.  I wanted to 
know how people conceptualized HCV, whom they told about having it, and reactions to 
their disclosures.  The interviews followed the same general pattern using the Interview 
Guide but I did not adhere to a strict ordering of questions and instead let the interview 
flow more naturally.   I started the interviews with asking respondents where they were 
from and about their families of origin following a chronological order to bring the 
11I estimated the mean based on income categories from the Background Information Sheet. 
12
 See Methodological Appendix on page 205. 
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conversation up to present time.  Next, we turned to discussing social relationships with 
family and friends.  People often offered additional information especially about their 
children or grandchildren although some lamented their estrangement from their families. 
Beginning with these questions allowed the respondent a chance to feel more comfortable 
with me and for us to develop some rapport. 
The next part of the interview focused on respondents’ lives before they were 
diagnosed.  I asked about knowledge of HCV including whether the respondent knew 
anyone with HCV, what they had heard about it, how they thought people got it and what 
they thought about HCV or people with HCV.  These questions are important in terms of 
how modified labeling theory applies to persons with HCV as discussed in Chapter 1.  
We then discussed the diagnostic experience.  Often respondents talked freely and 
essentially told the story of their diagnosis with little prodding on my part.  I gathered
detailed information about how the health care provider informed them about having 
HCV and what they were told about HCV including information about treatment, 
transmission and effects on the body.  I asked about the respondent’s emotional reaction 
to the diagnosis.  Some respondents described in detail the aftermath of diagnosis while 
others had very little to report about their experience.  
Many persons addressed disclosure practices at this point of the interview.  I 
usually asked if they had not already mentioned who they told immediately, why they 
told that person and what they revealed.  People often went on to talk about other 
disclosures and reactions to disclosures.  I asked them who they currently told and if they 
could describe a recent disclosure experience to me so that I could understand what 
information they were revealing and why.  I made sure to ask if any reactions to 
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disclosure have made them uncomfortable and why.  At this point, people often revealed
stigmatizing experiences if they had had any.  I asked how these experiences affected 
them and if they felt different about themselves or about having HCV after these 
experiences.  
Following a discussion of any uncomfortable reactions, I asked about support 
received from people they had disclosed to or if they had not received support, what they 
would have liked to happen.  Although I asked if anyone has been unhelpful or not 
supportive, this question did not elicit the data I was looking for.  Respondents often 
described a stigmatizing experience they had all ready told me about.  I was interested in 
ascertaining what respondents wanted in terms of support but did not tap into this well.  
Respondents also spoke about any experiences with support groups or why they would 
not go to one. 
Next, respondents talked about their current health status including the presence 
of any symptoms, if any.  I asked how symptoms have impacted their lives and how they 
explained them to other people.  We often discussed various testing that persons have 
undergone and continued to undergo as well as experiences with a liver biopsy.  If the 
person had done treatment or was currently on treatment, they usually spoke extensively
in regards to how bad it was or how well they had fared with it.  Respondents also 
discussed any effects that treatment had on their family lives or work environments and 
reactions from persons to their experiences.  If the person was thinking about trying 
treatment, they often expressed trepidation.  Several respondents described and justified 
why they were not going to take treatment.  
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I then addressed the meanings they associate with HCV as well as basic 
knowledge of the disease. Some respondents discussed what they would like to know 
about HCV. I asked if having HCV had impacted how they thought of themselves and 
how they made sense of having this illness.  People talked about how meanings 
fluctuated over time because of interactions with others or because of new information 
gained.  Finally, respondents spoke of the overall consequences of having HCV such as 
impact on physical health, emotional stability, relationships, work opportunities, and 
lifestyle changes.  
THE INTERVIEW EXPERIENCE
I completed three pilot interviews in the spring of 2004 in Indiana to refine my 
interview guide.  These three interviews are included in the final sample.  As others have 
found, these initial interviews were useful learning tools (Johnson 2002).  I knew two of 
the respondents and thus opportunistically included them in the research.  My first pilot 
interview was with a friend who has HCV.  A benefit to this dynamic was he was able to 
offer some feedback after the interview about the process.  I was stiff during this 
interview and did not allow for the natural flow of conversation to develop because I was 
so concerned with following my guide to ensure I asked all my questions.  My second 
pilot interview was also with an acquaintance.  This interview went more smoothly than 
the first.  Again, he offered some advice afterwards about questions I might ask 
respondents.  Both of these experiences did help prepare me for my third pilot interview 
that was with a stranger.  By this time, I was more comfortable with the Interview Guide 
and more familiar with the questions I wanted to ask.  While there may have been 
disadvantages to interviewing persons I knew first, it was also useful in that my 
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awkwardness was more easily forgiven perhaps.  My interviewing style evolved through 
the data collection process.  The first few interviews in Louisiana were similar to the pilot 
interviews in that I heavily relied on the Interview Guide.  However, by the time I 
finished data collection, I no longer needed to look at the Guide during interviews as I 
was so familiar with the line of questioning.      
I started all the interviews in the same fashion.  I re-introduced myself or 
introduced myself to the few respondents I had not yet actually met.  I told them I was 
affiliated with Indiana University in order to distance myself from any local source and 
explained that I was interested in hearing about their experience having HCV.  Although 
each respondent had all ready been given a Study Information Sheet, I gave them a nearly 
identical informed consent statement that they had to sign and date for me.  While the 
respondent read the statement, I prepared the digital recorder.
The majority of the interviews felt like conversations and most respondents spoke 
fairly freely and naturally.  Of course, I guided the conversation more so than in a natural 
conversation (Johnson 2002).  Depending on the location, some respondents answered 
phones, changed channels on the television, drank beverages, ate food, smoked cigarettes, 
took bathroom breaks, etc. during the interview.  At respondents’ homes, most treated me 
like a guest and kept offering me drinks.  At the end of the interview, respondents filled 
out a Background Information Sheet.13  I assisted two respondents in this endeavor.  One 
respondent asked me how to spell “minute” and “Baptist” and misspelled “nurse” and 
“retired” on the form and another respondent had poor eyesight and asked me to read and 
fill out the form for him, which I did.  I had not anticipated having respondents who 
could not read and should have planned for this.  
13
 See Methodological Appendix on page 205. 
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The interviews ended in similar fashion with quite a few respondents wanting to 
chat.  I offered the Hepatitis C Support and Information Sheet to some  respondents
because they had expressed interest in support groups or requested information about 
HCV from me.14  Several respondents expressed gratitude and kept telling me how much 
they enjoyed talking to me.  Meredith, a hairstylist twice mentioned she wanted to do my 
hair for free so she could, “do something for me.”  Andrew insisted on buying me a coke 
at the gas station near the library after the interview and Tom also insisted on paying for 
my coffee at Shoney’s.  Others repeatedly thanked me because it felt good for them to 
talk about their experiences and/or because they were happy I was researching an issue 
that they felt needed attention.   These responses to the interview experience indicate that 
many respondents did reveal confidential information about themselves and that the data 
reflect their sincerity.  Catherine told me as I was leaving that she felt like she really 
knew me.  I barely spoke during our interview but Catherine revealed a great deal to me 
and she obviously felt close to me afterwards because of her revelations.  Catherine along 
with many other respondents, usually female, impulsively hugged me when I was 
leaving.  I did not, however, establish the same level of rapport with all respondents and 
some persons maintained more of a distance.  
LOCATION OF INTERVIEW
Interviews were done at a location chosen by the respondent.  I conducted over 
half of the interviews in respondents’ homes.  At times I had trepidation about going to 
some respondents’ homes because they lived in crime-ridden neighborhoods.  I never felt 
unsafe, however, upon arriving at anyone’s home.  At least a few potential respondents 
expressed that they did not want me to see their homes presumably because they were 
14
 See Methodological Appendix on page 205. 
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poor, when trying to schedule interviews.  Interviews conducted in respondents’ homes 
were probably the best environment as the respondents felt comfortable, safe, and did not 
worry about privacy.  They did not try to hurry through the interview and spoke in a 
regular tone.  The recordings were also better without background noise although several 
respondents did have the television on during interviews which affected the quality of the 
recording.  Two respondents who lived in rural areas that I was unfamiliar with met me at 
gas stations off the interstate or highway to allow me to follow them to their homes.
 I interviewed the other respondents at libraries, restaurants, coffee shops, and a 
few other public venues.  I was concerned that an interview in a library would be 
disruptive but most went smoothly and we quietly chatted in a secluded nook of the 
library.  One respondent, however, spoke very loud and we were chastised by a librarian 
much to my embarrassment.  Most of these interviews went very well.  For example, I 
met Tom at a Shoney’s.  He was sitting in the smoking section and was a bit reserved at 
first as we had never met.  He quickly warmed up to me and spoke freely in a fairly quiet 
tone. I did feel that a woman in the next booth might have been eavesdropping at one 
point but Tom did not seem to notice. I recruited Meredith through the public clinic and 
met her at a local coffee shop. She was forthcoming during the interview.  I interviewed 
another woman, Melissa, at a coffee shop. She, too, was quite open and spoke at length 
about her experiences.  A drawback of interviews conducted in public was that there was 
a good bit of background noise on the recording making transcription more difficult. 
Other public venue interviews were perhaps less than ideal.  I met Roxanne at a 
McDonalds while she was on her lunch break.  She was fairly clipped in her answers and 
seemed to be watching the time closely so she could get back to work on time.  It was 
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also very loud and crowded at that time.  The interview I did at an off-track betting 
facility was the worst interview experience in terms of data collected.  The respondent, 
Eric, was watching the television screens of different race tracks the entire interview 
which was incredibly short, lasting less than four minutes!  Although this was obviously 
not an ideal location, I am not sure I would have gotten any better information in another 
location as Eric was in denial about having HCV.  
Finally, I conducted three interviews at the public clinic.  I experienced some
difficulty recruiting through the public clinic.   Despite receiving many names and 
contact information while at the clinic, I had difficulty actually scheduling interviews and
had many cancellations and no-shows.  Dr. Cassidy encouraged me to interview patients 
while at the clinic.  I was hesitant to hold interviews at the clinic as I knew there would 
be issues with privacy and constant interruptions.  I, nevertheless, interviewed Ellis, a 
middle aged Black man. We started the interview in the exam room and then moved to 
the nurses’ office as they were at a meeting.  Ellis rushed through his answers as he 
mentioned several times that he wanted to “get this over with.”  In addition, the nurses 
came back from their meeting during the interview which was uncomfortable although 
we did stay and finish.  The other interviews there fared better although the public clinic 
was not, however, an optimal environment for conducting interviews.
APPROACH TO DATA ANALYSIS
After returning home after interviews, I downloaded the interview onto the 
computer and immediately assigned the respondent a pseudonym.  No identifying marks 
were kept on the discs or tapes linking the data to a particular respondent.  The consent
form with the respondent’s name and number was shredded after each interview.  All of 
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the informed consent forms were kept separate from any other data.  I wrote field notes 
about the interview within 24 hours or less in order to remember details.  These notes 
often described the location of the interview, the body posture and dress of the 
respondent, and/or other details either not actually recorded or non-verbal data.  The field 
notes have been useful while analyzing data in order to remember specifics about the 
interview process and interactions with respondents.
WORKING WITH UNDERGRADUATE RESEARCH ASSISTANTS
In order to facilitate the speedy transcription of the interviews, I worked with six 
undergraduate research assistants.  I had students sign a document outlining the 
responsibilities associated with the position.15  Each assistant had to pass the Institutional 
Review Board’s “Protection of Human Research Participants Certification Test” so that 
they understand rules regarding confidentiality when working with human subjects.  The 
research assistants transcribed all verbal utterances in the interviews, although I do not 
include all utterances in this document for sake of presentation. After transcribing an 
interview, each assistant filled out an Interview Outline Form.16 This form helped to
manage the data by noting the socio-demographics of the respondent and then outlining
an initial, brief overview of the respondents’ illness concepts, patterns of disclosure, 
levels of social support, and experiences with stigmatization.
We met every other week to discuss these initial analyses and responses to the 
data.  Each transcription was read and checked by another assistant to ensure high 
accuracy.  I also reviewed all transcripts for accuracy as there were some initial problems 
with the assistants misunderstanding some of the respondents due to dialectical 
15
 See Methodological Appendix on page 205. 
16
 See Methodological Appendix on page 205. 
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differences in speech. While the assistants’ work of transcribing was invaluable, the 
meetings discussing the data were also very useful for me because this first stage of 
analysis prevented me from starting to code prematurely without a grasp of the data.
USING ATLAS.TI
After this first stage of analysis, the transcribed interviews were entered into 
ATLAS.ti. (Scientific Software Development 1997.)  ATLAS.ti is a qualitative data 
analysis software package that allows the user to organize data and discern themes in the 
data.  This second stage of analysis of the data involved initial coding of the data
(Charmaz 2002)17.  My approach falls between what some see as a technical approach 
versus an emergent intuitive approach in that I approached the data with regards to my 
research questions in mind in terms of initial coding so as to not get overwhelmed by the 
data (Marshall and Rossman 1999). For example, I started labeling data in terms of
broad categories, such as disclosure.  I later, further refined the category of disclosure 
into typologies, such as disclosure at work, disclosure to family, and disclosure to friends
(Lofland and Lofland 1995).  Thus, I read all the transcripts with attention to disc losure 
practices yet also noted other themes that emerged.  I repeated this entire process 
numerous times with attention to different research questions.  This repeated process 
helped me become very familiar with the data and allowed me to see emergent patterns in 
the data.  I often re-read the field notes I had written when looking at a transcript to help 
remember details that I might not remember from the transcript alone.  Reviewing the 
field notes helped the analysis in that I could think of the person and their experience 
holistically.  I continuously revised, collapsed, and expanded codes as I went through the 
data.  I did not separate the transcripts by race, class, or gender in the coding process but 
17
 I performed all of the coding. The research assistants did not participate at this stage of analysis. 
49
looked at the sample as a whole.  I sorted data by codes to allow for patterns to emerge 
rather than forcing any clusters by demographics, for example, on the data. 
After I coded the data, I then began to explore how race, class, and gender did or 
did not affect experiences with HCV. While these data are qualitative and most 
appropriately analyzed with that methodology in mind, I did perform some quantitative 
comparisons.  While there are limited approaches to quantitatively assessing this type of 
data, the results do strengthen the arguments set forth from the qualitative analysis. 
Many interesting themes emerged from the data and I chose to write about the 
patterns that seemed most salient to respondents as well as relevant to existing discourse 
on chronic illness.  In the writing process, I used ATLAS.ti’s sorting tools to find relevant 
chunks of text associated with certain codes to support my assertions.  I intersperse many 
comments from respondents through out this document as in depth interviewing provides 
rich and thick description.  My analyses were further developed through conversations 
with research assistants as well as colleagues.  I presented a chapter at a regional 
conference as well as a departmental colloquium.  Thus, my analyses benefited from 
others’ feedback.  My reading of the data while grounded in sociological literature is also 
a product of my own history and identities and must be situated as such. 
REFLEXIVITY: RESEACHER’S PLACE IN THE RESEARCH
Many researchers have documented the importance of acknowledging the 
researcher’s own place in the research (Ellis and Berger 2001).  It is important to note 
how my own characteristics and beliefs shaped this research.  Who I am as a person 
affected my entry into the field, interactions with Dr. Cassidy and the nurses, the 
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interactions with respondents, the data I collected, and the subsequent analysis of the 
data.  I also address my own emotional reactions to the research. 
At the time of data collection, I was 28 years old.  I am a Hispanic woman of 
average height and weight.  I grew up in an upper middle class family in Louisiana but do 
not have much of a Southern accent and speak fairly articulately often unwittingly 
signaling my social class status to others.  I am fairly charismatic and chatty and can 
easily spark up conversation with most anyone which definitely helped in the research 
process.  I have an extensive amount of tattoos that I covered not always successfully.  I 
chose to wear long sleeved shirts and pants or skirts despite the extreme heat and 
humidity because of social stereotypes and prejudices concerning tattoos.  I did not want 
potential respondents to be distracted or not participate because of my appearance.  I 
dressed slightly more conservatively than usual in rather plain, business casual style 
clothing.  Most importantly, I have HCV as a result of intravenous drug use although, of 
course, this was not obvious by my appearance.  Although my upbringing kept me mostly 
surrounded by middle class whites, my past drug usage facilitated interaction with people 
of varying socio-economic statuses and racial identities.  These interactions helped in 
relating to people very different in some ways than me during data collection.  Regarding
my HCV, I have undergone a liver biopsy but not treatment, which limits my ability to 
fully understand experientially what some of my respondents have undergone.  
Nevertheless, my own experiences with HCV have undoubtedly shaped this research as 
will be discussed.        
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INTERACTIONS WITH MEDICAL STAFF
My introduction to Dr. Cassidy was a result of his professional relationship with 
my father who is also a physician.  I first met Dr. Cassidy and one of his nurses in 1995 
when I was diagnosed with HCV.  All of Dr. Cassidy’s nurses at the private practice 
knew I had HCV, while this was not common knowledge at the public clinic.  From what 
I could tell, the nurses at the private clinic did not necessarily have stereotypes about 
persons with HCV perhaps because they saw so many different types of people with it.  
The other explanation is that they did not reveal any prejudices in front of me because I 
also have it although this did not seem to be the case.  I did witness some derogation of 
persons with HCV at the public clinic by some of the residents based on comments they 
made but these seemed to pertain more to people who continued to drink alcohol and/or 
use illicit substances once infected with HCV.         
My own experiences being a patient of Dr. Cassidy’s may have allowed me to 
relate better to my respondents than someone who had not had this experience.  However, 
I was always seen privately and “under the table” so to speak as a courtesy to my father.  
Thus my experience is in some ways different from the people I interviewed because I 
was given special treatment by Dr. Cassidy and his staff.
Another result of my privileged position was the ability to even conduct this 
research with the ease that I did.  Conducting social scientific research in the medical 
field is not always easy and many researchers have difficulty gaining access (Morse 
2001).  I did not have any difficulty for the most part.  I was treated perhaps better than a 
researcher with no affiliations might have been.  I was constantly being referred to at the 
public clinic as “Dr. Suarez’ daughter”.  This recognition seemed to influence how 
52
people interacted with me in that they seemed more willing to help me with my research
once they knew who I was.  This “name-dropping” was quite effective with the residents 
at the public clinic as well since they all knew my father.  When I thanked Dr. Cassidy at 
the end of the data collection process, he shrugged it off saying that it was a way for him 
to repay my father for his kindness when Dr. Cassidy first began teaching there. Thus, my 
social capital definitively helped my entry and status in the field.
INTERACTIONS WITH RESPONDENTS
I relied on various aspects of my multiple identities when interacting with 
respondents.  While I never pretended to be someone I was not, I emphasized different 
aspects of my identities with various respondents to establish rapport.  This tactic is used
not only by ethnographers but by all persons in daily interactions with others as has been 
addressed by symbolic interactionists (Harrington 2003).  For example, sometimes I tried 
to downplay my upper middle class status or my education while other times I drew on 
these identities to form connections with respondents.  I related to respondents as a 
woman, pet owner, food lover, Southerner, Midwesterner, minority, tattooed person, ex-
drug user and someone with HCV.  I had the most internal conflict regarding my 
identities as an ex drug user and person with HCV.   
My gender did affect my interactions with respondents. In some ways, being a 
young woman helped with recruiting as I was perhaps seen as non-threatening.  Based on 
several comments from male respondents about my physical appearance, it seems that 
several male respondents agreed to be interviewed because I was a young and in their 
view, attractive woman.  For example, when I asked Jerry if he was pretty happy most of 
the time, he replied, “When I see beautiful people like you.”  At the end of another 
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interview, a respondent, David, asked where all I was tattooed and told me how beautiful 
I was.  I became uncomfortable and began to get ready to leave.  He asked for a hug to 
show that I didn’t think he had leprosy (a fear he had expressed during the interview).  I 
hugged him and he tried to kiss me.  I quickly left and was quite upset.  I did learn to 
keep up my guard especially with male interviewees as another male respondent asked 
me out to dinner.  
Schwalbe and Wolkomir (2001) suggest that inappropriate sexualizing by 
heterosexual men being interviewed by women is a way to reassert control (Schwalbe 
and Wolkomir 2001).  They comment how some remarks might seem innocuous such as 
when Little Brother remarked on how pretty my hair was (Schwalbe and Wolkomir 
2001).  Other situations may be indicative of a man trying to disempower the female 
interviewer and de-legitimize her role.  While David’s attempt to kiss me was at the end 
of our interview, he may have been trying to assert his power to counteract the potentially 
discrediting information he had told me during the interview.  Men may have seen the 
nature of the interview as more threatening than women because to be ill is often 
frightening and thus may question a sense of fearlessness and invincibility associated 
with masculinity.  Sparky addressed this fear outright when he started crying for the third 
time during the interview and said, “I’m a big cry baby. Ever seen a fifty-one year old cry 
baby?”  I told him that men expressing their emotions was a good thing and he responded 
with, “I tell people if you don’t cry you ain’t human.”  Sparky’s outright emotional 
reaction was rare among the men I interviewed but more common among the women. 
Eliciting emotional stories from my female respondents may have been easier 
because of culturally sanctioned norms regarding gender and the expression of emotions.
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Women might have felt more comfortable talking to me than they would have a male 
researcher.  My interviews with women were longer on average than men lasting 64 
minutes compared to 52 for men with the overall average interview lasting 57 minutes.  
However, I cannot discuss the issue of gender as if all female experiences are the same 
(Reinharz and Chase 2001).  The meshing of race and gender also affected the interviews. 
My racial identity is tricky with regards to interactions with respondents.  While 
technically I identify myself as Latina/Hispanic, culturally many regard me as White,
especially in Louisiana.  Race affected the interactions between respondents and me as 
can be seen by the length of the interviews. The average length of the interview for my 
minority respondents was 37 minutes while the average length for White respondents was 
63 minutes.  In addition, there were gender differences with regards to average length of 
interviews for minority men (29) compared to White men (65) and minority women (46) 
compared to White women (76).
Thus, my shortest interviews were with minority men.  Perhaps these men felt the 
least comfortable with me because of our disparate identities.  Ellis, a 49 year old Black 
man, constantly called me “ma’am” during the interview thus indicating the distance he 
felt from me.  Short responses from interviewees may be a result of the questions
seeming too simple, rhetorical, or culturally insensitive (Dunbar et al. 2001).  I may have 
asked questions in a manner that was inconsistent with the cultural understandings of my 
minority respondents, especially the men.  Likewise, the women of color may have not 
seen me as another woman of color but as a White woman and felt more distance from 
me than the White women in the study.  Thus, the stories I elicited from my White 
respondents may be richer in detail as these interviews were generally longer.  Another 
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explanation for the racial differences could be the different knowledge of illness as a 
whole by minorities as will be discussed in Chapter 5.
Finally, part of the differences in length of the interviews may be educational 
obtainments as respondents with some college had an average interview length of 63 
minutes compared to 52 minutes for respondents with a high school education or less.
My own educational background may have been seen as intimidating for some 
respondents as David remarked upon finding out I was working on a PhD that he thought 
I was a “common person” like him. Thus, respondents with more education may have 
been either more comfortable with me or more comfortable with the whole concept of 
being interviewed because of their appreciation of our interview society (Gubrium and 
Holstein 2001). 
My identity as a person with HCV affected my interactions with respondents.  
When I first was planning this research, I thought my insider status would be extremely 
important in establishing rapport with respondents (Adler and Adler 2001; Ellis and 
Berger 2001).   As I began to refine my research plan, I began to question how disclosing 
my own HCV status would affect my research.  Ironically, considering my research 
questions, I was afraid of respondents asking me how I got HCV.  I asked respondents 
how they got HCV and if they knew I had HCV, they might have felt entitled to ask me 
the same question.  If my sample would have been limited to persons who were infected 
through drug use only, I might have disclosed to them.  I was, however, concerned that 
respondents who were infected through other means would judge me and more 
importantly affect the information they gave me in the interview because my credibility 
might have been questioned.  The more I thought about this issue, I came to believe that 
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by appearing to be a “normal”, I would actually collect more detailed data (Goffman 
1959).  By presenting myself as wanting to learn about their experiences, respondents 
explained things on a level as if they were teaching someone who knew nothing about 
having HCV.  If they knew I had HCV, they might assume shared experiences or 
understandings between us and not explain their perspectives.  Reinharz and Chase 
(2001) address that there is little literature about the effects of self-disclosure on the 
interview and that disclosure may lead the respondents to feel constrained (Reinharz and 
Chase 2001).18
I did struggle with my decision to not disclose to respondents.  Following feminist 
models of research was important to me and I did not want to encourage an unequal  one 
way exchange (Reinharz and Chase 2001).  For the most part, I realized that I was 
providing something to respondents-a listening ear that many greatly appreciated as 
discussed earlier.  I decided that if anyone flat out asked if I had HCV I would not lie. 
Ronald is the only respondent who asked me this question and it was at the end of his 
interview. I told him yes and that I was willing to have coffee with him at another time to 
discuss my experiences as he was interested.  This did not end up happening because of 
scheduling issues. 
I did reveal my potentially discrediting identities to four other respondents besides 
Ronald.  I interviewed a woman from the support group, Samantha and disclosed my 
status to her after the interview.  Samantha was a young woman with a history of drug 
use and I related to her so much I felt compelled to share my experience.  I was almost 
apologetic in that I hadn’t told her initially and said I hoped she didn’t feel tricked. I 
18
 It is interesting to note that my interview with Eric who knew I had HCV before our interview lasted a 
brief four minutes and thus our shared identity alone did little to facilitate rapport.   
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explained why I was not telling respondents because I thought it would affect the 
dynamics of the interview and I feared judgment.  She said she understood and 
appreciated me telling her and that my experience was inspiring to her.  She did however 
relay how another woman from the support group mentioned how cool she thought it was 
that someone who did not have HCV was studying it. I definitely felt dishonest and 
uncomfortable hearing that.  I asked her to not tell anyone from the support group as I 
was interviewing some of them and didn’t want them to have that information before our 
interviews.
I also revealed my status to Meredith.  Meredith was an astute woman in her 
forties with a history of drug addiction. Meredith was unfazed by my revelation after the 
interview and was just excited about the research.  Finally, I also disclosed my past 
history with drugs to Jeff and Karla. Karla asked during the interview if I had ever “been 
on drugs” and I told her yes and briefly explained my battle with addiction.  My impetus 
to disclose then was first that I did not want to lie when someone asked me a direct 
question and also as a means to relate to the respondents who were in many ways quite 
different than me.  I did not reveal my HCV status as it was not directly relevant at that 
point in the interview.  I also used my tattoos to relate to Jeff and Karla as he was a 
tattooist.  
My choices to reveal my full history to Meredith and Samantha were motivated 
by my feeling a connection to these women because of our similarities.  However, 
looking back, my own disclosures might have been more useful for more disadvantaged 
women and men to hear about.  Meredith was confident and not afraid of revealing her 
status.  Samantha was more careful and fearful of revealing her status.  My disclosure 
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might have been more useful for persons who were very afraid of disclosing.  It might 
have helped them to feel more comfortable.  Ultimately, I made decisions regarding 
disclosure that felt right at the time.  If I were a man or older, it might not be as 
discrediting to reveal these identities.  However, being a woman and young, I made the 
right choices.  
REFLEXIVITY AND DATA ANALYSIS
Having HCV myself has been both advantageous and a liability in looking at the
data.  West (1990) discusses how researchers either get public or private accounts from 
respondents.  Public accounts refer to behavior or experiences that persons “ought” to 
have while private accounts are though to refer to actual experiences (West 1990).  West 
cautions that first interviews often lead to public accounts and that follow-up interviews 
often produce private accounts (West 1990).   My insider status of having HCV may help 
counteract some issues and serve as an informal means of triangulation that is 
recommended by West (1990) to check the validity of accounts.  Johnson (2001) notes 
that many researchers rely on lived experiences as a member or participant of what is 
being studied and that the subsequent data is often richer than if the researcher was 
inexperienced in the issues.  My own experiences, however, are just that, my experiences.  
I learned through the interview process that I brought biases about how I thought people 
should respond to their ilnesses.  Davis and colleagues (2004) note that people are 
expected to “think of their health as a self-made project and therefore monitor their 
bodies and behaviours, assess these for risk and apply the appropriate adjustments in 
lifestyle” (1809).  I realized that I brought some of this type of bias to my research in my 
own reactions to respondents.  It became important to me to recognize my own privileged 
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position with regards to information about the disease and ability to act autonomously 
regarding my health.  Acknowledging my biases helped me to analyze data as there are 
many different experiences with HCV. 
ETHICAL ISSUES 
Researching illness can be difficult for the researcher for a variety of reasons. 
I struggled with how to deal with a few of my respondents who seemed to really need 
help or be confused about their disease.  I had decided that during the interview I would 
not correct people when they spoke erroneously about the disease.  For example, several 
respondents told me they got HCV through drinking alcohol, which is impossible.  I was 
not going to correct them as they believe that is how they got it reflecting their lack of 
understanding about the disease.  Afterwards, if they asked, I would offer some 
information and always give them a Study Information Sheet so that they could seek out 
more information themselves.  However, I felt torn between being attempting to be the 
elusive impartial observer and wanting to intervene and help educate people.  
The most poignant case was my interview with Sherri.  Sherri cried during the 
interview and revealed other health problems that she thought were because of HCV.  
She mentioned blood in her bowels and urine as well as inability to hold her bowels
which really concerned me as this is not at all a symptom of HCV and seems indicative 
of other serious health problems.  In this interview, I felt I really broke out of my usual 
role and crossed the line in terms of advice giving.  She was going through a divorce, 
struggling financially, was obviously having serious health issues, had a history of 
depression, and had told virtually no one about her HCV.  She said she had some sort of 
test done about her stomach but had not been given the results.  I encouraged her to ask at 
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her next appointment about the results and to make to sure to mention her depression.  I 
also asked if she could talk to any of her friends and family about any of this. She said 
no. I told her about a hepatitis hotline that was toll free that she could call.  In addition to 
feeling totally helpless during this interview, Sherri seemed to think I was a doctor at first 
and kept asking me about treatment for HCV. I explained to her what treatment entailed 
and then she asked about her bleeding wanting me to explain that.  I was befuddled and 
said, “I don't know about that.  Cause I'm not a medical doctor.  I'm a social scientist.”  
To which she replied, “You don't know anything about the, um, the disease itself?”  I felt 
even more confused and responded with,
“I do.  I do know about it.   But not the same that a medical doctor would.  
Because what I’m studying is more how it affects people like in their mind and in 
their heart.  You know, um, not as much the physical aspects of it.  Does that 
make any sense?” 
Thus, as other qualitative rese archers have noted, despite my introduction with the 
informed consent, it was evidently not clear to Sherri who I was or what I was doing, 
further adding to my concern about the interview (Warren 2001).   While I handled the 
interview the best I knew how, I left feeling that I could have done more for her or that I 
had let her down in some way.  These feelings reflect a problem experienced by many 
researchers studying disadvantaged populations in that they are unable to change the 
dismal realities of many of the people they interact with.  
STUDY LIMITATIONS 
While this study will offer numerous contributions to existing discourse, there are 
also limitations.  This research is not representative of all persons with HCV in the 
United States, Louisiana, or Baton Rouge.  The majority of the respondents are patients 
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of Dr. Cassidy, which may affect their illness experience as the diagnostic experience 
does affect this process.  This similarity may limit the sample, but as the illness 
experience is so multi-layered, the effects are probably minimal.  Also, the same doctor 
will interact with different patients in various manners.  While I did recruit outside the 
healthcare system, my respondents are more representative of persons who are receiving 
healthcare for their illness.  Because of the racial and ethnic makeup of Baton Rouge, my 
sample is mostly limited to Whites and Blacks and as discussed earlier, my data may 
better represent a White experience with HCV.  My sample reflects respondents who 
agreed to be interviewed.  These persons may be different than those who decline to 
participate, especially as there was no monetary compensation or material incentive to 
participate.  
There are also limitations with recruitment.  While the introduction of the 
research by the nurses at the private practice may have been beneficial in gaining 
participants, on at least one occasion a nurse chose to not tell a patient about the study.  
She told me that I would not want to have talked to the patient because she thought he 
was difficult and disliked him.  She and the other nurses would often look at who was 
coming in for that day and make remarks about how a certain patient would be a good 
person for me to talk to.  I assured them that I wanted to talk to any of the patients and to 
please tell all of them regardless of their disposition.  A limitation of relying on the 
nurses may be that they used their discretion at times despite my urging otherwise.     
In terms of the data, I caught a snapshot by interviewing just once. Many of the 
concepts I am studying are processes that are constantly changing.  Multiple interviews 
are often desirable in terms of illness careers in order to assess some of the changes 
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(Conrad 1990).  While I agree with this approach idealistically, feasibility becomes more 
difficult especially when studying respondents in another state with no funding.  
Collecting sensitive data concerning possible illegal behavior also makes record keeping 
for follow up interviews a dicey issue with regards to confidentiality and protection of 
respondents. 
Thus, while the research has some limitations, it is also one of the first of its kind 
in addressing the experience of having the most common blood borne disease in the 
United States.  While the findings cannot be extrapolated to all persons with HCV, they 
do reflect the multiple ways that persons deal with having a relatively unknown disease.  
The respondents’ experiences are as varied as their backgrounds and the research allowed 
them to express their often silent sufferings as well as their empowering experiences with 
HCV.   
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APPENDIX 2
2.1 RESEARCH PARTICIPANTS DEMOGRAPHICS
 PRIVATE PRACTICE (N=22)
Minority Men Age Years of Education Household Income Range (in 
Thousands)
Jerry 51 10 $10-19
Stick 52 9 $30-39
Andrew 44 12 $10-19
Maruf 43 12 $30-39
Minority Women
Connie 70 15 $50-59
Don Yi 68 8 $20-29
Ann 51 13 $10-19
Tari 39 14 $60-69
Jamie 53 13 $20-29
White Men
Sparky 51 13 $40-49
Mark 35 12 $30-39
Donald 70 5 $60-69
Larry 53 16 $10-19
Charlie 53 18 $90+
Jason 22 14 $90+
David 48 14 $30-39
Tom 51 15 $50-59
White Women
Lucy 53 13 $60-69
Sharon 60 14 $0-9 
Lauren 59 13 $10-19
Melissa 49 16 $80-89
Roxanne 35 13 $30-39
AVERAGE 51 13 $42
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PUBLIC CLINIC (N=21)
Minority Men Age Years of Education Household Income Range (in 
Thousands)
Little Brother 42 12 Missing
Ellis 49 12 $50-59
Grant 51 10 $20-29
Matthew 53 12 $0-9 
Mack 52 13 $10-19
Minority Women
Catherine 41 11 $10-19
Sherri 46 12 $0-9 
Vanessa 41 13 $20-29
Emma 54 9 $10-19
White Men
Daniel 46 9 $60-69
Joey 50 12 $10-19
Nick 47 8 $0-9 
Rick 54 12 $0-9 
Jeff 40 6 $0-9 
Derrick 36 12 $20-29
White Women
Liz 53 12 $40-49
Cece 45 9 $10-19
Daisy 61 11 $10-19
Sally Anne 50 12 $20-29
Karla 37 11 $0-9 
Meredith 46 14 $20-29 
AVERAGE 47 11 $21
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OUTSIDE RECRUITMENT (N=10)
Minority Men Age Years of Education Household Income Range (in 
Thousands)
Eric 49 12 $20-29
White Men
Yellow 50 13 $10-19
Harold 47 16 $40-49
Ronald 54 18 $40-49
Bob 33 15 $10-19
Eddy 47 20 $40-49
White Women
Jenn 50 14 $50-59
Samantha 26 12 $0-9 
Isabella 41 16 $30-39
Peggy 53 13 $70-79
AVERAGE 45 15 $36
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CHAPTER 3: WHOM TO TELL AND WHY? LEVELS OF DISCLOSURE AND 
IMPLICATIONS
Disclosure of health status can have numerous benefits as well as possible costs 
for the individual.  Some research posits a link between disclosure of illness status and 
positive mental health outcomes (Figueiredo et al. 2004).  Conversely, through disclosing 
an individual may be stigmatized, and actually experience poorer mental health, strained 
relationships and possible loss of autonomy (Charmaz 1991; Comer et al. 2000).  
In this chapter, I discuss levels of disclosure, motivations for lack of disclosure 
and reasons for revealing health status.  I compare these findings to the extant literature to 
reveal some support for current discourse although much of the literature better explains 
culturally visible diseases.  Thus, this research can help broaden our understanding of 
disclosure patterns beyond well known diseases.  In addition, I show the influence of 
race, as well as other factors, on disclosure patterns and the ensuing implications.   
The respondents in this research varied a great deal in terms of how much they 
disclosed to others.  Their patterns of disclosure can be organized along four categories: 
persons who practice Activist Disclosure, respondents who exhibit Open Disclosure, 
persons who have Limited Disclosure, and finally, those who employ Reluctant 
Disclosure.  Disclosure is a dynamic process and persons may shift their disclosure 
patterns over time.  Respondents described a variety of reasons for not wanting to tell 
others about their HCV status. The main themes that emerged fall along two dimensions: 
not disclosing because of Concern for Others, and not disclosing because of Concern for 
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Self.  Interestingl y, reasons for disclosing also fall along the same dimensions in terms of 
Concern for Others versus Concern for Self. 
PATTERNS OF DISCLOSURE
ACTIVIST DISCLOSURE
Activist disclosure refers to a type of disclosure whereby a person often reveals 
their health status in a quasi-public environment, a technique Charmaz (1991) calls 
strategic announcing.  Such a strategy is often necessary when the illness is more 
invisible or minimized by others, thus applying to HCV.  Corrigan and Matthews (2003) 
discuss levels of disclosure in regard to mental illness.  They report a pattern of 
disclosure similar to activist disclosure called “broadcasting” where the goal is to educate 
others about mental illness (Corrigan and Matthews 2003).  Broadcasting “fosters their 
sense of power over the experience of mental illness and stigma” (Corrigan and 
Matthews 2003).  Activist disclosure does seem to be a coping mechanism for some 
respondents perhaps in response to experiences with enacted stigma as well as engaging 
in felt stigma.    
Five persons, or 10% of the sample, fall into this category.19  Bury (2000) points 
out how some current conceptualizations of the chronically ill as political activists are 
perhaps limited in nature and more readily apply to younger and middle class persons.  
Based on education and income, everyone in this category including Sharon could be 
seen as middle class, as Sharon used to earn over $70, 000 per year and her current 
income does not reflect her middle class status.  However, in discord with Bury (2000), 
Connie and Sharon, 70 and 60 years old respectively are not young, chronically ill 
individuals.  All five persons were involved in support groups, which may help explain 
19
 See Appendix 3.1 on page 103. 
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their desire to share information with others although it is unclear which came first.  
Corrigan and Matthews (2003) also found that support groups facilitate the coming out 
process for sexual minorities as well as individuals with mental illness.   
Several of the persons in this group described disclosing at work and all had 
openly disclosed to family and friends.  Sharon, who was recently retired from a business 
in the medical field, told all the people she worked with, including physicians, 
management, and patients as well as all her friends.  “I told everybody.  I am not a person 
who’s ever found it easy to hide what I do.  It may not be somethin’ people approve of 
but I'm not gonna hide it.”  She said later:
“It's, I just never had a problem in telling.  I guess it's because I don't care, I mean 
I am who I am, and if I did something twenty years ago or thirty years ago that 
was a mistake, I'm probably terribly sorry now that I did it, but I did it. I mean and 
I'm not gonna say somethin' that's not true.20”
Sharon’s statement shows that she recognized a connection between HCV and deviant 
behavior, yet she disclosed regardless.  Connie had been diagnosed twenty years ago.  
She freely told people when she was still working.  Harold told clients where he worked 
at the rehabilitation center for substance abuse.  
The difference between respondents who are in this category and other persons 
who disclose openly is their activism.  Isabella had been the founder and leader of a 
support group for HCV for a number of years.  Despite verbal attempts to minimize her 
contributions, Isabella was very proud of her work with others with HCV and showed me 
a plaque she had been given in recognition of her work.  HCV was very salient in her life 
because of this.  She described why she started the support group:
“So I said Okay, I guess I'm kinda like the pioneer.  And, you know, it's kind of a 
spiritual thing I think in me and I, I'm somewhat of a spiritual person and you 
20
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know, I think, you know, God guides you in different areas and you just listen and 
he, I really think that he guided me in a way because of how devastated I was and 
how I didn't give up.  You know, I could have either gave in to the Hep C, 
committed suicide or, you know, I coulda stood up and fought, even though I 
wasn't clearing the virus I could do somethin.  So, you know, that's the birth of the 
support group.  Uh, I think what the brute of my goal was not to let anybody 
suffer mentally like I had.”
Charmaz (1991) suggests that strategic announcing can help confidence for chronically ill 
persons which seems to be applicable to Isabella’s statements about being a “pioneer” as 
well as her showing me her award.  She did, as did others, truly enjoy helping others.  
Isabella regularly received phone calls from strangers who have found her information on 
the internet or through a crisis hotline. Sharon also received calls from strangers seeking 
support or information because she published a memoir in a widely circulated national 
magazine using her real name.  She said, 
“But people had gone to the trouble, to find my name and find my city and find 
my phone number.  And then they all told me, please excuse me for bothering 
you.  And everybody asked, did I mind talking about it, and of course I don't.  I 
am so willing to do anything to promote awareness, I mean it doesn't hurt me and 
perhaps it can help someone else.”  
Connie had a story written about her in the local newspaper not long after she was 
first diagnosed, chronicling her struggle with diagnosis. She brought the article to show 
me when we met for the interview.  She has also been very involved in a local support 
group.  Harold has been involved in a fundraiser put on by an HCV awareness group and 
has raised his hand at public events showing he was infected.  He has also done HCV 
educational lectures at facilities where he has worked.  Harold described disclosing to 
people who come into AA with hepatitis:
“…the, AA, there’s so many people that, you know, that come in on occasions, 
and some of will come in and say I have Hep C.  And you know, I’ll talk with 
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them and you know, give ‘em suggestions of what I’ve done.  And how I get 
through you know, each day with this disease.” 
Jenn, like Harold, disclosed in a work related environment. She attended a 
conference for work about public health, specifically HIV.  She was in a session on 
hepatitis and felt compelled to disclose when the session leader began describing 
symptoms of hepatitis:
“And so what, he, when he got to the part about the general malaise, the flu like 
symptoms and all that stuff, you know, and I just stuck my hand up [J laughs]; 
and said and that’s the truth.  I said I’ve now been on treatment six weeks.  I said 
after my trip here yesterday I was totally exhausted last night, I couldn’t even 
make it to dinner.”
These patterns of disclosure were not the norm in this sample although they may 
be an effective means of combating ignorance and silence surrounding HCV.  These 
behavior patterns, however, may not be readily available to all persons and may be more 
limited to middle class Whites as all respondents except Connie, a Japanese woman, were 
White. 
OPEN DISCLOSURE
The next pattern of disclosure includes those who were also fairly open about 
their HCV status although they have not involved themselves with activism. Nineteen 
people or 37% of the sample are in this category. 21  Most of the respondents are White 
with the exception of Maruf, a Middle Eastern man, Catherine, a Black woman, and Don 
Yi, a Chinese woman.  Eleven men and nine women follow this pattern of disclosure.  
The household income and educational obtainments are quite diverse for persons in this 
category.  More than half of the people in this group believe drug use many have been the 
21
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source of infection.  Thus, mode of transmission is not related to the level of disclosure 
(2 =.01, p>.1) as has been found with HIV (Tewksbury and McGaughey 1997).22
Similar to persons involved in activism, persons who openly disclose had told 
family, especially spouses and parents, as well as friends.   When I asked who they had 
told about having HCV, a typical response was, “Everybody knows.”   When I asked 
Maruf if he told all his family, he replied, “Yeah everybody knew, everybody, you know, 
it’s normal to tell, you know, your immediate family that you have a problem, and they 
all supportive, and they willing to help whenever they can.”  Yellow managed to 
communicate with his son who was in the Navy through e-mail.  
Many persons in this group had also disclosed at work.  Cece worked at a halfway 
house where she had been a client when she was diagnosed.  After diagnosis, they had a 
meeting and she told her life story to the whole house.  So everyone knew at her work.  
Peggy has told everybody in the area of the hospital where she worked.  She had been 
infected by a needle stick at work.  Lucy, a postal office worker whose husband also has 
HCV, had also told everyone at work.  Many of these persons seemed to disclose very 
casually.  Daniel and his wife talked about how Daniel, a brick mason, had worked at a 
woman’s home who had HCV and the woman called to tell them she had been treated 
and Daniel’s wife then told her about Daniel finding out he had it.  He said he has been 
open about it since first finding out.  Jeff, a who is married to Karla who also has HCV, 
said that, “Yeah, I mean, we don't keep it from nobody.  I tell 'em.  I mean, they gonna be 
my friend, they gonna be my friend.  The way I am, like I told 'em, you know.”  
Another respondent presented conflicting views of his level of openness.  Maruf 
said, “I’m wide open.  I mean I, I, I, don’t have to hide from anybody.  I don’t care what 
22
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others think.”  Yet later, he says, “Doesn’t matter really, and I wouldn’t discuss it with 
anybody that I don’t really feel comfortable with anyway.”  This seeming contradiction in 
terms of Maruf’s statements may be indicative of the fact that the interview is an account 
given by the respondent to myself.  Maruf may have been trying to present himself as 
someone who is immune to other’s opinions, based on the first statement.  His second 
statement may reflect more of the tension inherent in disclosure.  
Again, similar to persons who follow an activist disclosure pattern, this type of 
pattern seems to be limited to mostly Whites.  While these levels of disclosure may allow 
for more social support than silence would, it also opens opportunities for discrimination, 
a consequence perhaps many people of color are unwilling to risk.   
LIMITED DISCLOSURE
The next level of disclosure is a more limited or reserved behavior pattern.  This 
group comprises 38% of the sample and is more racially diverse than the previous two 
patterns as almost half are Black.23  Education ranges from 8 to 18 years. Income again 
varies widely with some respondents earning little and others earning ninety thousand or 
above.   Again, more than half of the persons in this group reported drug usage as a 
means of transmission.  
Persons following this pattern typically have told some close family and some 
friends.  Stick talked to a friend who had hepatitis C.  David said about disclosure, “Well 
just my direct family.  Most of my direct family though doesn't even know that it's come 
back (he did not sustain a response after stopping treatment).”  Tari has told some of her 
sisters but not all of them.  Grant had told his girlfriend at the time of diagnosis, but has 
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not told his sons.  Melissa has not told her sister while Jerry said he only talked with 
siblings and his children about it.     
A few persons have disclosed at work, but often only to friends at work. Stick, a 
construction worker, has told several people at work. He thinks several people there 
probably have it.  Tari, whose husband is also infected, works at a doctor’s office and she 
has told a handful of people there including a nurse practitioner, a doctor, and several 
friends. Tom, an electrical supervisor, and Jamie, a correctional officer, have both told a 
few people at work, but with minimal details about it. Meredith, a hair stylist, has told her 
boss everything and he even allows her to go to AA meetings when she isn’t busy at 
work. She, however, is not as forthcoming with others at work:
“People who, I try to consider the source and like, there's a couple a people I work 
with who I just tell 'em that I'm in treatment, that I'm doing, that I have a liver 
disorder and that I'm part of a research team and that's it, you know.  I just leave it 
at that.”    
The main difference between this pattern of disclosure versus an open disclosure 
pattern, is that these people mentioned not telling others specifically and/or described less 
general disclosure than other respondents.  David says that, “I mean, cause it’s, but 
there's not a whole bunch of people, I mean I don't tell most people.”  Little Brother said, 
“Like anybody else, you know, I try to keep it down, you know what I'm talkin about.  It 
ain't nothin like to be just spreadin”.  Bob revealed that, “Is, is enough to make me gun 
shy to, to where now I don’t, I don’t wanna tell women, you know, that I sleep with that I 
have it.”  
Charlie expressed an interesting contradiction within this interview about his level 
of disclosure.  Early in the interview, Charlie told me, “Nah, I didn't really tell a lot of 
people”, but later said, “I have talked to a lot more than you really think”.  Charlie’s 
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statements are similar to Maruf’s comments previously discussed where he described 
different levels of disclosure.  Similar to Maruf, Charlie may have been trying to distance 
himself from any sense of feeling stigmatized or reticent about disclosing.
 A limited disclosure pattern is practiced by a wide variety of men and women in 
regards to race/ethnicity and class. This option may allow individuals to access some 
benefits of disclosure while shielding them from too many potential negative 
consequences of disclosure.  However, disclosing in a limited fashion does not promote 
awareness.
RELUCTANT DISCLOSURE
The final pattern, reluctant disclosure, refers to those who are virtually silent 
about their HCV status and have told very few people.  These respondents are different 
from those practicing limited disclosure in that they mentioned secrecy or shame and 
took pains to avoid disclosure as a whole.  This group is 15% of the sample or eight 
people, although this is probably an underestimate because of the data collection process. 
In other words, the most reluctant persons may not be getting healthcare or if they are, 
chose to not participate in this study.  This category is diverse in terms of education, 
household income, gender, and race.24
Persons who are reluctant may have disclosed to a family member(s) although it 
often took time to even do that.  Ronald said, “I have told my family.  I finally--it took a 
while.  I didn't tell anybody for, uh, you know a long time.  I didn't tell a soul.”   Lauren
reported that she only told God at first and eventually her mother.   Vanessa limited what 
her family knew, “But my family was, was good with it now.  I didn't--my-my brothers 
24
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and sisters and stuff, they don't really know what I have now.”  Those who have a spouse 
or partner have told them.  Mack has only told his wife.  Vanessa revealed, “'Cause I 
really didn't want anybody to know, you know, except just, uh, you know, my husband 
knows, but my kids now, they just know that I'm sick, you know.  They don't know 
exactly what it is.”  Andrew, who lived with both parents, has only told his mother, 
although he said his father knows a little bit about it. 
In regards to disclosure to friends, there is some variety within this group.  Lauren 
said, “But I just, I, now I’m not interested in sharing anything with any of the people that 
I knew before, I haven’t told any of my friends.  Like I told you just my family.”  While 
Ronald revealed, “I gradually told my best friend, and I, I presented it to him that I had, I 
didn't never, I didn't come right out and say it was Hepatitis.”  Sherri, who had told no 
one that she specifically has HCV did say that, “Some of the people-like my pastor, his 
momma, his wife- they know I have problems with my liver but they don't exactly know 
what it is.”   None of these people have disclosed at work.  Mark, a law enforcement 
officer, is adamantly opposed to disclosing at work.  Vanessa also doesn’t want anyone at 
work to know.  Eric has told no one except a physician he knows from off-track betting 
who has run a few blood tests for him.  Ronald said, “But, I'm actually, since you're doin' 
this research, and for your thesis, I'm, I was kinda grateful in a sense to be able to have a 
interview about it because I don't talk about it hardly at all.” 
Following a reluctant disclosure pattern is seemingly exhausting for some.  Mark 
was adamant about not meeting me near the town where he lived, a sentiment also 
expressed by Lauren.  Sherri started crying in her interview because of her fears possibly 
because she never talks about it with anyone (although numerous respondents cried). 
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Ronald also expressed how he had at times been consumed by fear and worry about the 
disease and finally had to talk to someone.  Thus, this pattern of disclosure does not 
afford accessing any benefits of disclosure which at least for some, has real 
consequences.  However, Andrew and Vanessa who practice reluctant disclosure did not 
express distress in the interview process, although this could reflect a more sophisticated 
presentation of self than other respondents. 
DYNAMIC PROCESS
 Levels of disclosure are not static and change depending on circumstances and 
across time, as others have also found (Charmaz 1991).  Several persons described how 
their levels of disclosure have changed.  Samantha has moved from being quite reluctant 
to more limited disclosure as she has gained information. Sallie Anne has also 
transformed her disclosure as she has realized the severity of the diagnosis compared to 
her Non-A, Non-B diagnosis in the 1980’s.  “Right, they told me it was, if it wasn't 
Hepatitis B, it was non communicable, it was don't worry about it you know, it was 
basically like it was a kidney infection and stuff”.  Thus, she simply didn’t take it 
seriously or think it was important enough to share with others.   Only once being 
diagnosed with HCV and gaining information did she begin to disclose.  Larry, who 
described a limited disclosure pattern, could move in the direction of being more 
reluctant because of a very negative reaction he had recently received after disclosing at 
his former job.  Catherine changed over time from being more limited in her disclosure to 
more open.  This transition was because of her strong religiosity.  She centers her health 
and illness around her faith and felt that she should be more open as a testament to her 
God.  She had been diagnosed eleven years ago, but started to more openly disclose two 
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years ago.  “But then I you know, I just started coming out with it, because I remember 
God’s word, he said if you be ashamed of me before men, I be ashamed for you.  So I 
started letting people know.”  However, Catherine iterates how disclosure can fluctuate 
even on a daily basis:
“You know and it's still sometime there are like days ok you just feel like ok this 
is not anybody’s business, and then there are days that just like I don't care, you 
know so, it has it's days, but I’m at the point now, to where I look out to the 
world.  Cuz I’m a picture of health.  I'm here to prove it.”
Finally, Roxanne seemed to be moving in the direction of more open disclosure because 
she has cleared the virus through treatment and could talk about it in the past tense.   
Gray et al. (2000) found a similar pattern among men who had undergone a 
prostatectomy in that they could now disclose because they no longer “had” the disease.  
REASONS FOR LACK OF DISCLOSURE
As seen from the preceding discussion, many respondents choose not to disclose 
to a few or many people.  According to Charmaz (1991), avoiding disclosure keeps 
illness apart from notions of self and skirts any potential experiences with stigmatization.  
Throughout the interviews, various reasons emerged for not telling others about having 
HCV.  The reasons mentioned fall into two broad categories: lack of disclosure because 
of a Concern for Others in some regard and lack of disclosure because of a Concern for 
Self.   Persons mentioned a lack of disclosure because of the self slightly more than 
silence because of concern about others.     
CONCERN FOR OTHERS
Prevent worry.   Seventeen percent of the sample mentioned not wanting to worry 
or bother others.  Although cultural notions of gender may indicate that women would be 
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more likely to express not wanting to cause concern, in this sample, men and women who 
disclosed at varying levels expressed this.   Others have found that HIV positive persons 
are reluctant to disclose for fear of disappointing or burdening others, especially family 
(Chin and Kroesen 1999; Mason et al. 1995; Simoni et al. 1995).  Older respondents in a 
study on men with prostate cancer were especially likely to say they did not want to 
burden others with disclosing their health status (Gray et al. 2000).  
Interviewees in this sample often mentioned family when talking about not 
wanting to worry others.  Grant explained why he had not told his sons, “My one in 
prison, out of town somewhere in Shreveport. And the other little one he just got grown, 
so I'm gonna let him be grown.”  Catherine expressed a similar sentiment about telling 
one of her children that it was hepatitis:
“And I don't want him going around worrying about you know my Mama, you 
know, is my Mama gonna die. Is something gonna happen to my momma. Cuz he 
had enough of disappointments in his life, just growing up you know, with his 
daddy, you know, not really being there for him, being in and out of jail, so I don't 
want to do that to him.”
Tari has not told one of her sisters: “And my other sister she just recently had some heart 
trouble.  And I just didn’t want to worry her with that, but I don’t mind telling my, I just 
don’t want to worry her with it right now, cause she’s going through so much.” Eddy says 
of when he told his family, “I don’t remember if I told my parents, I told them relatively 
quickly. I told the whole family relatively soon. My delay would not have been 
embarrassment, but being, creating worry for them.”   
Others believe that persons may associate hepatitis with dying and will cause 
them tremendous anxiety.  Sherri doesn’t want to tell her kids that she has HCV 
(although they know she has a problem with her liver) because, “Ah, well.  They know I 
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have problems with my stomach.  And they think every time I get sick I gonna die, so I 
try not to talk about it.”  Vanessa’s children also know she is sick, but don’t know exactly 
what is wrong.  Vanessa said about disclosing to a friend:
“My friend, and it was, it was a while before I told her you know, because I just 
didn't, you know, I just didn't want everybody, you know, to say oh my God, you 
know, and start you know, because then they start lookin' at you and they're 
wonderin', you know, they're, you know, and it starts and go, you know I don't 
want her to die or whatever, so I mean, I don't want people to get that mentality, 
so I just, I just kinda, I guess sugar coat it, yah.”
Derrick describes how his grandparents might know, but he doesn’t discuss it with them. 
“They don't think of me dying anytime soon.  So I'm not gonna even go there with that 
with them so.”  
Reminder of past lifestyle.  Hepworth and Krug (1999) found that diagnosis of 
HCV brings up reminders about past drug usage for many persons with HCV which in 
turn generates fear about interactions with others concerning their HCV.  Many 
respondents mentioned that their drug use was widely known about in their family and 
perhaps this knowledge suppresses any concern about reminding them.  Considering that 
58% of the sample reported past drug usage either intravenously or intranasally as a 
possible means of transmission, it is curious that only three respondents or 6% of the 
sample mentioned this as a reason for not disclosing. Bob who had only recently re-
established ties with his family took care to not remind them of his past:
“Well I think a lotta the estrangements on my family runs back maybe from the 
time I was like twelve and it’s really just recent years, the last maybe five years 
that those have been starting to be bridged and I have a decent relationship with 
my close, closest family now but even then, yeah I can remember not too long ago 
at a like a family get together probably around a holiday at a, at the dinner table 
we’re having dessert and coffee or something after dinner and like direct families 
and grandparents and just a bunch a people and like me saying something about 
the past, I don’t know if it was about shooting drugs or living on the street or what 
but I remember saying something and my mom just being like don’t tell me, I 
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don’t wanna know, you know, like I can just imagine I don’t wanna know and so 
there’s def-you know there, just sorta this like don’t, don’t tell don’t-what’s the 
policy in the army about gays?”
It could be that for many of the respondents, their drug usage had not led to complete 
estrangements with their families such as the case with Bob and therefore they did not 
need to go to the lengths to distance themselves from past behaviors. 
CONCERN FOR SELF
Fear of discrimination and prejudice.   25% of respondents mentioned not 
disclosing because of a fear of discrimination and/or prejudice, the most common reason 
given among this sample for not disclosing.  People who mentioned these fears were also 
more likely to have disclosed in a more limited fashion or be reluctant (2 =6.6, p<.01). 
HIV positive Asian Pacific American women feared discrimination because of ignorance 
about HIV (Chin and Kroesen 1999).  Part of the fear among persons with HCV may 
stem from the public’s fear of contamination similar to what Tewksbury and McGaughey 
(1997) found in regards to disclosure and HIV.  
The theme of being seen as contagious permeated many comments.  Vanessa 
explained:
“You know because people get kinda, you know--if you say certain things 
especially if you're dealin' with somethin' that's contagious or whatever people get 
kinda scared and stuff.  You know, and I don't want everybody to you know, but, 
it's, you know it's not been easy dealin' with it, you know.”
Isabella worried at first that her husband would leave her because she had a disease that 
could be sexually transmitted.  Larry’s mom reminded him frequently to not tell other 
family members because they have small children and she didn’t want them worrying 
about being around him. Larry agreed with her fears.  Several researchers have found 
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among other chronically ill persons that family members have encourage silence around 
others (Charmaz 1991; Chin and Kroesen 1999). Catherine had intense fears at first:
“You know I was looking at my life, I say, God, you know, I say, nobody will 
ever marry me.  You know, you know I was sad  (Catherine crying) because you 
know with the hepatitis, I say, you know I say, you know I'll have this the rest of 
my life, you know, and I say, you know, I'll always be alone, I say, because if 
somebody know the truth, they will not you know want to be around me.”
David also felt he might be shunned. “I fear that most people when they hear that I have 
it, I feel most people react like that.  Even you right now, I feel like you feel like well 
glad he’s over there he’s got leprosy.”  Samantha told me that, “…but I mean I’m 
embarrassed to go tell the doctor, here, test my daughter for hepatitis C because she 
might have caught if from me because of my irresponsibility.”
 Part of being seen as contagious would mean being interpreted in a new light by 
others.   Tari was afraid a friend of hers at work would treat her differently.  Mark, a law 
enforcement officer, feared disclosure would affect cohesion at work and that others 
might hesitate to save him in the case of an emergency, “…some of em' will get kinda 
antsy being around you if they knew.”  Roxanne feared losing her job if they knew she 
had HCV because it is a healthcare organization.  Larry spoke about future decisions in 
regards to work:
“If I don't have to work with them, or be around them, or we're not forced to be 
together in a situation, I won't, you know, I don't care.  But if we're forced to be in 
a situation, like at work, I won't say a word anymore.  That's it.  I know it can't be 
contracted that way, but they don't.  And I can't blame them for that.  So I'm not 
going to, I'm just not going to say anything.
Fear of being shunned was so strong that Samantha described letting her ex-boyfriend 
shoot up with the syringe she had used despite knowing her HCV status. “And I just, I 
couldn’t say it. You know?  I couldn’t and I guess in a way I justified by saying, oh we 
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shared needles so many times before I knew I had it.”  Bob also expressed internal 
conflict about his lack of disclosure to sex partners:
“…it sorta weighs on me actually, not sort of, it does weigh on me, weighs on my 
conscious because I don’t, it’s one a those things that I live with [B clears throat]; 
that’s a moral kinda twist because morally, I think I should.” 
 His feelings of guilt from not disclosing are similar to what Nack (2003) found when 
women with herpes did not disclose.  
Waiting to disclose.  Numerous researchers have delineated the aftermath of 
diagnosis as a stressful, uncertain time for people (see Chapter 5) (Glacken et al. 2001; 
Hepworth and Krug 1999; Weitz 1989).  This uncertainty however helps explain the 
phenomenon of waiting to disclose mentioned by 23% of the sample.  Gray and 
colleagues (2000) also found that men diagnosed with prostate cancer discussed waiting
before disclosing with family.  Most people explained that they wanted to have more 
information before telling others about having HCV.  Tari says in reference to one of her 
sisters, “But the other one I just didn’t tell her cause she’s too emotional, but now I can 
tell her, cause now I have more facts.  And I can tell her now.”  Grant told me, “I was 
more depressed myself… I just wanted to think about this awhile. And see what I was 
gonna have to do to correct this.”  Jerry said about waiting to tell his family, “I don't 
know.  I just--I go through a lot.  Wanted to go through it by myself, you know, then I'd 
see what it was then I'd tell 'em, you know?”  Jenn waited to tell her kids for about a 
month after being diagnosed. I asked her why and she said, “I’m not sure, I th-I, I think 
that I was afraid that they’d probably didn’t know that much about it and cause my older 
son in fact says you’re gonna die (when she did tell him).”  Ann also mentioned wanting 
to gather more information before telling her kids.  Samantha also waited quite a while to 
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tell her family. “No, I didn’t tell anybody for a while, just probably in the last couple of 
months when I started learning about it.”   Many of these comments suggest that for these 
persons, they wanted to avoid what Charmaz (1991) calls “spontaneous disclosure” 
which if often wrought with emotion, and instead have a protective disclosure that is 
much more controlled.  Interestingly, a “Fact Sheet” on a HCV website suggests that 
persons “should be advised to wait until they feel emotionally ready and have enough 
facts before divulging their status” (Franciscus 2002).  Thus, numerous respondents are 
practicing what “experts” are advising persons with HCV to do. 
Private information.  Finally, 17% of the sample explained that they did not 
disclose because it was simply private information.  Charmaz (1991) describes how 
illness status is as private as sex and finances for many people.  Racial and ethnic 
minorities in this research were more likely to report this (2 =13.26, p<.001).  To some 
people, their HCV status is simply private and of no concern to others. Jerry, a Black 
man, does not discuss his health with certain family members. “Well, I don't talk to 
nobody but my family about my sickness, you know?  I don't talk to no outsiders.  I don't 
even talk to like my cousins, first cousins.”  Catherine said that, “… not nobody, it was 
just something I really didn't want to talk about to people.”  Tom said, “Well yeah they're 
my friends and I don't, you know, I used to consider it private but I guess the better word 
would be I’m a reluctant person.  I don't, I don't put my business out on the street.”  
Andrew commented about disclosures by people with HCV at the dialysis center he 
attends:
“But I figure that’s personal business so I don't discuss it out there.  They sit there 
and, they sit there and talk about it.  But I figure that’s personal business so I don't 
discuss it out there with a couple with it that come in and a guy and they have 
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Hepatitis C.  But they talk about it freely.  And I'm thinkin, I'd just rather not talk 
about it.  I mean in a public area.  You know”. 
He reiterated again later, “That's not really anybody's business.  Not that I'm ashamed of 
it.  You know, but just, it's nobody's business.”   Of course, a respondent might have said 
they didn’t disclose because it was private to save face during the interview rather than 
reveal other fears that kept them from disclosing.    
Fear association of HCV and deviance.  12% of the sample feared others would 
associate HCV and drugs or homosexual behavior. Andrew has not outright told his 
father, “No, cuz he's kinda [makes a noise].  You know. It get out in the club, somebody 
do too many drugs, go oh you know you got hepatitis.”
Mack fears an association with homosexuality, a theme that came up several 
times in his interview.  He has not told his sisters because: 
“No, I mean it's like, I think that people are, like I say, there's not much known 
about it, and I feel that people will draw a adverse inference as to how a person 
got it.  You know the ignorant factor comes into play.  You know I've been to 
prison, so you know they'll probably be thinkin' some of everything.  You know 
what I'm sayin'.  And I, you know I don't have time for that…Worst case scenario, 
is that about any type of involvement in homosexuality.  ”  
Roxanne’s mother did at first associate her being a lesbian with HCV and Roxanne said 
she feared that association as well at one time. “Because of my lifestyle I knew people 
would say that was how I caught it”.  
REASONS FOR DISCLOSURE
Reasons for disclosing also can be looked at in regards to disclosure because of a 
Concern for Others and disclosure because of Concern for Self.  In contrast to reasons 
given for not disclosing, people mentioned disclosing for others’ sake almost twice as 
much as disclosing because of a concern for the self.    
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CONCERN FOR OTHERS  
Protect others.   Forty percent of the sample mentioned disclosing to protect 
others from HCV, although men were less likely to mention this (2 =6.42, p<.01).  
People who mentioned wanting to protect others as a reason for disclosure were more 
likely to practice limited or reluctant disclosure (2 =7.08, p<.01).  In addition, 
respondents with at least some college were more likely to mention disclosing to protect 
others (2= 11.48, p<.01).  Peggy explained she told everybody because she had to take 
precautions. Tari talked about her reasons for disclosing to her son:
“Before I knew anything, because…I wanted him to know so that he can be 
careful, you know, with his life and his decisions that he make, and that if you 
know, sometimes you don’t know what your kids have done.  Like if he’s used 
Lonnie’s razor or even my razors, cause I have my own now too.  When Lonnie 
got diagnosed we always kept everything, like razors and stuff, his, being a boy, 
we made sure he had his own, but you never know when we’re not around.  We 
didn’t tell him about Lonnie, when it happened to me I did tell him about me, and 
he knows about Lonnie now.”
Mack also told his wife to urge her to get tested.  Sharon said, 
“I had my children tested, I had my daughter in law tested, and I had the baby 
tested (referring to grandchild).  Because although it's not an easily transferable 
disease there is a possibility that you can get it by brush--, by using somebody's 
toothbrush, and I couldn't remember whether my children had ever gotten cut, 
when I was cut, you know?”  
When I asked Andrew about his mother’s reaction when he disclosed to her, he said he 
explained to her how he had to be careful with his toothbrush and razors around the house 
and that she eventually understood.   
Ann eventually told her son although she almost seems to have told him to 
absolve herself of any responsibility:
“But then I found out that my youngest son, after my mind kinda bottled,  I 
settled down and got things settled in my mind, I told him he need to go and be 
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checked because I remember a while back, he's gettin' pneumonia quite often.  
And one the doctors at, the Lake, had told us that he, it look like he might have 
had hepatitis.  So I don't know if he end up gettin' it from me I guess.  But you 
know how these young people are you know, I'm a go mom, I'm a go, I'm a go, I 
mean he's twenty-six I can't really make him go. It's not like he a little bitty kid 
and I can do it, he grown now so, all I can do is inform him about he need ta be 
checked, and I advise the other of it too.  To do the same.  That's all I can do.”
 Roxanne’s statement suggested she disclosed to protect her own sense of responsibility 
perhaps more than to warn others. “So I mean I really wasn't too worried about it but I 
didn't, I didn't lie to anyone? Straightforward, I mean this is what I had and there is a 
chance, ya know.”  (Scheon and Crosby 2004) found that among some HIV positive gay 
men, disclosing HIV status is a welcome release from responsibility which is perhaps 
seen in these statements about disclosing HCV status. 
A few respondents mentioned wanting to contact persons who they may have 
used drugs with or knew they had a history of drug use as was the case for Melissa.  She 
fretted over telling her sister who she does not have contact with:
“It was a real hard thing for me to decide, and I also was concerned about my 
sister, who I’m estranged from, and I knew that she had been through the same 
thing.  And I know she’s not as I am, well read on it or anything, and I thought 
she probably didn’t know if she might ask about being tested.  And I really went 
around in circles with that, because I wanted so bad to let her know to do it.  And 
it was very hard for me to decide not to do that.  I guess through just talking.  I 
guess I got the impression that she would probably find out, because it was 
becoming more wi----, you know, widespread and people who’ve been 
involved… Again it was a very, very hard decision.  I thought about how to do it 
anonymous.  There just didn’t seem to be a way to be able do that without her 
realizing I didn’t want to be contacted.”
Charlie said he plans on calling a family member.  “I have a cousin who's just like a 
brother, I'm gonna call him and tell him he needs to go (get tested).  He and I are thick as 
thieves for a long time.  I mean, we ran together for a lot of years.” Charlie also spoke of 
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as he found out more information after diagnosis, he became concerned about friends. He 
told them to get checked for it:
“But, yah, the more I found out about it and the more I sit there and knew people 
who ran with me and we did things that we shouldn't do together, you know, like 
toot cocaine with the same rolled hundred dollar bill.  And it might give you a 
nose bleed, no body would think nothin' about it.  And, uh, you know I was 
concerned--I still am.  I mean, I'm not finished.” 
It is interesting that Charlie mentioned two times during the interview how he planned on 
contacting these people yet he had known about having HCV for eleven years. 
Others mentioned telling romantic and sexual partners out of a sense of 
responsibility.  Sallie Anne told a boyfriend she had while her and her husband were 
separated so that he could get tested.  She wanted me to know that she was not, 
“spreading it around”.  Nick also mentioned telling anyone he was with and that neither 
his girlfriend nor wife ever contracted it and that it was the first thing he told them.  Bob 
as previously mentioned was torn about disclosing to sexual partners and usually did not 
and then felt guilty.  Simoni and colleagues (1999) discuss how HIV positive women 
disclose to partners out of sense of ethics as well.   
Several people mentioned disclosing to protect health care workers. Sharon talks 
about when she fell and cut her head and had to go to the emergency room:
“And I kept tellin' everybody, Listen, I have Hepatitis C, please wear gloves.  And 
one guy looked at me and said, What are you so worried about?  We're not gonna 
give you anything.  And I was furious, Alicia, because I wasn't worried that he 
was gonna give me somethin', I didn't wanna give him somethin'.”  [S laughs]. 
Lauren also stated that if persons about to draw her blood seemed like they were not 
going to wear gloves, she made sure to tell them she has HCV to warn them.  Vanessa 
said, 
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“Yes, yes I make sure, I make sure I tell  every one because, I, you know, I don't 
want, you know them not to know because they have to treat me and if somethin', 
you know, if somethin' happens, well, they, they…Yah, and they need to know 
what they're doin' in order to be able to protect themselves just, like, you know, if 
I go see the dentist or somethin' I make sure, you know, you know, I circle it on 
the little paper or whatever, but I make sure I tell them, you know because 
sometimes people don't read”.
Charlie told me he tells all doctors he sees as did Eddy.  Eddy explained,
“It’s usually not something that is a big deal, but, uh, every time I go in to a, a 
health care person, or dentist or anything like that, I do say it, because I don’t 
want them to get infected. I want them to know that if blood splashes, they should
(Alicia and Eddy laugh because Eddy makes ducking motion), you know?” 
Lucy has told many people at work to warn them:
“Yeah, yeah.  I mean I wouldn’t care, you know, like, like I work with eight 
people.  Eight people that work on the weekends so when I first found out that I 
had Hepatitis C I told them all I said You know, if I cut myself or fall out, don't 
touch anything.  You know, cuz, you know we will get a paper cut or, you know.”
The tone of many of the descriptions about disclosing to protect others was often 
ethical in nature, that the individual had an obligation to tell others.  Gray and colleagues
(2000) found that men with prostate cancer described disclosing when they felt obligated
to prepare their family for a possible death during surgery, genetic risk or because the 
family would want to know.  While many of the respondents in this study certainly felt 
obligated to tell others to warn them, part of the impetus to do this could stem from 
medical discourse.  Hepworth and Krug (1999) discuss the medicalization process of 
persons with HCV that begins at diagnosis.  They posit that doctors and other health 
practitioners teach newly diagnosed persons that to be a “good patient”, persons with 
HCV must disclose their status.  In addition, pamphlets given to HCV patients encourage 
disclosure without attention to the ramifications of disclosure (Hepworth and Krug 1999).  
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Thus, respondents in this research may be reflecting pressure from the existing medical 
discourse to disclose their status.  Vanessa and Lauren, both of whom are reluctant to 
disclose, explicitly mentioned telling health care workers in order to protect them, 
lending support to Hepworth and Krug’s (1999) assertions.  Another interpretation of this 
type of disclosure is that people are simply informing others objectively about their 
illness to help them avoid getting it (Charmaz 1991). According to Charmaz (1991) 
people who inform do not see informing as risky or view having the illness as 
discreditable (121).  While this may apply to a few people who mentioned this, such as 
Peggy or Sharon, overall, the connection between mentioning this and lower levels of 
disclosure does not support Charmaz’ (1991) findings.   
To explain atypical behavior.  32% of respondents mentioned disclosure to 
explain their behavior because it deviated from their previous or usual behavior.  All who 
mentioned this reported symptoms from the disease itself and/or treatment which 
corroborates findings by Figueiredo, Fries and Ingram (2004) in that they also found that 
women with breast cancer disclosed in relation to their increasing levels of fatigue, pain,
functioning, and energy.  In addition, those who mentioned this were likely to be activists 
or open (2 =6.07, p<.01).  Kelly (1991) described how individuals with ileostomies also 
told others when they needed to explain unusual behaviors.  
Several respondents described disclosing to friends.  Sharon talked about telling 
all her friends through a letter she found off one of the hepatitis support websites.  The 
letter exemplified what she was feeling, “…people had to understand that you are 
exhausted, you are drained, your liver is not filtering.  And, you may be able to walk 
fifteen minutes one day and the next day you might not be able to get out of bed”.  Cece 
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told a friend of hers who came to pick her up that, “…this last shot did a number on me.  
I said it's like it's just suckin' the life outta me or something.”  Daisy talked about telling 
her friends at church preemptively in order for them to know about the possible side 
effects of treatment so they would understand her behavior.  David also told friends he 
practiced tai chi with because he felt they were noticing his endurance was down.  
Several people discussed disclosures at work in order to explain absences or 
inability to perform in an appropriate fashion.  (Munir et al. 2005) found that chronically 
ill individuals are more likely to disclose at work if management of the illness involves 
specific regimens.  Jason told people at work when he started treatment to explain his 
frequent doctors’ appointments.  Larry disclosed at work:
“So when I was out there, trying to swing a sledgehammer in this heat, it was just, 
it was killin' me.  And I could, I could drive a stake half-way down, I'd have to 
squat down.  [Makes panting sound] And everybody was saying what's wrong 
with you, what's going on, so I finally I leveled with everybody out there.”  
Charlie has told the nurse at work and also some co-workers to explain any deviant 
behavior while on treatment.  “Yah.  I went to human resources and I talked to them.  I 
went to everybody.  I went to human resources and I said there's side effects from takin' 
this medicine and one of them is you can lose your temper.”  He also said that, 
“I've talked to everybody who works for me and told 'em what I'm doing.  And I 
said, now if I seem stupid or kinda scatter brained or forgetful 'cause I'm not a 
forgetful person, I said, ya'll have to abide by it.  I mean, there's nothing wrong, 
I'm just I'm on this medication and it makes you kinda goofy.  And it does, it 
makes me goofy sometimes.”  
While at a conference with coworkers with whom she used to drink alcohol, Jenn felt she 
needed to explain why she no longer drank.  Jenn also made sure to tell her superiors at 
work about the possible side effects of the treatment:
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“Uh huh.  And I gave him a list a the possible side effects, you know, espec-and 
then I one day I did get, not into it but I got smart with the assistant director he 
goes There’s that irritability!  [A laughs]; cause they know what the side effects 
are, I wanted to make sure they knew, so.”
Vanessa’s comment supports the idea that disclosure is necessary when one can 
no longer pass as healthy.  “So I'm glad I didn't start to lookin’like I was sick, so I didn’t 
have to answer any questions because if you start to look like somethin's wrong with you, 
then you have to tell, you know.” 
Activism   29% of the sample mentioned the desire to educate and or help others. 
Women were more likely to mention this (2 =3.86, p<.05).  While all the people who 
disclose at the activist level mentioned this, people who disclose across varying levels 
also frequently mentioned wanting to help others.  (Joachim and Acorn 2003) also found 
among some persons with scleroderma, a rare disease, a desire to educate others.  While 
Gray and colleagues (2000) found that younger men with prostate cancer tended to 
disclose widely with the intent of educating others, I found no differences by age among 
those mentioning wanting to help or educate others.  Larry mentioned talking with old 
friends of his at the methadone clinic who he has known for decades:
“Oh yah.  Oh yah.  Let's see. Joe, Joe, two three of them have Hepatitis C, and 
you know we all talk about it.  And they always come to me, and say how's that 
medication treatin' you.  And I say, you know, sometimes it's better, and 
sometimes it's good, sometimes it's bad, but I keep tellin' em', they need to have 
get a blood test, cuz about the same amount of time, and I they need to Jerry my 
friend that died, very good.  I said, you saw what happened to Jerry.  They say I'm 
gonna go, I'm gonna go...when they say it, I, you're not going anywhere.  But the 
clinic does test once a year, to see if the enzyme level has changed, and that's an 
indicator right there, that something’s wrong.  And so they're getting tested once a 
year.”
Several respondents talked about wanting to contact persons who may be at risk as 
discussed in terms of wanting to protect others.  This could also be seen as wanting to 
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educate or help others.  Respondents’ levels of disclosure are related to their experience 
in disclosing to help others.  For example, Sparky, who discloses openly, told others at 
work in limited detail.  He revealed to some coworkers how a safety meeting they had 
where hepatitis was discussed “…was fifty percent wrong.  I said it’s not, not real 
accurate, some of its, okay, if you wanna really know ask somebody that’s into it then 
you’ll know.”  Sharon, an activist, said, “ And I had offered, and still offer, and will 
continue to offer myself... for the awareness of Hepatitis.  I've done a radio show for a 
friend of mine who does it all over Louisiana.” 
Catherine said, “And, you know I just wanted to let them know, to give them 
some knowledge on it.  That I'm still Catherine, that I'm not poisoned, I'm not contagious, 
that I live a normal life everyday just like you.”  Catherine also mentioned telling other to 
give them knowledge and help them find God:
“Because sometime I will meet people and it's like, they'll be sick, they'll have 
like cancer or something like that, and they'll be talking about, you know, my 
cancer, and that's when I get to minister to them, about it's not your cancer, and I 
let them know you know about the hepatitis and what God did for me.  And that's 
when his word gets out, but I just don't run around telling everybody.” 
She told an interesting story about disclosing to address others’ ignorance.  She was 
among a group of women who were discussing hepatitis:
“She say, they say it's worst than AIDS, and she say, it make them, you know, she 
just saying how it makes them look, and how they get when they get it, and she 
say you know if you catch that, she say you know that they don't have no cure for 
that, she say, because you know they don't have medication for that…I say well 
how does hepatitis C look.  And she say, you know they be sick, all poor and you 
know they just don't look like their self.  I said really, I say because I have 
hepatitis C.  I say so how do I look…I say, and no you can't catch hepatitis from 
shaking someone’s hand.  I say, and you can't catch it from kissing a person or 
none of that.  I say hepatitis is given through blood.  I say through somebody 
sticking you or something like that…I said, I've been to where they pierced my 
ear with this little gun thing…You know I say, we don't none of us know where it 
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came from, you know, I say, it's just something probably been around long time, 
that they just gave it a name.”  
Thus, as Catherine’s story indicates, wanting to educate others may be a means for 
addressing stereotypes about HCV and can serve as a means of empowerment.  Because 
in this sample women were more likely to mention wanting to help or educate others, it is 
important for future research to ascertain whether this is a viable means of empowerment 
for men also. 
As a Symbol of Trust.  Disclosure is a means of feeling close to others and this 
came up for 10% of the respondents who indicated that telling people they were close 
with was a symbol of their intimacy or trust. Lee and Craft (2002) found a similar 
phenomenon among people with genital herpes.  They mentioned that persons with 
herpes disclosed because to not tell would impede on a valued relationship.  Gray and 
colleagues (2000) found that men with prostate cancer mentioned telling family because 
they didn’t want to hide anything.  
Catherine talked about how when she had a “friend” for several years that, “he 
knew, and this was no secret.  You know, because this was the man I was going to 
marry.”  Ronald also told his girlfriend who does not speak English and he is not sure she 
completely understands. He wanted to bring her to a bilingual doctor so that it could be 
explained to her as his Spanish was not that good. “I don't know what she thinks.  But I 
told her, and I'm gonna make sure she understands.  I just--that's just only fair.”  This 
comment also reflects the obligatory, moral aspect reflected in comments made by others 
about disclosing to protect others.  Andrew said he did not tell the last woman he was 
with because they used protection and were only together six months.  His statement also 
supports the idea that disclosure is only necessary for serious relationships.  Bob has told 
94
the women he has been in serious relationships with, “…so when I was like talkin’ to her 
we were in love and I was like tellin’ her about my history and who I am and, you know, 
and certainly this was part a that and I was being intimate with her.” 
CONCERN FOR SELF
Seeking Compassion.  While many disclosures could seemingly be interpreted as 
being for compassion, only 33% of the sample specifically mentioned disclosing for this 
reason.  At least some of these disclosures can be seen as “spontaneous disclosures” in 
that they are not planned and intensely emotional (Charmaz 1991).  Joey’s mother told 
me about how he called her crying when he was diagnosed.  Samantha also mentioned 
crying and finally telling her partner after he kept asking her what was wrong.  Ronald 
finally talked to his best friend.   Because of his secrecy, he was experiencing thoughts 
about death and mortality and needed to talk with someone. He also eventually told his 
AA sponsor.  Isabella, Maruf, and Jenn all told co-workers before anyone else either 
because they were at work when they got the news or going to work in Maruf’s case.  All 
were looking for support in post diagnosis concern.  Ann, Sherri, and Daisy have all told 
their pastors (although Sherri only revealed it was a liver problem). 
Daniel talks about wanting to talk to others on treatment because only they 
understand how difficult it is:
“And I was tryin’, and really and truly it’s good to be able to talk to other people 
that’s on it, cause the person that ain’t on it, they don’t know what it’s like.  They, 
they can’t even imagine.  You can, you can try to imagine but you can’t.  And 
everybody that’s ever been on it will tell you the same thing.  You can’t imagine 
the way you feel, there’s no way to explain it. Um, you can tell somebody you’re 
depressed, you can tell somebody you’re edgy, you can tell somebody, but you 
can’t explain the way you really, you really don’t feel like yourself at all.”   
 Bob talks about reasons for disclosing to some friends: 
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“…like my friend Joe and a couple other people who are, I, I’m very close with in 
confidence with about either sharing myself for kinda to get stuff off my chest or 
to and, kinda talking with people and finding out things about them like kinda 
sharing, sharing in myself and, you know, to kind of a, I guess to sort of ease that 
feeling of like, that I talked about earlier about like social outcast kinda thing, you 
know, that, that wow, you know, here I have it too, you know, to kinda, sort of 
demystifying or devaluing the, the kind of junkie’s disease sort of stigma.”
While Bob is seeking compassion, his comments also mesh with research findings 
concerning herpes where people disclose to self-verify their non-HCV identities although 
he is the only respondent who explicitly mentioned this (Lee and Craft 2002). 
David told his employers at a previous job, “Because I felt like I needed to.  And I 
felt like by telling that I would get, some moral support, or support”.  He goes on to tell 
me that he lost his job there perhaps as a consequence of his poor performance because of 
being on treatment.
Some respondents said they feel more comfortable telling medical personnel. 
David believed health care workers would understand because they had education about 
HCV.  Ronald finally talked with his family doctor because he trusted her. He has had 
difficulty telling people about his HCV:
“She's known about my drug use and different things and she explained more.  I 
finally came out and told her, and she explained more to me about this issue and 
said you know, that--I can't remember if it was her or Dr. Ruth that convinced me 
we needed to know how much damage was already done.”  
Ronald’s decision to disclose to her may have been for instrumental help, which he did 
receive.  Thus, for persons such as Ronald, the decision to disclose to his doctor was 
quite beneficial. She gave him information and recommendations that he followed.
Derrick was the only respondent who seemed to go beyond disclosing for 
compassion to the point where it was for sympathy or as an excuse, a phenomenon 
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described by Charmaz (1991) as flaunting illness and links back to Parson’s notion of 
secondary gains (Parsons 1951).  Kelly (1991) discusses how some persons with 
ileostomies disclose for sympathy or because they enjoy being in the sick role and that 
these disclosures may lead to social ridicule or rejection by others.  Derrick, a 
horticulturalist, explained how he could no longer work outside, “Do the things I used to 
do.  It kills me, literally, when I get home at night I'm, my legs turn red from heat rash or 
whatever.”  He told of his last work experience:
“You know fourteen hours a day out in the hot sun anymore.  I just, I was killing 
myself.  I just told the people I had to go.  I can't do this, I turned in my uniforms.  
Thank you, but no thank you.  I can’t handle this.” 
However, he told me he goes fishing whenever he can out in the sun.  He told me about 
his experience at work shortly after his biopsy:
“And they told me I couldn't go to work for you know four or five days because 
of the type of work I did.  And my boss didn't like to hear that….My boss sent me 
out all by myself 102 temperature, sick as a dog, to do irrigation work down out at 
Cortana Mall.  I did that for the first day, the second day, I only did it for half the 
day.  And I just told him, I'm going home or I'm going to die.”
Later, I asked Derrick how he felt most of the time and he replied, “Uh, usually pretty 
good, you know.”  He also relayed an interaction with someone at the disability office 
because he applied for disability. “And I told him look I’m not an idiot. I said I have 
Hepatitic C, I’m terminally ill, I’m dying here. And they told me I could work in a 
restaurant. They said I wasn’t sick enough.”  Derrick was a stage two in terms of liver 
fibrosis which is moderate scarring and numerous other respondents reported similar 
stages if not much worse.  It is also curious that Derrick told me information that is 
inarguably incorrect about the biopsy experience.  No doctor recommends not working 
for a period of days after biopsy.  In addition, one would not have fever because of a 
97
biopsy.  Thus, it is unclear why Derrick told me these things when I was studying HCV 
and would presumably know they were inaccurate.  
In short, Derrick was not upholding the expectations delineated by Parsons (1951) 
with regards to the sick role.  While he felt that he should be exempt from normal social 
obligations, such as working, the government (disability office) did not sanction this as 
his illness was not seen as severe enough.  Derrick discussed how his girlfriend, a person 
with paranoid schizophrenia, was on disability and got brand name Xanax because of her 
benefits while he had to take generic, suggesting how he would like to use his HCV as a 
means for secondary gains (Parsons 1951).  He did not seem dedicated to getting “well,”
another expectation associated with the sick role.  While he had sought technically 
competent help, he did not cooperate with the physician in terms of getting well in that, 
he still drinks alcohol and has rejected treatment because among several reasons, he 
would have to quit taking Xanax (Parsons 1951).  During my interview with him, Derrick 
did seem to be performing.  Charmaz (1991) describes how persons flaunting illness may 
“objectify self and illness and treat them as products that they manipulate for audience 
effect” (127).   
For Instrumental Help.  In order to receive support or assistance of various kinds, 
individuals have to tell others on occasion about their HCV status.  23% of the sample 
talked of disclosing one or more times for some pragmatic purpose.  Cece told me about 
calling a woman who worked at the halfway house because the woman’s husband worked 
at the Department of Health and Hospitals. She was having trouble getting an 
appointment at EKL as they had given her an appointment for many months ahead.  
Mack did talk with a guy in prison who was doing interferon because he wanted to know 
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how the guy felt.  Charlie told a friend of his whom also had it because Charlie was 
feeling that he needed to see a specialist again. His friend referred him to Dr. Cassidy.   
Jenn talked to all her friends that had gotten tattoos together in attempts to understand 
how she was infected.  Tari told her friend who worked in the lab at her work in the 
hopes of getting her labs run without identifying information attached to them, which her 
friend did.   Rick in trying to get information disclosed widely, “Yeah, well I go asked 
everybody I knew about havin it…Then I started talkin to more and more people and 
gettin information…”  David disclosed at work thinking he might get some help as he 
was having a hard time.  Derrick also disclosed at work because he was so sick he felt he 
needed to go home. Both men described these work environments in a negative fashion, 
so it is surprising that they disclosed as Munir et al. (2005) state that employees are less 
likely to disclose if they feel work is a negative environment.  Isabella had already 
disclosed at work but had to go to them again about the trouble she was having on 
treatment. 
Self-care.  Few respondents (6%) mentioned telling others about their health in 
order to attempt to get proper care for their disease.  Tom reminded his doctor about his 
HCV in order to make sure they didn’t prescribe any medication that may hurt him. Thus, 
one reason for disclosure to medical personnel is to protect one’s health.  Nick also told 
staff when he was admitted to prison to try to get proper care for himself even though he 
said, “ …sometimes when you say you got it it’s like [N sighs]”.  Rick, too, tried to get 
care while in prison, “No, in the in the jail system I just I tried to inquire about and get 
into some kind of program when I heard they had some kind of treatment for it.”  Several 
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respondents mentioned trying to get help or treatment for their HCV while incarcerated.  
This information is important considering the extremely high rates of HCV in prisons. 
CONCLUSION
Understanding varying levels of disclosure is important to grasp a holistic 
understanding of the overall illness experience across this diverse group.  Previous 
research on HCV has found that some people are afraid to disclose because of fear of 
discrimination (Glacken et al. 2001; Hepworth and Krug 1999; Zickmund et al. 2003).  
This research also reflects a group of individuals who are reluctant to disclose about their 
HCV status.  However, a large portion (47%) of the sample is disclosing very openly.  
Similar rates of disclosure were found in research among HIV positive women in Los 
Angeles with nearly half of the women having disclosed completely to their whole social 
network (Comer et al. 2000).  The few existing studies on HCV have not focused on 
these disclosure patterns.  
The most important finding resulting from this research is the connection between 
race and disclosure patterns among persons with HCV.  While my research is mainly 
limited to African Americans and Whites, significant differences emerge in terms of race 
(2=6.34, p<.01).  Racial or ethnic minorities, again who were mostly Black, were 
significantly more likely to be reluctant or disclose in a limited fashion.  HIV positive 
Latino men disclose less than Whites (Mason et al. 1995).  HIV positive Spanish 
speaking Latinas disclosed less than English speaking Latina, White, or African 
American women (Simoni et al. 1995).  However, Comer and colleagues (2000) found no 
differences in levels of disclosure among HIV positive women by race or ethnicity.  Chin 
and Kroesen (1999) studied HIV positive Asian Pacific American women and disclosure 
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because of the collective nature of Asian culture compared to an individualistic Anglo-
Saxon culture.  As suggested by Mason and colleagues (1995), African-Americans in this
sample may disclose less because of their fear of being further marginalized, 
discriminated against, or stigmatized.  Simoni and colleagues (1995) posit that Latinas 
disclose less because of less education about HIV in the Spanish speaking Latino 
population. Thus, perhaps knowledge of HCV is even poorer in the black population than 
among Whites.  
Other research that did not find racial or ethnic differences in terms of levels of 
disclosure for HIV positive women, did find differences related to mental health and 
levels of disclosure (Comer et al. 2000).  For Latinas, higher levels of disclosure were 
related to poorer mental health although this was not the case for White or Black women 
(Comer et al. 2000).  While my data does not allow for an evaluation of mental health 
status, future research should focus on any correlations with race, ethnicity, and mental 
health among persons with HCV.  Furthermore, the racial differences I found appear to 
be cultural in nature and not linked solely to socioeconomic status, as income was not 
related to levels of disclosure.    
Factors that affect disclosure with regards to other disease and that would 
seemingly matter for HCV are not especially useful in explaining levels of disclosure in 
this research.  Some researchers have found that disclosure of having HIV was affected 
by disease severity, among other factors (Mason et al. 1995; Tewksbury and McGaughey 
1997).  However, others have not found such a relationship (Comer et al. 2000).  For the 
respondents in this research, the presence of symptoms either because of the disease itself 
or because of treatment, whether a person has or has not undergone treatment, and years 
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since diagnosis are all unrelated to level of disclosure although presence of symptoms 
does affect reasons mentioned by respondents for disclosing.  Route of transmission is 
also unrelated to levels of disclosure (2 =.002, p>.97) which has affected disclosure for 
HIV positive persons in some research (Tewksbury and McGaughey 1997).  Persons who 
were infected through intravenous or intranasal drug usage are just as likely or unlikely as 
those infected through other means to disclose their HCV status.  This finding supports 
the premise that there is a lack of discourse about HCV in the United States, including 
accurate knowledge.  Therefore the public may not associate HCV with drug usage.  As 
mentioned previously, the AGA survey found that 30% of the non-infected American 
public connects HCV with drug addiction and other unhealthy lifestyles (AGA 2003).  
This finding contrasts with research in Australia that contends that there is readily 
available cultural imagery associating HCV and drug usage (Hepworth and Krug 1999).  
Although (Krug 1995) argues in an earlier article that HCV was not predominately 
associated with intravenous drug usage in print media or TV coverage in Australia. 
While there are some findings that gender affects stigma management, including 
disclosure, for other diseases (Tewksbury and McGaughey 1997), others find no 
differences by gender (Lee and Craft 2002).  We could also expect gender differences in 
disclosure patterns because of gendered conceptions of illness and risking being seen as a 
“double deviant”(Anderson 1991; Radley and Billig 1996; Schur 1984).  However, in 
terms of these persons with HCV, there are no gender differences in terms of varying 
levels of disclosure.  Age and education are also unrelated to levels of disclosure.  These 
are factors that have affected disclosure of HIV status in other research (Comer et al. 
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2000) although Mason et al. (1995) did not find age to be relevant to disclosure patterns 
in their sample.   
In this chapter, I discussed the various patterns of disclosure among persons with 
HCV ranging from Activist Disclosure to Reluctant Disclosure. Persons’ reasons for 
disclosing and not disclosing can be organized along the lines of being focused on others 
or the self.  As a whole, many persons with HCV do disclose and at fairly high levels. 
The higher rates of disclosure among Whites appear to be cultural and are unrelated to 
income.  In the next chapter, I address the various reactions to acts of disclosure
including stigmatization, lack of reactions, and positive reactions as well as the 
consequences of these reactions for the individuals.
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APPENDIX 3
3.1 ACTIVIST DISCLOSURE
Name Gender Age Race/Ethnicity
Education 
(Years)
Household Income Reported Mode of 
Transmission
Isabella Female 41 White 16 $30,000-39,999 Transfusion
Jenn Female 50 White 14 $50,000-59,999 Sex/household
Sharon Female 60 White 14 $0-9,999 Transfusion
Connie Female 70 Japanese 15 $50,000-59,999 Transfusion
Harold Male 47 White 16 $40,000-49,999 IV drugs
3.2 OPEN DISCLOSURE
Name Gender Age Race/Ethnicity
Education 
(Years)
Household Income Reported Mode of 
Transmission
Cece Female 45 White 9 $10,000-19,999 IV drugs
Daisy Female 61 White 11 $10,000-19,999 Transfusion
Karla Female 37 White 11 $0-9,999 IV/sex/household
Liz Female 53 White 12 $40,000-49,999 IV drugs
Lucy Female 53 White 13 $60,000-69,999 Sex/household
Peggy Female 53 White 13 $70,000-79,999 Needle stick
Catherine Female 41
African-
American 11 $10,000-19,999 Snorting drugs
Don Yi Female 68 Chinese 8 $20,000-29,999 Surgery
Daniel Male 46 White 9 $60,000-69,999 IV drugs
Derrick Male 36 White 12 $20,000-29,999
Snorting 
drugs/tattoo
Donald Male 70 White 5 $60,000-69,999 Transfusion
Eddy Male 47 White 20 $40,000-49,999 IV drugs
Jason Male 22 White 14 $90,000 or above Transfusion
Jeff Male 40 White 6 $0-9,999 IV drugs
Joey Male 50 White 12 $10,000-19,999 Snorting drugs
Rick Male 54 White 12 $0-9,999 IV drugs
Sparky Male 51 White 13 $40,000-49,999 IV drugs
Yellow Male 50 White 13 $10,000-19,999 IV drugs
Maruf Male 43 Jordanian 12 $30,000-39,999 IV drugs
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3.3 LIMITED DISCLOSURE
Name Gender Age Race/Ethnicity
Education 
(Years)
Household 
Income
Reported Mode of 
Transmission
Melissa Female 49 White 16 $80,000-89,999 IV drugs
Meredith Female 46 White 14 $20,000-29,999 IV drugs
Roxanne Female 35 Hispanic/White 13 $30,000-39,000 Transfusion
Sally Anne Female 50 White 12 $20,000-29,999 Transfusion
Samantha Female 26 White 12 $0-9,999 IV drugs
Ann Female 51 African-American 13 $10,000-19,999 Transfusion
Emma Female 54 African-American 9 $10,000-19,999 IV drugs
Jamie Female 53 African-American 13 $20,000-29,999 IV drugs
Tari Female 39 African-American 14 $60,000-69,999 Sex/household 
Bob Male 33 White 15 $10,000-19,999 IV drugs
Charlie Male 53 White 18 $90,000 or above IV drugs
David Male 48 White 14 $30,000-39,999 IV drugs
Larry Male 53 White 16 $10,000-19,999 IV drugs
Nick Male 47 White 8 $0-9,999 IV drugs
Tom Male 51 White 15 $50,000-59,999 IV drugs
Ellis Male 49 African-American 12 $50,000-59,999 Drinking 
Grant Male 51 African-American 10 $20,000-29,999 IV drugs
Jerry Male 51 African-American 10 $10,000-19,999 Unknown
Little 
Brother Male 42 African-American 12 Missing
Earring/Drinking after 
others
Stick Male 52 African-American 9 $30,000-39,999 Tattoos
3.4 RELUCTANT DISCLOSURE
Name Gender Age Race/Ethnicity
Education 
(Years)
Household 
Income
Reported Mode of 
transmission
Lauren Female 59 White 13 $10,000-19,999 Transfusion
Sherri Female 46 African-American 12 $0-9,999 Transfusion
Vanessa Female 41 African-American 13 $20,000-29,999 Tattoo
Mark Male 35 White 12 $30,000-39,999 Transfusion/sex
Ronald Male 54 White 18 $40,000-49,999 IV drugs
Andrew Male 44 African-American 12 $10,000-19,999 Drug related
Eric Male 49 African-American 12 $20,000-29,999 Unknown
Mack Male 52 African-American 13 $10,000-19,999 IV drugs
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3.5CHI-SQUARE CROSS TABULATIONS
Levels of Disclosure and Mode of Transmission (2=.01 p<.97)
Drug Related Other Mode Total
Limited/Reluctant 15 13 28
Open/Activist 13 11 24
28 24 52
Levels of Disclosure and Fear of Discrimination (2=6.6 p<.01)
Expressed Fear No Fear Total
Limited/Reluctant 11 17 28
Open/Activist   2 22 24
13 39 52
Race and Private Information (2= 13.26 p<.000)
Private Information No Mention of Private 
Information
Total
White 1 33 34
Minority 8 11 19
9 44 53
Gender and Protect Others (2= 6.42 p<.01)
Protect Others No Mention of Protect 
Others
Total
Female 14 10 24
Male   7 22 29
21 32 53
Levels of Disclosure and Protect Others (2= 7.08 p<.01)
Protect Others No Mention of Protect 
Others
Total
Limited/Reluctant 16 12 28
Open/Activist   5 19 24
21 31 53
Education and Protect Others (2= 11.48 p<.01)
Protect Others No Mention of Protect 
Others
Total
Less than High School   1 12 13
High School   4 10 14
More than High School 16 10 26
21 32 53
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Levels of Disclosure and Atypical Behavior (2= 6.07 p<.01)
Atypical Behavior No Mention of Atypical 
Behavior
Total
Limited/Reluctant   5 23 28
Open/Activist 12 12 24
17 35 53
Gender and Activism (2= 3.86 p<.05)
Protect Others No Mention of Protect 
Others
Total
Female 10 14 24
Male   5 24 29
15 38 53
Levels of Disclosure and Race (2= 6.34 p<.01)
White Minority Total
Limited/Reluctant 14 14 18
Open/Activist 20 4 24
34 18 52
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CHAPTER 4: IS HCV A STIGMATIZED DISEASE?  REACTIONS TO 
DISCLOSURES
Disclosing health status for persons with HCV can be a perilous endeavor or a 
relatively mundane experience, as discussed in Chapter 3.   Respondents cited numerous 
reasons for not disclosing.  However, people with HCV do frequently disclose their 
health status.
Much of the literature on stigma begins with an assumption that certain traits or 
attributes are stigmatizing for persons having the attribute.  As discussed in chapter 1, I 
use Link and Phelan’s (2001) definition of stigma in which labeling, stereotyping, status 
loss, and discrimination occur because of the attribute.  Previous research finds that HCV 
is stigmatizing yet does not elucidate what factors affect who is stigmatized (Hepworth 
and Krug 1999; Hopwood and Southgate 2003; Zickmund et al. 2003).  Existing research 
on HCV presumes that HCV is a salient identity for those who have it and that persons 
with HCV experience discrimination.  
I contend that persons with HCV are a heterogeneous group and should be 
conceptualized as such.  Slightly over half of the sample had heard of HCV before 
diagnosis, but Prior Knowledge varied.  Not all respondents seemed Aware of Stigma
associated with HCV.  More than half of the respondents engaged in self-labeling or felt 
stigma and/or had experienced enacted stigma with race affecting likelihood of 
stigmatization.  Felt stigma usually centered on the idea that others would associate HCV 
with a Deviant Lifestyle, that people would fear them because of Contagion, and that they 
would be seen as Dirty.  Respondents reported that enacted stigma was based on an 
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association with HCV and Deviance or a Fear of Contamination.  Several persons 
mentioned experiences of stigmatization in Healthcare Settings or the Workplace.  Some 
disclosures led to others Minimizing the Illness.  Not all responses were negative as some 
respondents described No Reaction to disclosure or Positive Reactions from Family, 
Friends and in the Workplace. Finally, I address methods of coping with stigma 
including Information Control as a means to avoid stigma as well as resist stigma, 
Condemning the Condemners, and Collective Action.
PRIOR KNOWLEDGE OF HCV
For most diseases, there exists vast cultural imagery and discourse.  Once 
becoming diagnosed, individuals must then come to terms with what that discourse 
means now that it applies to them.  This phenomenon is the crux of modified labeling 
theory.  It is more difficult, however, to apply this theoretical approach to HCV because
there is a lack of expectations about what it means to have the disease.  Many have never 
even heard of it.  Of the 45 interviews in which I could establish their previous 
knowledge about HCV, 56% said they had heard of HCV before diagnosis.  However, 
29% of the sample either admitted to just having heard of it, but not knowing anything 
about it or gave no indication that they knew anything about the disease.  Harold said, for 
example, “I’ve heard, you know I’ve heard a Hepatitis A, Hepatitis B, and I’ve heard 
some people talking about Hep C.  But I did not really look into it.”  David also reported, 
“I had heard of Hepatitis A and B and I heard that there were some other varieties of 
hepatitis, which I didn't know anything about, I just, was nothing I even thought about 
really.”  Daniel explained, “I didn’t know what it did to you, I didn’t know that it, I didn’t 
know it was a liver sickness, nothin.  I didn’t know any of that, I just knew that it was, it 
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was hepatitis, and it was a, it was a sickness.”  Others echoed these sentiments and in 
some cases I feel respondents may have said they have heard of it when I asked them so 
as to not appear ignorant.  For example, I asked Emma if she had ever heard of it and she 
told me yes. When I asked her what she knew about it, she told me “nothing”.
Slightly over a quarter of the sample had information beyond having heard of the 
disease. Daisy said, “Well, I'd heard of it, but I, you know I never dreamed I'd ever you 
know have it.  I've always heard of A, B, and, and C.  I always heard it was the silent 
disease, killin' disease and all.  That's the first thing that goes through a person's min d, 
you know.”  Some learned of HCV because of their drug use. Ronald said, “But I had 
heard of Hepatitis C plenty because of bein' part of the drug culture.”  Samantha adds, 
“The last time when I went out and really messed up in life, like everybody I was around 
had hepatitis C and I saw some people die from it, you know”.    Grant, Stick, Larry and 
Daniel had heard of HCV because they had friends who had it.  Tari’s husband was 
diagnosed years before her.  Peggy worked in a hospital so she was familiar with it and 
Jenn worked with a health education organization so she was informed.  Mark worked in 
law enforcement where he said many people have HCV. Derrick’s mother worked in 
healthcare, as did Matthew’s mother, so they knew of it through their mothers. 
Thus, some respondents did have some previous knowledge about the disease 
before being diagnosed, albeit not always accurate knowledge.  Many did not.  Because 
there is still such a lack of larger, cultural imagery surrounding HCV, knowledge about it 
did not necessarily give respondents a sense of what it meant to have HCV.  This 
invisibility accounts in part for some respondents being unaware that HCV is seen as 
stigmatizing by some.
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AWARE OF STIGMA
Over three quarters of the sample gave some indication in the interview that they 
were aware that HCV could be seen as stigmatizing.  Those respondents who have 
experienced enacted stigma, an act of discrimination, from disclosure were more likely to 
be aware of stigma (2 =6.51, p<.01).25  Respondents who were aware of stigma were 
also more likely to describe fear of discrimination (2 =5.04, p<.05).26 Whites were more 
likely to be aware of stigma than racial and ethnic minorities (2=6.41, p<.01). Whites 
disclosed at higher rates than other respondents and perhaps through more disclosure, 
they have become more attuned to possible stigmatization although level of disclosure 
alone is unrelated to awareness of stigma (2=.54, p<.5).   
Some comments simply reflect the idea that hepatitis scares others.  Sherri 
explained, “Cause I know some people get terrified when they hear hepatitis.”  More 
generally, others expressed a sentiment that any contagious disease is stigmatizing.   Rick 
said, “Oh, of course, a lot of people do [think HCV is stigmatizing]... Or link it with 
AIDS or any kind of disease that they think is contagious.” Ann said of why people might 
be secretive about it:
“Well, the enemy'll keep they mind focus on, don't nobody need ta know I have 
that, people a not gonna wanna talk ta me anymore, or they not gonna wanna be 
around me anymo'.  So those type a things that make people afraid not to openly 
talk about what they're goin' through.
People feared an association of HCV and deviant behavior including sexual 
behavior, drug use and alcohol abuse as mentioned in Chapter 3.  Many interviewees 
recognized the association between HCV and drugs and that this could be stigmatizing, 
25
 See Appendix 4.1 on page 145. 
26
 See Appendix 4.4 on pages 146-7 for cross tabulations for all chi-square calculations in Chapter 4.  
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although as previously mentioned, only some of the respondents felt this personally 
affected their own disclosures.  Ellis says, “I never talk to nobody who, got it from no 
drugs, if they did, they didn’t admit it.”  Liz tried to start a support group and no one 
showed up. She said it was because no one wanted anyone to know they had HCV. When 
I asked why, she responded, 
“Most people connect it with a drug disease.  You know.  And, and I mean it 
depends on who you hang around with [L laughs], but you know, but I don't 
know…I don't understand why people have such a problem with that.”   
Maruf outright denies any stigma when I ask about it. Yet he adds,
“And a lot of people think whoever had hepatitis C may have AIDS or may have 
other diseases, but I don’t… Yeah most people think oh if you have hepatitis C 
you did drugs before, you shot needles or you if you have hepatitis C probably 
have AIDS.  I know people will think like that [M sighs], but anyway the people 
that know about my problem is the family so I mean I don’t think they gonna go.”
Numerous respondents brought up the issue of stigma before I could even ask 
them.  Karla had actually stigmatized others before she and her husband were diagnosed. 
She says of a conversation with a friend whose girlfriend had HCV, “What the hell is 
that?  Oh it's like AIDS.  And that was--I just left it at that.  I said you slept with her, you 
nasty thing.”  Sharon says, 
“The stigma.  There's a huge stigma attached to Hepatitis C.  It's a lot better now, 
but two years ago, five years ago, I mean it was worse than HIV.  (I ask what the 
stigma is about)…IV drugs.  It's always been called, Hepatitis C.  There was an 
article in Times, in April of that year— Hepatitis C was always called the drug, a 
drug disease, because it was transferred mostly in those early 70's and 80's and 
60's by IV drug users, and tattoos and stuff like that.“
Twenty three percent of the sample seemed unaware of a stigma associated with 
HCV although I did not always specifically ask if they thought HCV was stigmatized. 
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Yet most others explicitly or implicitly mentioned it. So either these people did not find it 
salient enough to bring it up or are aware of stigma but did not mention it.  
FELT STIGMA
Felt stigma refers to the process of self-labeling.  People may use Mead’s concept 
of the generalized other to “take on” how they believe others perceive them (Link 1987).  
Persons may change their interaction style if they engage in felt stigma because they are 
expecting rejection of some sort.  Some suggest that felt stigma is even more damaging 
than enacted stigma (Greil 1991), while others feel that felt stigma actually reduces 
enacted stigma (Jacoby 1994).  
While several studies looking at HCV have focused on enacted stigma, there is 
less attention on felt stigma or it is briefly mentioned.  Hopwood and Southgate (2003) 
remark that “people newly diagnosed with hepatitis C often describe a sense of being 
perceived differently by those around them” (254).  Hepworth and Krug (1999) also state 
that persons with HCV must grapple with the knowledge that they have a stigmatized 
disease. 
 In this research, over half of the sample mentioned various type s of felt stigma.  
The three themes that emerged were fears that others would associate HCV with a certain 
lifestyle, that others would fear them because HCV was seen as contagious, and finally a 
sense that others would see them as dirty because of having HCV.  Engaging in felt 
stigma was not related to having experienced enacted stigma (2=3.31, p>.07).   
HCV AND DEVIANT LIFESTYLES
Almost a third of people mentioned that they worried that others would associate 
HCV with lifestyle choices involving drugs, alcohol, or sex, supporting findings by 
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Zickmund and colleagues (2003).  Some of these respondents did not get HCV through 
drugs but feared others would think they did.  Jenn says of disclosing to people at work:
“… course my kids knew I’d never injected drugs or anything so I knew they 
weren’t gonna think that that’s how I got it you know, but people I’ve only known 
for four or five years [J chuckles] those are the ones I kinda wondered about.  
Donald mentioned how he drank some during his life, but not enough to hurt his liver.  
He recognized that liver disease is associated with alcohol. Lucy also explained how she 
was previously married but was never promiscuous and never even drank a beer.  Lucy 
mentioned again that “But you know, I don't even drink.  Never drank, never smoke, 
never did dope, you know, nothin.”  She also spoke of how surprised she was when 
Donald was diagnosed because he wasn’t a “dopehead.”   Lauren said, “And, that, that 
worries me too that people even think I was an alcoholic and, or on drugs, because that’s 
the main thing that goes wrong with your liver, most people think.”  Other respondents 
who did contract HCV through drug use worried what others would think. David says, 
“And especially when you have that and people know well, if you have that, you did 
something you shouldn’t a did, done.” 
 Like Lucy, Sallie Anne noted that she was not infected from promiscuous sex.  
She talked of when she and her husband were separated, “And I did not, but at that time 
you know I did not have multiple boyfriends, or multiple sex or anything like that.  So I 
know that I didn't get it then.”
HCV IS CONTAGIOUS 
Nearly a third of respondents worried about being seen as contagious.  Tari feared
being treated differently because of having a disease. Likewise, Vanessa adds, 
“Because people get kinda, you know--if you say certain things especially if 
you're dealin' with somethin' that's contagious or whatever people get kinda 
114
scared and stuff… but you know, if you say [whispers] Hepatitis, every body
knows that, that it's deadly.” 
 Part of Lauren’s fear was also about the contagious aspect:
 “Right, yeah.  And, nobody wants to give a chance to, you know, I mean, if, I 
heard that you had somethin’ you know, anything, and it worried me that, oh, I 
don’t want to be around you cause I might get it.  I felt stuff like that.”  
Roxanne says, “…and if they knew I had Hepatitis C, they wouldn’t let me work.” 
Three respondents associate HCV with leprosy.  They may be relying on the 
history of leprosy as being an extremely stigmatized disease to emphasize their fears 
about having HCV.   David says, 
“I was, my, one of my fears was rejection from people because I felt like I was 
gonna be, you know, be treated like a leper…And you know like, get away from 
me, you know, don't breathe on me, don't touch me, you know, and, you hate for 
people to make you feel like that”.  
Ronald says,
“Was that I kinda put the, you know I felt like that, you know, anyone that knew I 
had it, you know, they'd shy away or get… I'm ashamed.  You know, basically 
shame and not wanting to deal with their reactions to it.  In other words, I'm afraid 
they'll be afraid of me, like I'm a leper or something.”  
Meredith said when I asked about what she thought others associated when they heard the 
word hepatitis:
“Somebody who had a really fucked up life.  Um, somebody, they think of hep--
when they think of Hepatitis they think unclean... That, that you, you are unclean, 
you know [M chuckles], it's kind of like, it's almost like a, to me, if I were, if I 
were to write it down I would associate it with like leprosy.”
Zickmund and colleagues (2003) had a respondent who said, ‘They treated me like a 
leper’ (835). Thus, the reliance on this imagery is not unheard of in other populations of 
persons with HCV. 
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PEOPLE WITH HCV ARE DIRTY
The association of HCV with contagion and leprosy closely follows with the 
theme of being seen as dirty, expressed by 13% of the sample. Isabella said, 
“Cuz you think that you know, you’re poison.  You're, I mean, I felt, when I was 
dia-- I felt dirty you know and I've heard a lot of people with IV drug histories say 
they were dirty but I felt dirty too.  You know, with the, just, and the stigmatism 
that’s attached to Hepatitis.”
There were no associations in this sample between describing this feeling and mode of 
transmission. Eddy also said, “Dirty, dirty. It was, it was, the thing, it’s been, I mean it 
hasn’t come up for a lot of years, but it occasionally comes up again, it’s the, it’s the my 
blood is toxic feeling.”  Samantha feared, “I’m thinking, shit, I gave it to him, he’s gonna 
hate me, I’m dirty, how can you look at me, I’m disgusting and I just felt so filthy.” Mark 
said, “You’re a nasty person…Dirty, yah, you're not a clean person, or something like 
that.”  Hepworth and Krug (1999) also note how persons with HCV described feeling 
dirty and unclean.
AWARENESS OF FELT STIGMA
Several respondents recognized that their self-labeling may affect their 
interpretations of interactions with others.  David, despite asserting that he had trouble at 
work because of HCV said this when I asked him if he had had a negative reaction from 
disclosing to anyone:
“I have felt like that, but I don’t know specifically if it was-if I was really seeing 
that, or if it was just me, you know, thinking that they were feeling like that--I 
mean I didn’t have any, I didn’t, I can’t really say that I had somebody definitely, 
that I definitely know reacted that way.
Isabella states, “Um I felt...I've had feelings of rejection.  Which, you know, you think 
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that people are rejecting you, maybe they’re not, maybe they are, they could be.”  Bob 
said, 
“Not because of it, because I, so few people know and I think that most of 
the…most of it comes from myself.  I really do, I think that most of it comes from 
myself because and, and that’s maybe why I’m, you know, I don’t broadcast that, 
cause I tend to be someone who broadcasts a lot of things about myself, personal 
things that aren’t necessarily nice, I don’t necessarily paint always a pretty picture 
of myself but I don’t tell that, you know, and there’s a certain perception that I 
have like it’s the plague.”
FACTORS LINKED TO FELT STIGMA
White respondents are more likely to report felt stigma (2 =4.71, p<.05).27
Whites do disclose at higher levels and similar to their awareness of stigma, the higher 
rates of disclosure may allow more opportunities to project how others might view one 
and thus engage in felt stigma, although there is no direct relation between felt stigma and 
levels of disclosure.  How a person acquired the disease is unrelated to engaging in self 
stigmatization.  Thus persons who acquired the disease through drug use are no more or 
less likely to self stigmatize.  
ENACTED STIGMA
 Enacted stigma refers to the process whereby persons are labeled as different, 
stereotyped, seen as the “other,” and experience status loss and discrimination (Link and 
Phelan 2001).  Nearly half of the respondents (49%) in this research indicated that they 
had experienced some type of enacted stigma as a result of disclosing their health status.  
“Othering” persons with HCV and discriminatory behavior surfaced as a fear of 
contamination resulting in status loss in various forms.  Labeling and stereotyping often 
had to do with associating HCV with drugs, alcohol, or sex.  Some respondents felt that 
27
 See Appendix 4.2 on page 145. 
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people used their HCV as an excuse to shun them. Respondents also discuss specific 
experiences in the workplace as well as in healthcare.  
DISCRIMINATION AND FEAR OF CONTAMINATION
Over one third of respondents revealed that they had experienced discriminatory 
behavior that centered on fear of contamination.  Several respondents described 
interactions that could be defined as discriminatory, although they did not portray them as 
such.  Sharon’s son was worried that she might give it to the grandkids so she sent him to 
talk to the doctor.  Liz describes telling some of her friends:
“What's--well, I've got Hepatitis C.  And it was like all of them, 'bout six women, 
stepped backwards.  Only one of 'em stayed in position.  And I was like, I'm not 
contagious.  They went, oh we didn't do that, you know.  I said, that's ok, 
whatever, you know I'm just pickin' on you all anyway, I mean.”
Daniel experienced mild anxiety from others a few times:  “Not much, but I did have 
people like I would tell somebody about it like in the store or whatever and we’d be 
talkin’, they would say stuff like, well you can’t catch that from somebody, can ya?”  
Roxanne said, “Um, some of my friends it made a difference, some I had over or 
something somebody pop a mosquito and then it had blood in it or somethin' they'd freak 
out, you know, I am like, it’s cool.”  Cece recounted people shying away from her as did 
Yellow and Roxanne.  Nick mentioned that in jail some of the guys were wary of 
touching any of his things. He mentioned that the Black men were scared but not the 
White men. Rick said, “Yeah, people that still think you can catch it sexually.  There's 
comments you know, when you are tryin’ to have a general conversation, like in a 
group.”  Jerry said that some people stare at him (he has severe skin problems from 
HCV) but that it doesn’t really bother him. He said, 
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“No.  It's just some people that I know of look at me and they go talk to their 
friend and they point at---He got a bad rash.  Just get back to my home.  I just 
ignore them.  I don't call and tell em’ nothing and the people I hear it from, they 
something wrong with them’ they family, I won't get out there and say nothin' 
about it, you know? “
When I asked if that doesn’t hurt his feelings, he admitted it does a little bit but that, “I 
don't stop goin' and doin' the things I--I go out in public. I go to the grocery store, you 
know, and that.”
 Several interviewees described experiences surrounding eating utensils.   Isabella 
said, ““And it's you know, I, they did it when I first got diagnosed they specified that I 
used this particular cup at the house.”  Tom had noticed people were scared to eat off the 
same plate as him.  Joey’s mom told me how people at the blood blank were scared to 
touch things and then she mentioned how she does not let anyone else in the family drink 
out of Joey’s cups. 
Other stories centered around objects of potential contamination as well.  
Meredith told me about an acquaintance not wanting her to use his eye drops:
“Just like, son of a bitch, you know, cause I knew what it was all about cause, you 
know, even though they're considered like, he considers himself an open minded 
individual, you know, whatever still there is that.  And you know, I mean, there is 
a lotta stuff runnin' around out there but to, I try not to get it too mixed up with 
paranoia.”
Karla said of one of her sisters:
“When Jeff first got diagnosed with Hepatitis C, was when he was in the hospital.  
I was covered in blood, and, uh, my sister acted real funny because she wanted me 
to take all my clothes off and she wanted to burn 'em instead of washin' 'em.”  
A few respondents had intense negative reactions from others.  Samantha told an 
acquaintance about her HCV status:
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“She was talking about how her dad had it and I was like oh yeah, you know, and 
I mentioned how I had it and stuff and well, next thing you know, her grandma 
was calling like some people that we both knew saying Samantha has this 
hepatitis disease and she was around her, my friend, her little baby…and her 
grandma was like you know, she was around the baby. I just want to find out what 
is going on, because I need to get the baby tested because the baby probably has 
it, you know, I’m going to get tested because I probably have it now because she 
was at our house, you know”. 
Jenn’s good friend was furious with her because she was going to school to be in 
healthcare and feared she might have gotten it from Jenn and would not be able to work.  
Ellis said about his ex-wife, “…to the Hepatitis thing, full time she kinda lost her trust in 
me.  And so uh, we kind a separated by it.”  Yellow said in regards to his ex-wife of 
twenty-eight years, he said, “Everything went fine 'till, 'till, until I got this Hepatitis C 
and, and she was lookin' for other angles out, and, you know when it happened it 
happened”.  
Of all the respondents, Karla and Jeff reported the most discrimination.  Karla 
disclosed to her daughter, “…and I told her I had Hepatitis C, so that right there tell ya 
that she don't have nothin' to do with me.  She said it ain't no different than havin' AIDS 
to her.”  Karla has no contact with one of her brothers either:
“Yeah.  My brother Mike said Jeff couldn't come to his house because if he catch 
any diseases, he wanted to catch 'em on his own.  And he said but you can come.  
I said well, I can't come either.  Why not?  I said I got Hepatitis C too, so I'll see 
you when you die in hell, ok? [K chuckles]  I hung up on 'em.  I hadn't talked to 
him since then.”  
Jeff explained:
“But some people feels that they can catch it just by being around you.  You 
know, by--ok, you sit there, I can't sit there.  Some people are--my, like Kenny 
and them, they know, you know they--Kenny knows, he lives with us.  And this--
her, well, her kids live across the street.  Now, their grandpa-- he says no.  They 
don't know--can't nobody tell him no different.  They can get it from me just by 
talkin' to me.  I said alright, whatever you want to believe, you know.  So if she 
wants to see her kids, she has to go over there.  They can't come here.”
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Karla adds that she is not allowed to hug or kiss her kids.  Karla talks about her children’s 
father’s mother’s behavior.  “But Miss Patsy, she does it for spite.  She kisses and hugs 
on me.  She says maybe if I waller all over you, he [her husband] won't have nothin' to do 
with me.”  Another study found similar responses with regards to hugging and kissing 
among families when someone has HCV (Crofts et al. 1997).  
LABELING AND STEREOTYPING HCV AND DEVIANCE
Almost one in four respondents described some type of labeling and stereotyping 
linking their HCV with deviance. Yellow says, “ Ah, it's just, my sister, my oldest sister 
came up to me one day and she says, It's only because of the lifestyle that you lived, is 
the reason why you gonna die. And, uh, it really tore me up.”  Likewise, Larry says of his 
mother:
“She doesn't come out and say it, but you know, that's what it's all about, the 
bottom line, it's because I got it through drug use, I know that's what it's all about, 
and she'll go to her grave you know  blamin' me, it's done, it's over with, get over 
it, I've gotten over it.”
Bob told one of his girlfriends:
“I remember talking to her about it and looking into it cause I was nervous and I 
think she was really nervous too like wow-and she didn’t know what it was, you 
know, and it was like, wow you gave me junkie’s disease, I’m not even a junkie, 
you know.”  
 Roxanne’s mother attributed it to her being a lesbian. “Like I said at first, she 
treated it as AIDS, as well, you know.  This is you're lifestyle, see I told you, this is 
gonna get in trouble and all this stuff.”  Tom said, “People act like it’s a dirty disease, 
like you gave it to yourself.”  Ellis revealed, 
“Well my mother, she is a very religious lady and all she did was fuss.  I told you 
bout drinkin’.  I told you ‘bout bein’ out in the streets.  I told you about bein’ with 
people, these certain people, these people are gonna get you in trouble, get you 
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killed.  But my wife, she didn't.  Well I been married two times my first wife, she 
didn't, she didn't take it too well.   I think she may have thought I was foolin’ 
around or somethin’.”
These persons were blamed by others for contracting the disease from behaviors they had 
engaged in. They have experienced status loss in that they are seen as deserving of the 
disease and different from others.
STIGMA IN HEALTHCARE 
Discrimination in healthcare settings was not nearly as common of a problem as 
prior research suggests (Hopwood and Southgate 2003; Zickmund et al. 2003 ).  Seven 
respondents reported discrimination in healthcare settings.  One drawback of my 
recruitment method is that I went through one hepatologist.  It could be that he treats his 
patients well and thus they report little discrimination. However, numerous respondents 
had seen and continue to see other physicians in different healthcare settings for various 
other healthcare needs.  Another possible explanation is that perhaps there is simply less 
discrimination in healthcare currently than when previous research was done, although 
quite a few respondents in this research have had HCV for many years.  Several 
respondents did, however, describe negative experiences.  Eddy recalled, 
“I don’t remember what it was-Ahh, no it was, maybe it was at the dental school 
that I had to get, if I had hepatitis C, I had to get some kind of certificate from a 
doctor saying something, you know just something ridiculous…it was either that 
they said, we won’t treat you or we have to get a certificate, uh, and so I lied. And 
this is just a really vague memory, so I may be wrong, but I think that’s what it 
was.” 
After Isabella gave birth, a nurse put a big sign on the room door saying she had HCV, 
which her in-laws did not know about it at the time.  Lauren also had a traumatic 
experience:
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“This doctor.  Dr. Ray.  Um, I went up to see him, forgot what he was oh, he’s an 
internist…he came in and he stood over in the corner with his arms folded and I 
said, what’s wrong with you?  And he said, I consider you highly 
contagious…And he stood across the room, but he had to feel my liver so he put 
on gloves, and very, you know like, my liver was gonna jump up and bite or 
something, but, I just, I couldn’t stand him, I was supposed to see him and I could 
not”.
Bob revealed a patronizing experience from healthcare workers:
“I was in the hospital for, um, liver related illness and even other illnesses and 
kinda gotten the response like why would you do that to yourself, don’t you know 
what you’re doin’ to yourself?  And it’s sort of like very motherly kind of finger 
pointing and not in a really oppressive way but just in a in enough way to really 
make me uncomfortable and question why I even bother telling them, you know, 
um.”
Several respondents experienced stereotyping about HCV. Two women were 
teased by their female doctors when they disclosed their HCV status. Cece told me about 
her experience with a pain management physician. “She's an Asian lady about in her 50's 
and she says Cece, you was a bad girl, you know, 'cause when I told her my history, you 
know.” Jenn had a similar interaction with her dentist. “She said, she laughed about it, 
she said oh just admit you were a wild little thing when you were young. I said well yeah 
I did do a lotta runnin’ around when I was young and unmarried.”  Neither woman was 
offended by these comments and both seemed to be amused by them instead.  However, 
others could possibly have a very different reaction to similar comments perhaps if made 
by a man or someone much older.  Both Cece and Jenn were fairly open with disclosure 
in general and were white women.  While Cece and Jenn did not seem to experience 
status loss as a result of these interactions, the same behavior by healthcare professionals 
could have drastically different results with different people. 
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STIGMA IN THE WORKPLACE
Crofts, Louie, and Loff (1997) found numerous problems with discrimination and 
HCV in the workplace.  Over a quarter of respondents in research by Zickmund and 
colleagues (2003) reported problems at work.  Four persons in this research spoke of 
discrimination and employment.   When David told a manager at work, “I think it even 
made it worse, so uh, I think my manager had it in for me, and I think she was looking 
for-so I ended up, what I did, was I finally made a realization that I wasn’t gonna make 
it.”  He also said about this job, “That I had to work at a hundred percent or not at all.  
That was, that was the words from 'em, I tried ta, seek help through an attorney but and 
disabilities…” Roxanne had lost jobs from having HCV. Derrick also attributed losing 
his job to disclosing at work.  He said more about this:
“Everybody has their conspiracy theories but I was costing this insurance 
company which is United Health Care, I was you know, I was thinking about 
going on the medication, and they had approved it, and they knew that it was a 
thousand dollars plus a month. So I think because he was a small company, they 
told him it would be better for him to just cancel his policy, and then my policy 
would be cancelled also”. 
Larry, when working construction, disclosed to several guys at work. He told me this 
story:
“And so I got a little shot of water, and it hit me all over the face, and everything 
cuz I was so far away from it.  And a little while later, I noticed some, they were 
all standing over there talking, the cups had gotten there.  And they were all 
standing there talking, and all of a sudden, one of the laborers threw the water 
barrel, in the uh, in a little bobcat, and run up to the front to get some fresh water.  
I said, I wonder if that water was left over from yesterday.  And then my buddy 
came over, he had been standing over there, he said, you better watch how you 
drink your water around here, these people gonna kill you.  I said what you talkin' 
bout.  He said, they saw you uh, leaning over and getting water.  I said, yah, but 
my lips didn't get no closer than 80 inches from the spigot.  I said, you can't get it 
that way anyway.  But I said, I'm even super careful then.  He said, well I don't 
know what to tell you.  He said, they gettin' clean water.  And that was the 
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deciding point there.  I said, you know, if it's going to be like that out here.  I 
might as well just go to the boss and about ten minutes later I went to the 
superintendent, cuz see he found out about it too.  And he already, he knew that 
something was going on.  So I went ahead and explained it to him, and pretty 
much quit right then and there.  So, I I've learned one thing, I never tell anybody 
again.  That's the last time I I'll ever tell anyone, on the job, that I have to work 
with, you know.”
INTERPRETATIONS OF ENACTED STIGMA
Several respondents, as previously mentioned, did not describe discriminatory 
reactions to disclosure as negative.  However, I categorize their experience as 
stigmatization based on the working definition of stigma that I am using.  When I first 
asked Eddy if he had experienced any weird or uncomfortable reactions, he said no.  
However, he then remembered the previously mentioned experience he had with a 
dentist.  The experience either did not have a lasting effect on him or he pushed the 
memory away in order to distance any feelings of stigmatization.   He added later that, 
“I’d be very offended, take legal action if anybody discriminated against me because of 
it.”  Sharon also did not feel she had ever been stigmatized.  Yet she relayed this 
interaction, “They, you know my son's a little nuts and so he, he's a little afraid that I 
might do something that would hurt his children and then that's when we all got tested 
and I sent him to talk to my doctors because it is a concern for him and I understand 
that.”  Joey’s mom did not let anyone else in the family drink out of his cup, yet this is 
not a viable means of transmission.  Finally, Daisy was repeatedly asked by doctors if she 
drank or did drugs, yet she did not feel that she had ever had a negative reaction from 
anyone:
“Yeah, but that was so funny because when they told me I had Hepatitis, they 
wanted to know how much I drank, I said, I don't, I'm not a drinker.  They went, 
how much drugs do you do.  I said, Mhmm.  I don't like needles and I don't do 
drugs, and they looked at me like I was kind of storying to 'em.”
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These persons may be interpreting these experiences in such a way as to minimize any 
impact on their sense of self-worth, a frequently used strategy in coping with stigma 
(Shih 2004).  Or it could be that they simply did not evaluate these behaviors as 
stigmatizing, which does seem to be the case for Joey.
FACTORS LINKED TO ENACTED STIGMA
Hopwood and Southgate (2003) discuss HCV related discrimination as occurring 
at the governmental, institutional and interpersonal level.   Zickmund and colleagues
(2003) found that 57% of their sample recruited through a hospital reported 
stigmatization (they did not include felt stigma).  Age, education, professional status, and 
mode of transmission were all unrelated to likelihood of experiencing stigmatization.  
They found that women were more likely to report stigmatization than men.   
Roughly half of this sample experienced enacted stigma.  Unlike Zickmund’s 
research (2003), I found no gender differences in experiences with stigmatization28.  
Reported mode of transmission was not related to experiences with stigmatization.  
However, mode of transmission may be unrelated because of the lack of knowledge 
among the public about how people get HCV.  Even with HIV, fear of contamination is 
often the source of discrimination more so than any association with homosexual 
behavior (Tewksbury and McGaughey 1997).  Fear of contamination was also a large 
source of enacted stigma in this sample.  
Whites are more likely to report enacted stigma than black respondents (2
=13.12, p<.001).  Perhaps because of their more open patterns of disclosure as a whole, 
Whites have had more negative reactions to their disclosures than minorities with more 
28
 See Appendix 4.3 on page145. 
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than half of Whites reporting a negative reaction compared to one fifth of minority 
respondents.  However level of disclosure alone is unrelated to enacted stigma (2 =2.79,
p>.1).  As stated previously, Whites are more aware that there is a stigma associated with 
HCV.  Having experienced enacted stigma is related to awareness of stigma (2=6.51, 
p<.01), although causality cannot be determined with this data.  It could be that Blacks 
experience similar behaviors, but because of already having one stigmatized status, do 
not attribute discriminatory behavior to having HCV per se.  Conversely, it could be that 
Black people in general are less discriminating towards persons with HCV than Whites 
assuming social interactions are mainly with one’s own racial and ethnic group, which in 
the research locale is not presumptuous.  Whites have been found to blame people with 
AIDS and have more negative feelings towards them than blacks (Herek and Capitanio 
1993), which could translate into feelings about HCV as well.  Finally, Whites in this 
sample had a better understanding of the disease than blacks as will be discussed in 
Chapter 5.  Although this is speculative, Whites generally may have more knowledge of 
HCV and thus more negative affect towards it than Black laypersons.  Future research 
needs to assess levels of public knowledge among different groups.  
OTHER REACTIONS TO DISCLOSURE
There are numerous other interactions respondents described besides stigmatizing 
experiences in response to disclosures.  Some respondents had persons minimize their 
illness, give little to no reaction, or described positive or supportive reactions. 
MINIMIZING ILLNESS
Three respondents mentioned that they felt others minimized their illness.  Liz 
described how some of her family discounted her symptoms while undergoing treatment. 
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“Well, I was sick most of the time, and certain members of my family were like, there 
ain't nothin' wrong with her, she just don't wanna be, you know--she just wants to sit 
around at home all day, you know.”  Isabella’s sister also seemed to doubt the seriousness 
of HCV.  “One of my sisters kept callin’ me one time tellin’ me about a girl she was 
workin’ with that had Hepatitis C and sayin’ this girl's takin’ off too much work, I don't 
really think she's all that sick.  And I think she's makin’ it up.”
While minimization of illness was not commonly reported among this sample, it 
is not surprising considering the lack of discourse about HCV.  Numerous “syndromes” 
in the twentieth century have been denied full, legitimate disease status, such as myalgic 
encephalomyelitis, repetitive strain injury, and multiple chemical sensitivity (Cooper 
2001).  While HCV is different in that is it fully recognized as an organic disease by the 
medical profession, it does lack easily identifiable symptoms to the public.  A person can 
have HCV and “look” fine.  Even more confusing is that many persons can have active 
HCV and have no symptoms.  Persons with myalgic encephalomyelitis commonly 
experience disbelief and misunderstanding concerning the symptom of fatigue (Cooper 
2001).  Cooper (2001) describes how “when patients talked of ‘fatigue’, they explained 
afterwards that they meant something different from what was commonly understood by 
the term” (115).  Sharon, a woman with HCV in my research, made a similar statement. 
“If you don't, if you've never had fatigue you don't know the difference.  But once you've 
had fatigue you understand that there is a humongous difference between tired all the 
time and fatigue.”
Fatigue is a main symptom for people with HCV.  However, there is even debate 
among medical specialists about whether fatigue is even a “real” symptom.  Compared to 
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persons with Hepatitis B virus (HBV), persons with HCV do have a reduction in quality 
of life for both physical and mental health aspects (Foster et al. 1998).   Yet numerous 
researchers assert that it is a labeling effect that makes patients suddenly start 
complaining of fatigue in addition to other symptoms and that those who are unaware of 
their HCV status have similar quality of life measures as control groups (Cordoba et al. 
2003; Rodger et al. 1999; Schwarzinger et al. 2004).  Several of my respondents did 
make statements supporting a labeling effect.  Peggy had very elevated liver enzymes at 
the time of diagnosis, which often translates into severe fatigue as well as other 
symptoms.  However, when I asked her if she felt poorly, she responded with a laugh, 
“Not until they decided I had it.”   Samantha comments on the difficulty of establishing 
whether her physical symptoms are even from having HCV. “I don’t know if it’s because 
of the hepatitis, or the medication I take. I’m tired, I feel worn out a lot. I don’t know 
what it could be, I just feel worn out a lot.” 
 Numerous other respondents, however, described debilitating, severe fatigue.  
Sharon described, “I got to a point where I would walk in this door and I would on hands 
and knees crawl upstairs to my bedroom.  I could not make it standin' up.”  Connie told 
me about an experience that led to her diagnosis and negates a labeling effect.  I can’t 
stand anymore.  I was so tired.  So I sit down on the front of the building there little space 
you could sit, and I said this is not like me.  Because I always have some energy, 
anymore.  And I can’t stand up you know.”
Some persons with HCV may have only started experiencing symptoms once 
diagnosed while others had and continue to experience symptoms.  While it is unlikely 
this debate has moved much beyond medical specialists studying hepatitis, the 
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implications are foreboding in terms of doctor patient interactions as well as knowledge 
and discourse about the disease emanating from physicians who discount the existence of 
symptoms.        
NO REACTION
Fifteen percent of the sample reported others had no reaction to their disclosure.  
Stick’s wife told his son and daughter and law.  He told me that they “Didn’t say 
anything.”  Grant’s siblings also did not say anything to him when they were told.  When 
I asked if they were worried, he replied, “No, they didn't never say nothin'.”  When I 
asked Andrew about his mother’s reaction, he said, “Well, you know, she, wasn’t too 
much she could of said.”  Lauren’s live in friend did not express a lot of emotion. “Mmm, 
all I remember him sayin' was, oh baby, you know and that was it.  He's not very, he 
doesn't know how to put his emotions into feelings and stuff.”  When Emma told her 
family, “Wasn’t really like they broke down or nothin’ but I know they was, like, hurt…I 
could see it in their faces.”  Grant’s wife seemed more concerned about her health when 
he disclosed to her:
“She said, you've got Hepatitis I said yah, she said well, when I go back to my 
doctor I’m gonna ask my doctor to check. That's about it. Cuz she's kinda worried 
but the doctor I told her the doctor said you couldn't catch it.”  
These type of reactions from family or friends may be disappointing for persons 
with HCV if they expected more outward signs of concern or support.  Persons who 
mentioned others having little or no reaction are less likely to report enacted stigma 
though (2 =5.04, p<.05).  Thus, no reaction may be seen as more desirable than a 
negative reaction. 
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In some situations, no reaction is desirable because they are people who one 
would not expect compassion or support from.  In addition, often in these situations, no 
reaction indicates that the person does not see you as different after disclosure, thus 
reaffirming your non-HCV identity.   Jeff said that all the people he tattooed still kept 
going to him after he told them and that they were not concerned because he wore gloves.  
Roxanne said her tattoo artists have had little response when she has told them.  Others 
report their physicians had little to no reaction when told. Connie said her dentist simply 
thanked her for telling him. Eddie also said he got no reaction upon disclosure to some 
physicians.  Vanessa mused about healthcare workers’ lack of reaction, “Yah, they, uh, 
they don't really say anything.  I guess they are maybe educated about it or somethin’-so 
they don't.”  Lauren said this about disclosing to most healthcare workers, “In fact the 
majority of them appreciate it and go, whoa, most people don’t tell us ‘till after, you 
know.”  
POSITIVE REACTION
While quite a few respondents described negative reactions to disclosure, over a 
third of respondents talked of some positive reactions when they disclosed their HCV
status.  These positive reactions to disclosure are a reflection of social support when it is 
conceptualized as "positive, potentially health promoting or stress-buffering aspects of 
relationships such as instrumental aid, emotional caring or concern, and
information"(House et al. 1988).  Research shows social support is a beneficial coping 
resource (Thoits 1995).  Persons mentioned family most commonly and then the positive 
reactions of friends and at work.   
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Support from Family. Family can provide various types of support for individuals 
with HCV.  Persons in this research mentioned emotional support frequently.  Liz says, 
“My mother was--my mother's worried about me.  She's been worried about me.”  She 
talked about how her mother always tries to offer her medicine, food, etc. to make her 
feel better.  Several respondents mentioned overall positive reactions from family.  
Ronald says, “But the people that I've told were the people that I'm the closest to and 
they've all just mainly shown concern.  None of them were negative about it.  They were 
all--showed, you know, were concerned about it.”  Harold describes similar reactions 
from his family, “No, it’s all been positive.  Uh, you know they ask how I’m doing from 
time to time, and everything.  So uh, you know there’s an overwhelming support.”  Jamie 
made almost an identical statement, “…but like I said all my friends, neighbors, and 
everything, supportive family they all know.”  Eddy explains, “It hasn’t really, I mean, 
nobody has been anything but supportive. It’s all been very straightforward, which is 
fine.”  Tari said of telling one of her sisters:
“Told the one that’s in North Carolina, because she’s a nurse, and I told her, and 
she was like, ‘well they have treatment for that.’  You know, she was very, trying 
to encourage me that it’s okay, and she was like, “well let’s see what your biopsy
say.”  Because she, she wanted to see what the facts are before she gets too.” 
Jeff told of numerous negative reactions but pointed out that his mom and one of his 
sisters still love him. 
Other types of support were instrumental help, for information, and social 
regulation or control (House et al. 1988; Thoits 1995). Yellow’s wife’s cousin looked up 
information for him after diagnosis.  Donald’s family and Rick’s family also did internet 
research for them.  Connie told her children, “They said anything we can do?  So I told 
them you know they might thinking about a transplant. The first things they say was, ‘get 
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mine, get mine, get mine,’ you know.”  Cece said about telling her daughter, “You know, 
said ‘you need to stop drinkin', you know, oh she was so-my little God send child, I tell 
you.”
Support From Friends. Friends were also mentioned as providing support through 
their positive reactions.  They offered emotional, instrumental, and informational support.  
Cece got help in securing a doctor’s appointment from a woman who worked at the 
halfway house where she was staying.  Daisy says of her friends from church, “Yeah, and 
they hung right in there with me.”  Religion has been found as a means to increase social 
integration, especially in rural areas (House et al. 1988).  Another friend of hers found 
information about HCV on the internet for her.  David said his tai chi friends were all 
very supportive. “They're really good, people that are good listeners.  They, they just 
were there and listened and whatever I wanted to pour out or say they were there, they 
didn't ask a lot.”
Support in the Workplace. Support from work was either emotional or 
instrumental.  Jason says of people at his work, “And I mean you know they were all for 
me to take the treatment.”  Connie said everyone at work was “so nice.”  Jenn, who 
works in HIV prevention and education, explains, “I think partly because of where I work 
they’re very understandable about what I’m doin.”  Isabella, who was pregnant when 
diagnosed immediately told her boss and she said, “She was like oh my God.  She goes, 
well go do whatever you gotta do.  Just, you know, take care, of it, you know, we'll, well 
you’ll, you know, just go.  Go take care of yourself.”
Tari works at a gastroenterology practice. “They offered, and even my CEO 
knows, they offered to give me free treatment there to see their doctors for nothing.”  
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Sharon’s old employer in the health care industry continues to pay for her medical 
insurance although she no longer works there. She describes people at work as being 
wonderful in their reaction when she disclosed.  “So, I had great feedback, my patients 
were my mainstay.”   Respondents reporting positive reactions at work were more likely 
to have a household income above $50,000 (2 =10.97, p<.001).  Thus, job status may be 
related to reactions at work.  Future research should assess the impact of type of job and 
disclosure at work as persons with less prestigious jobs may be at a disadvantage in this 
regard, disproportionately affecting lower socio-economic status groups.      
COPING WITH STIGMA
While some responses to disclosure are positive, other responses have been
stigmatizing.  Stigma may be conceptualized as a stressor and there are numerous 
methods for coping with this type of stress (Miller and Kaiser 2001).  The most 
frequently used coping mechanism in this study is information control.   Respondents 
reveal or hide information about having HCV to others.  Some of this information control 
seems to be efforts to avoid stigmatization while other behaviors concerning information 
can be seen as acts of resistance.  Condemning the condemners is another coping 
technique used to deal with stigma.  A small minority of respondents involved in support 
groups or education resist stigma through various types of collective action (Miller and 
Kaiser 2001).  Miller and Kaiser (2001) discuss disengagement coping, which involves 
avoidance and denial or minimization of prejudice and discrimination.  Persons who did
not mention being aware of stigma could be denying awareness of stigma.  As mentioned 
in the section on interpretations of enacted stigma, respondents may have explained away 
enacted stigma through denial and minimization as well.  As with disclosure patterns, 
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coping mechanisms are not a static process and people often experiment with different 
techniques to adapt to new social situations.
INFORMATION CONTROL AS STIGMA AVOIDANCE 
Information control can be seen as a type of avoidance in that people reveal 
certain information in order to manipulate situations.  All persons practice information 
control in some regard in that they don’t tell every person about having HCV or how they 
got it.  For some respondents, this avoidance is undoubtedly related to their awareness of 
stigma and their expectation of devaluation and discrimination (Link 1987).  Many 
respondents choose to disclose certain information to certain people. For example, 
Sparky said, “I told ‘em I had you know, about the liver part of it, and, a few of ‘em I told 
about, you know, what it was.  I mean I showed ‘em the paperwork.”
Persons who practice reluctant disclosure often do not reveal to others when 
disclosing their health status that they have hepatitis. Ronald told his girlfriend:
“I have not told her the name of it, but I told her, you know, and they've been real, 
you know, specific and open and honest about I have a disease, it's, there's a 
possibility it could be transmitted.  It's a disease in your blood that it, you know, 
attacks your liver, and, you know, it can--and there's no cure for it, or no sure 
cure.”
He revealed to another friend:
“I presented it to him that I had, I didn't never, I didn't come right out and say it 
was Hepatitis.  I just said that I had a blood, a disease in my blood that could kill 
me and that affected your liver primarily, destroyed your liver…”
Sherri said, “Some of the people-like my pastor, his momma, his wife- they know I have 
problems with my liver but they don't exactly know what it is.”  Vanessa, another person 
who is a reluctant discloser said:
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“The only thing I told them was I had a viral infection in my liver or whatever 
'cause I just didn't want, you know, I just didn’t want everybody to 
know…whenever I had to take family leave at work or whatever, you know, I just 
had Dr. Cassidy's office just put, you know, viral infection or liver problem or 
whatever, you know.”
Information control was used as a technique by persons who disclosed at various 
other levels also.  Catherine told her kids:
“I told them, I was telling them like in riddles.  Ok, mama has a liver condition.  
The doctors say that there's something wrong with mama's liver.  And mama has 
to take medication, and if the liver, something goes wrong with the liver, you 
know that mama will die.  You know I was going around in riddles with them, I 
didn't completely come out and say hey kids, look mama has hepatitis C.”
Tom says, “If I tell 'em I'm sick I tell 'em I have a viral infection.  You know, I, I have a 
viral infection in my liver.”  Roxanne told people she was undergoing chemotherapy 
when on treatment for HCV because cancer was to her less stigmatizing than HCV.
Respondents also use information control when asked how they got the disease.  
To my surprise, only 30% of the sample has been asked by one or more persons how they 
got HCV.  Respondents who have been asked how they got HCV are more likely to 
report enacted stigma (2 =6.17, p<.01).  I had thought that perhaps being young may 
influence whether others ask this question but age was unrelated to this experience for 
this sample.  In fact, gender, race, education, income level, and mode of transmission 
were all unrelated to a person’s likelihood of being asked this question.  The inquirer’s 
curiosity may stem from an innocent quest for knowledge about transmission of HCV, 
especially in the light of the lack of public education about HCV.  Other queries seem to 
be motivated by a desire to blame the individual or to absolve them of responsibility.  For 
example, Ellis said his mother and ex-wife, “Wanted to know how did I catch it.  Uh, 
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what did I do to get it?”  Cece said, “And everybody asks me well, how did you get it?  
That's the first question.  People say well, where did you get it?”
Responses to these inquiries varied.  A few respondents simply lied or omit the 
truth about the believed mode of transmission to some people.  Melissa says, “I did not 
tell her how I got it.  This would be so far removed from her… No, I pretty much offered 
that in the thing, but I lie about it.  I told people it was through a transfusion is how I got 
it.”  Tom says, “So I very rarely tell anybody that I work with how I truly got it.” Others 
stressed how it is just so hard to tell how they got it.  Mack explained, “Uh, so drug use is 
something that I did when I was younger.  You know what I'm saying.  And it could have 
been from that, and that would be the only thing.”   While Mack says that his drug use is 
the only possible means of exposure, he still does not say it has to be from that.  Jeff said, 
“They say tattoos or I was once an IV user... Yeah.  He says you know--I said well, I 
never can--I honestly can't say I ever used a needle after nobody, but tattoos, I been in jail 
before, and I said I did, you know, you don't, ain't no way to get needles.”  Liz says of 
possible ways she got it, “I don't really know for sure.  I said I did shoot drugs a couple of 
times.  I had a Caesarean.  I've had injuries, cuts, stitches.  I don't know for sure.  Could 
have been any of those number of things.”   David also first mentioned IV drug use as a 
means of transmission but then added other incidents such as a hospital visit, 
occupational needle stick, etc. that could have been sources of transmission.  Catherine 
revealed to me she might have gotten HCV through inhaling cocaine.  She told a group of 
women:
“I say where it came from, I say I can't even begin to tell you.  I said, I've been to 
where they pierced my ear with this little gun thing. You know I say they don't 
sterilize that stuff.  I said they have fifty people come in the store to get their ears 
pierced.  When do they have time to stop and sterilize their little gun?  You know 
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I say, we don't none of us know where it came from, you know, I say, it's just 
something probably been around long time, that they just gave it a name.” 
 These statements seem to be trying to minimize the means of transmission from 
drugs in order to absolve responsibility for the illness. 
INFORMATION CONTROL AS STIGMA RESISTANCE 
Information control, or lack there of, can also be conceptualized as a means of 
resistance in that quite a few respondents candidly discuss issues concerning HCV 
including questions about how they got it.  Numerous respondents described frank 
discussions about their health with friends and family members. Jenn said, “They had 
these brochures that says for family and friends so I gave one a those to each a the kids 
too, which has the transmission risks and stuff in it so I think it helped ‘em understand it 
more, you know.”  Sharon also gave out letters she got from an online support group to 
friends. Jason revealed, “And, you know pretty much when I told 'em you know I had 
Hepatitis and I had leukemia, you know, I laid it out all on the table and, you know, 
kinda, you know,  answered all their questions.”  Larry said, 
“I told em' that I'd contacted Hepatitis C.  I said this has been thirty years ago, 
when I was a young man.  And I said after 25-30 years your immune system just, 
you know can't, I told them exactly what the doctor told me.” 
Eddy tells houseguests:
“I think I have told the last two people who have stayed for any length of time, 
like who were watching the house. And, it was just kinda a very A,B,C, kinda you 
oughta know I have hep c and it is bloodborne, so don’t touch any razors and 
don’t touch the toothbrush.”  
Samantha finally told her family, “Cuz’ I told them I had like some information on it, 
said it’s hepatitis C is like really hard to catch and you know, usually blood transfusion, 
like that and , they were just like, you know, so.”
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At least 9 respondents were clearly upfront with the majority of people they 
disclosed to that they got HCV from drug use.  Daniel reveals:
“I told ‘em that it was, it was a disease that you, a sickness that you catch, that 
you get, from drug related things, such as, and I told ‘em that I got mine shootin’ 
up drugs, and there’s other ways that you can get it, but that’s the most common 
way and what it does, is I just told ‘em that from what they told me that it, it 
attacks your liver.” 
 Harold said, “I told my family that, it’s more than likely through my drug use okay.”  
Cece discloses, “You know, intravenous drug use.  Or that, you know, there's probably 
that or snorting, you know, 'cause I mean, it--either or.”  Bob said, “And I’m usually out 
forthright and say that I got, I’m pretty sure I got it from sharing needles and I don’t think 
there’s any other way that I could have got it…”  Meredith told me about an exchange 
with her sister-in-law:
“And I said I'm doin' treatments right now and she said treatments, your mother 
said you had a liver biopsy and you were alright and I said well I have Hepatitis C 
and instantly it was like, like how did you get that… I said well, you know, it's 
probably because of the consequences, is, it's part of the consequences of my drug 
use for so many years.  OH.  I think people are more taken aback by me being 
straightforward about it.”
Meredith’s roommate in a halfway house tried to play the role of a stigma coach, 
someone who tried to warn a person that others might see the particular attribute as 
stigmatizing (Schneider and Conrad 1983).  “My roommate actually said you know you 
might not wanna let people around here know, you know how they are about that sorta 
thing, you know, and I said well I really don't give two fucks about [M laughs].”  
Meredith, Bob, Cece, and Harold are all fairly open about contracting HCV 
through drug use.  All four individuals are also involved in Alcoholics Anonymous 
and/or Narcotics Anonymous.  The nature of these recovery programs demands an 
acceptance of past addiction and eventual redemption from shame which may explain 
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their ease in disclosing this aspect of their lives as they are now “recovering”.   Daniel is 
also an ex- drug addict who has been “saved” by Christ and thus also feels absolved of 
shame over his past.  There may be a relationship between frank disclosure of 
transmission through drug use and acceptance of past identity as a drug addict, either 
through religion or recovery groups. 
CONDEMNING THE CONDEMNERS
Condemning the condemners was originally conceptualized as a technique of 
neutralization or a behavior used by persons before they engage in deviant acts to justify 
their behavior (Sykes and Matza 1957).  In this research, condemning the condemners is 
a coping technique used as a cognitive restructuring tool in that instead of feeling badly 
about themselves when anticipating or experiencing stigma, persons place blame on the 
those treating them negatively (Miller and Kaiser 2001).  This technique is also used by 
persons to cope with a courtesy stigma of having a family member with Alzheimer’s 
(MacRae 1999).  
One respondent, Liz, chided persons who ask how she got HCV.  Liz tells people, 
“Yah.  And I usually tell 'em it's not polite to ask.  But I don't mind tellin' you.  Yah, I 
say, but remember in the future, it's not polite to ask people how they got anything that 
they got.”  Most other examples of condemning the condemners are harsher.  Liz says of 
her stepson’s mother who was unpleasant concerning the HCV, “But she was always 
lookin' for some excuse to do somethin'.”
The most common reason given for inappropriate behavior by others concerning 
HCV was that they were ignorant.  Harold says that when people are stigmatized it is 
because of ignorance. Rick says,
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“Too many people got stigma with it, they got lack of knowledge and they 
ignorant of the facts.  And you can't plan your whole life tellin’ things to each 
individual person, tryin’ to explain somethin’ to ‘em that it took you forever to 
learn.” 
When I asked him what people have said, he responded, “Nothin’, it’s just ignorance 
stuff, uh, it’s not even worth explainin’ when people are ignorant.”  Roxanne says, “But I 
mean it's not their fault, they're uneducated and they don't know, ya know?”  She adds, 
“Cause if they're that uneducated, they don't wanna be educated.”  Tom explains why 
people think it is a “dirty disease”, “No cuz they don't know, it’s ignorance.”  Nick says, 
“Oh yeah, they didn’t like touchin’ nothin’, I told ‘em you can’t contact this like that, so 
there’s a lotta ignorance out there.” Isabella says when discussing the nurse putting the 
sign on her hospital door, “This is then again the idiots and I'm sayin’ idiots because I 
think the medical profession should have at least known somethin’ about it if they were 
treating people for it with the drug.” Mack says, “I said, you know I don't discuss it with 
a lot of people, because of the ignorance that exists behind it the stigma, what people 
would think.” 
Another means of condemning the condemner is stating that persons who 
stigmatize are too concerned about what others think or are bad people in some regard. 
Samantha says she thinks her boyfriend is ashamed that she has HCV. She explains:
“He’s one of those people that’s just the typical all-American white boy, you 
know, people pleaser, you have to look this way, act a certain way, you know, 
watch out what cuz’ you know people will say this about you, you know, I mean 
he’s a business man, he’s got his own business, so it’s kinda, he’s gotta be I 
guess.”
Derrick condemns the employer who laid him off because of having HCV through 
describing their terrible employment practices regarding Mexican immigrants. 
Two respondents made disparaging comments about doctor patient interactions.  
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Lauren says of the doctor who treated her poorly, “See I don’t think they’re little gods.”  
Karla discussed how interactions with Dr. Cassidy at the public clinic are often in front of
medical students and/or interns.  Karla was diagnosed after her husband, who is covered 
in tattoos and a former drug addict.  She talks about confronting Dr. Cassidy who she 
thought assumed drugs or tattoos are the culprit of HCV:
“So when I went to Dr. Cassidy, sittin' in this room and had all these people 
comin' in, so I sat there and I said well, why don't you sit there and tell everybody 
how I got it.  And he, he looked--he just looked at me, and I said you don't see no 
eight balls on me.  [Referring to her husband’s tattoos].  I'm too fat to be a drug 
addict.  I said so how do I got it?  He didn't say nothin'.  He turned around and 
went.”
Although I cannot verify the accuracy of this interaction, Karla clearly enjoyed telling me 
about her interaction with Dr. Cassidy as she seemed proud of her confrontation.  As I 
mentioned previously, she and her husband have experienced more discrimination than 
any other respondents and she may have engaged in this confrontational interaction with 
Dr. Cassidy as a means of trying to resist the ever present stigmatization she experiences.  
If she exaggerated the interaction, she still was presenting herself as someone who does 
resist stigma perhaps indicating what she wishes to do.   
COLLECTIVE ACTION
The small of group of individuals actively involved in support groups are 
engaging in collective action in order to cope with stigma.  Although not all of these 
persons have experienced stigma, they all participate in activities that promote education 
and compassion concerning HCV, thus resisting stigmatization.   Sharon, who 
participates in an online support group, says, 
“Didn't matter to me and it, one of the first things they say, they, everywhere we 
go, I mean everywhere you go to read or on the bulletin board or for support and 
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help, the first thing you're told is, we don't wanna know where you got it, we don't 
care where you got it.  The issue is, you have it, we wanna help you deal with it.” 
Harold talks about someone in his support group who has experienced discrimination 
because of HCV:
“You know, it makes me want to be there for them and give my support. 
Whatever I can do to help.   I think that as prevalent as this disease is in society 
today that people hopefully will get educated, you know, and that they will do 
whatever it takes to learn about the disease.”  
Isabella runs a support group and discusses how she deals with people who got HCV 
through IV drugs. “And you know I tell those people, you know we and I don't 
discriminate against anybody you know how you got it, or how you know, or how you 
didn't.”  Isabella told me about how some people at the support group discuss how they 
got it, but that she tries to not continuously do that herself  because she does not want, 
“(To) Make them [person who got HCV through IV drugs] think that I am somewhat 
superior you know than them.”   
CONCLUSION
HCV is not definitively stigmatizing.  Persons lack ample cultural imagery to rely 
on for internalization of what a diagnosis of HCV means.  Thus, some respondents are 
unaware that HCV is even seen as stigmatizing.  Needless to say, these folks are not 
engaging in felt stigma unless their seeming unawareness is a ruse used as a coping 
mechanism.  Race and ethnicity are important factors affecting these processes, a finding 
suspected by some researchers who feel that studies of stigma have too often excluded 
structural inequalities when evaluating stigmatization (Parker and Aggleton 2003).  
Whites are more aware of stigma, more likely to engage in felt stigma and more likely to 
have experienced enacted stigma.  Whites could be more sensitive to stigmatization 
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relative to Blacks because of their un-stigmatized racial identity.  In other words, Blacks 
may experience similar rates of stigmatization but are less likely to recognize the 
discrimination as being about HCV per se because they occupy other stigmatized 
statuses.  However, some posit that, “individuals with less power are more likely to be 
chronically more attuned to the situation, to shifts in affective and nonverbal tone of the 
other, generally paying more nuanced attention to the other"(Oyserman and Swim 
2001)(6).  Blacks may indeed recognize HCV related stigmatization but don’t feel it was 
as salient to their HCV experience to discuss it in the interview process.  Blacks may also 
rely on minimization or denial of stigmatization as a coping mechanism to protect self-
worth more so than whites (Shih 2004). Future research should focus on racial 
differences as this factor seems to be one of the crucial differentiating characteristics 
delineating experiences with stigmatization. 
More than half of the sample did deal with felt stigma and/or enacted stigma.  
However, respondents also had other reactions to their disclosures including 
minimization of their illness, no reaction, and positive reactions.  Positive reactions in the 
workplace may be a function of type of job and merits further research attention.  Persons 
with HCV have a variety of coping mechanisms to deal with the real or imagined threat 
of stigma.  Respondents controlled information often as a means of stigma avoidance but 
also as resistance.  Condemning the condemners and collective action through support 
groups also helped some persons cope with the experiences of having HCV.  While in 
some ways, the percentage of the sample that have experienced stigmatization is 
encouraging in that not everyone feels stigmatized, I am not optimistic about future 
trends as I fear levels of stigmatization are related to levels of public awareness about 
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HCV.  Unfortunately, if HIV/AIDS education is any indication of trends, we may see that 
with more public education and awareness, there will be more HCV related 
discrimination (Herek et al. 2002).  Future research assessing public knowledge about 
HCV should stay attuned to changes in levels of stigmatization and coping mechanisms.  
If rates of stigmatization rise, perhaps rates of collective stigma resistance will rise as 
well.  In addition, we should note how possible rising rates of stigmatization interact with 
racial effects on experiences with stigma.  In the next chapter, I discuss how having HCV 
is a biographical disruption for individuals.  Persons must experience diagnosis and 
subsequent reactions.  As people continue in their illness careers, some gain a great bit of 
knowledge about the disease while others have little information.  Persons conceptualize 
their illness in variety of ways with some incorporating faith in order to make sense of 
their illness. 
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APPENDIX 4
4.1 AWARE OF STIGMA
2 p
Enacted stigma
   6.41**  <.01
Fear of discrimination 5.04*  <.05
Level of disclosure .54 <.5
White
  6.41**  <.01
4.2 FELT STIGMA
2 p
Enacted stigma 3.31 <.07
White
 4.71* <.05
4.3 ENACTED STIGMA
2 P
Aware of stigma
   6.51**  <.01
Gender   .02 <.90
Level of disclosure 2.79 <.09
Mode of transmission 2.34 <.12
No reaction29 5.04* <.05
White 13.12*** <.001
29
 Those reporting no reaction to disclosure are less likely to report enacted stigma. 
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4.4 CHI-SQUARE CROSS TABULATIONS
Aware of Stigma and Enacted Stigma (2= 6.51, p<.01)
Enacted Stigma No Enacted Stigma Total
Aware of Stigma 24 17 41
Unaware of Stigma  2 10 12
26 27 53
Aware of Stigma and Fear of Discrimination (2= 5.04, p<.05)
Expressed Fear No Fear Total
Aware of Stigma 13 28 41
Unaware of Stigma 0 12 12
13 40 53
Aware of Stigma and Race (2= 6.41, p<.01)
White Minority Total
Aware of Stigma 30 11 41
Unaware of Stigma 4 8 12
34 19 53
Aware of Stigma and Levels of Disclosure (2= .54, p<.5)
Limited/Reluctant Open/Activist Total
Aware of Stigma 21 20 41
Unaware of Stigma 7 4 11
28 24 52
Felt Stigma and Enacted Stigma (2= 3.31, p<.07)
Enacted Stigma No Enacted Stigma Total
Felt Stigma 18 12 30
No Felt Stigma  8 15 23
26 27 53
Felt Stigma and Race (2= 4.71, p<.05)
White Minority Total
Felt Stigma 23  7 30
No Felt Stigma 11 12 23
34 19 53
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Enacted Stigma and Race (2= 13.12, p<.001)
White Minority Total
Enacted Stigma 23 3 26
No Enacted Stigma 11 16 27
34 19 53
Enacted Stigma and Levels of Disclosure (2= 2.79, p<.1)
Limited/Reluctant Open/Activist Total
Enacted Stigma 11 15 26
No EnactedStigma 17 9 26
28 24 52
Enacted Stigma and Little/No Reaction (2= 5.04, p<.05)
Little/No Reaction Reaction Total
Enacted Stigma 1 25 26
No Enacted Stigma 7 20 27
8 45 53
Workplace Support and Income (2= 10.97, p<.001)
$0-19,999 $20,000-49,999 $50,0000 and Up Total
Support   1   1  5  7
No Support 21 18  7 46
22 19 12 53
Enacted Stigma and Asked about Mode of Transmission (2= 6.17, p<.01)
Asked Not Asked Total
Enacted Stigma 12 14 26
No Enacted Stigma  4 23 27
16 37 53
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CHAPTER 5: WHAT DOES IT MEAN TO HAVE HCV?  DIAGNOSIS, 
KNOWLEDGE, AND COPING
Having HCV is stigmatizing for some people.  As discussed in Chapter 4, Whites 
are more aware of HCV related stigma, more likely to engage in felt stigma, and more 
likely to report enacted stigma.  Not all reactions to disclosure are negative, however, and 
some respondents received positive support as a result of disclosure.  People devised 
different coping mechanisms to deal with the possibility of stigma.  
Before a person can disclose their health status, they must first be diagnosed.  
Being diagnosed with a chronic disease can be a life altering event. In this chapter, I 
discuss persons’ diagnosis, which came either as a Surprise Diagnosis or Individual 
Initiated Diagnosis.  Respondents experienced a multitude of reactions to diagnosis 
including Fear of the Unknown, Shock, Fear of Imminent Death, Sadness, and
Ambivalence. After persons experience diagnosis and the initial reaction, respondents’ 
behaviors and outlooks further diverge in terms of coping.  People had varying degrees of 
knowledge about their illness: Expert Knowledge, Moderate Knowledge, and 
Little/Inaccurate Knowledge.  Levels of knowledge are related to numerous outcomes for 
individuals and society.  A phase of the illness career involves learning how to make 
some sort of sense of their illness.  Respondents often turned to discourse about 
HIV/AIDS to understand their experience.  In other attempts to explain their illness, 
people employed a variety of approaches including conceptualizing the illness as 
Punishment, Challenge/ Acceptance, as Loss, and as Value.  Many persons with HCV 
mentioned their Faith as a coping resource. 
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DIAGNOSIS
SURPRISE DIAGNOSIS
For many persons with HCV, their diagnosis came as a complete shock as they 
had no idea that they were sick in any way.  Over half of the respondents found out they 
had HCV in this fashion.
Routine Screening.  Nineteen persons were diagnosed because of results from
routine screening.   Andrew said, “And that's when they determined that I had Hepatitis.  
And when they caught me off by surprise…”.  Mark recalled, “Had to take a physical, 
cuz we were changing the insurances at work, and the liver enzymes showed up high.”
Jenn was trying to get involved in a research study for her diabetes and was diagnosed as 
a result. Eddy explained,
“I had not had health insurance for a while and for some reason, I got health 
insurance, I guess my business might have just picked up enough so I had, I had 
health insurance and I think that is the reason, not sure, but I got health 
insurance… so I went just to get a regular physical and he did a blood test, he did 
kind of a basic everything blood test and one of the things he checked for was 
Hep C and he said, you’ve got it.”
Ronald relayed a very similar experience:
“I had insurance, and I thought that I was in real good health, so in-- to, to go and 
just to celebrate my great health, I just, you know, took advantage of the 
insurance and went in for a physical.  A routine, general physical.  And that led to 
this diagnosis.  When they did the blood work they said you have elevated 
enzymes in your liver and we need to kinda, you know, see what that's about, and 
so I didn't you know, really wadn't thinking about what that meant, but that's what 
it meant.  So it led to the diagnosis.”
Maruf also was trying to check on his overall health:
“Uh…but I decided to go and have a real full physical and all kinda blood test.  
Just for the hell of it, just a coincidence.  And the tests came back, and she said 
well the doctor said we gonna have to do the test again there’s something there 
that um kinda need to be sure about.”
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Joey said, “Oh, I went into rehab.  Cuz I was doin' too many drugs and stuff.  And they 
ran blood tests on me and told me I had Hepatitis.”  Samantha also found out while in a 
rehabilitation center, “Yeah, and I went to go ahead and you know, they gave me a blood 
test and all that to make sure, because they were going to put me on Antabuse and make 
sure my liver all right.”  Meredith found out while in prison for a drug related charge, 
“But while I was there they, right before I left for boot camp they took blood tests and the 
longer you're there the more they'll do different blood tests.  And that's when they found 
out.  And they told me that I had Hepatitis C.”
Blood donation/Plasma Center. Eight respondents were informed because they 
had donated blood or sold plasma. David said, “My mother was havin' surgery and she 
needed some blood on reserve, and so me and my brother went in”. Nick described how 
he gave blood as a way to get tested for blood borne diseases because he had been an IV 
drug user.  Rick and Charlie were informed about having HCV from letters from the 
blood donation organizations.  Sparky was mad that they had not told him because he had 
been to the plasma center before. “I almost went ballistic.  I said what are you sayin? I 
said I been here numerous times.”  Bob, who also found out from a plasma center had a 
different reaction, ““You have Hep C and I was like, I didn’t know what that was and 
that’s pretty much what I said, I was like so what does that mean, do I get the rest of the 
money or…”
Informed by Hospital.   One respondent was informed about possibly having 
HCV through a letter she received from the military.  While in the service, she had a 
blood transfusion.  The hospital went back through the records and contacted anyone who 
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had received blood before a certain year that they may have been exposed to HCV 
because it was before blood was being screened for it.  She was tested and diagnosed. 
INDIVIDUAL INITIATED DIAGNOSIS
While many respondents were completely caught off guard regarding their 
diagnosis, 20 respondents were experiencing symptoms and sought medical attention and 
3 other respondents requested or were advised for specific testing for HCV.  
Symptoms. Numerous respondents sought care because of fatigue and or 
problems/pain with their stomachs, sides, or backs.  It took several months after first 
seeking care that Sharon was diagnosed:
“It took us till about May to go through all the tests that are natural and normal 
and I was fine.  I mean everything about me was fine, I was just so tired.  Uh, and 
then I got to a point where I would walk in this door and I would on hands and 
knees crawl upstairs to my bedroom.  I could not make it standin' up.  And I went 
back and I said, John I can't stand this.  You know, this is not right.  That's when 
he said, let's try the Hepatitis.”  
CeCe also battled with fatigue. She told me, 
“And in, in '99 I woke up and said I gotta do somethin'.  Somethin's not right with 
me.  You know, I could feel my body just goin'--suckin' the life outta me…I kept 
gettin' sick and wouldn’t work for two or three days and just fall out with 
exhaustion.”
Catherine had a similar experience, “Yah, right after my mother passed.  I kinda, I was 
like, was feeling tired all the time, or you know I just thought maybe I wasn't getting 
enough sleep or something.  And I went to the doctor.”
Several respondents had severe symptoms that led to their diagnoses with HCV. 
Daisy had a frightening experience.  Her husband explained,
“Then one day here she started bleedin' real bad and she went to the bathroom and 
she was just, full of blood, you know.  So we took, I took her and she got weaker 
and weaker and weaker.  So I took her to the doctor in Baton Rouge, and they, 
they checked her as to whether there's somethin' wrong you know, they went 
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down into her esophagus, and all that, and checked all that, and found out she was 
bleedin' from the inside.  Come to find out she had varices veins...”
Jeff also had extreme symptoms that prompted his diagnosis, “And when I stood up, it 
was like a hose.  Somebody put a hose in me and made me sick.  I mean, blood comin'.”
Donald had a strange reaction to an alcoholic drink:
“Well we went to some neighbor's house I think that's when you actually kind of 
found out.  And one of the neighbors gave him a drink.  And he drank it and like 
ten minutes later he couldn't walk, he couldn't you know, could not do 
anything…Well a few days later he was still very disoriented and all that.”
All 3 of these respondents had poor prognosis when diagnosed and when I interviewed 
them.  Such acute and severe symptoms of HCV indicate very advanced liver disease.  
Asymptomatic Testing. Two respondents asked to be tested because of suspicions 
about HCV.  Tari’s husband was first diagnosed with HCV and she said, 
“Uh huh, and I used to use his razors and stuff, and after, when we got married 
earlier on, and after he got diagnosed with it, it was always in the back of my 
mind, you know, cause I kept thinking well I used his razors back then.  And we 
never knew when it happened to him so it was like…God.”
She subsequently asked her doctor to test her.  Larry found out a friend died from HCV:
“So I start really researching, and you know, looking into it.  I had heard, that you 
know, Hepatitis C could be, is fatal in some cases.  And the more and more 
research I dig in to, I said, well I better go and get tested.  Cuz I got it from him, I 
know I did.”
While Lucy did not have symptoms, she was advised by a physician to get tested because 
of her husband’s diagnosis of HCV.      
REACTION TO DIAGNOSIS
According to Link (1987), once patients are diagnosed, they must now apply what 
it means to have that label on a personal level.  As discussed in Chapter 4, 56% of 
respondents had heard of HCV before diagnosis.  However, only 27% of the sample had 
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any substantial knowledge of HCV and some of that knowledge was deeply flawed. The 
lack of information regarding HCV or misinformation shaped respondents’ reactions.
Fear of the unknown.  A classic reaction to diagnosis is a feeling of uncertainty, 
according to Bury (1982). Several respondents explicitly discussed how they were 
fearful because they did not have any knowledge of HCV.  Catherine said of first finding 
out:
“Cuz at first when I, when they first told me, it did scare me, because I didn't have 
the knowledge that I did have.  And when they first told me it was like, ok it's like 
a light that goes off, it's like, you know, you quite don't know what Hepatitis is, 
but you know it's somethin' scary.”
Melissa said, “And, I was stunned.  I was really, it was one of the surreal things, you 
know, when- I had some questions, but not a whole lot, because I didn’t know what to 
ask.  I was, it wasn’t like I didn’t care.  I was just kinda shocked…”  Rick explained, 
“Well, I was inquisitive.  I wanted to know what the hell it was…and that scared me 
worse, had me freaked out for a long time not knowing what the hell was going on.  After 
I realized they didn't know too much either you know.”  Andrew described, 
“And then when I found out, it was kinda, it hit me hard cuz, I was really lookin 
forward to a [kidney] transplant, not that I can't get one, but I'm kinda frustrated 
you know what I mean cuz when I found out you know I really wasn’t too up to 
date what hepatitis do to the liver.”
Shock.  Many respondents mentioned feeling shocked by their diagnosis. Sharon
relayed information her doctor had told her:
“Eventually we'll check you for Hepatitis but I know you don't have that cause 
you didn't do IV drugs.  You know and I knew during all that time and he said, 
anyway, it's a hell of a way to die.  And at the time it was, cause there was no 
Interferon or anything when he had said that, those words stuck in my head.  And 
I probably cried for three solid weeks.”
Daisy said upon being diagnosed, “Oh Lord, I thought the world was comin' to an end…”
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Emma echoed Daisy’s sentiments, “I felt like that was the end of the world, you know.”
Lauren said, “No, because I went numb.  [L chuckles]  I'm still numb about it…And but 
really when he first told me about it, I just, I just kinda went into shock.” Charlie 
revealed, “Well, it's kinda like, what the hell is this?  I said it's all I need.  It was kinda 
like a, it’s like bein' hit between the eyes.” Samantha said,
“I don’t know, it was almost like finding out you know, you had, a terminal 
illness, it is (laughs).You know and it was like, you know I am just like, 
everything sort of flashed before me, you know and I remember just being real 
scared, a lot of fear...”
Jenn’s shock resulted more from her knowledge of the disease and the means of 
transmission.  She explained,
“He called me at work Monday morning about 9:30 said well negative for A, 
negative for B, but positive for C.  And I just said huh?  You know ‘cause I knew 
I’d never, you know, I knew the main reasons [people got it].  Shocked.  I mean I 
was, when I was talkin’ to Cheryl [her boss] I was almost in tears.”
Maruf’s shock resulted from the dissonance in his conceptions of self and reality after 
diagnosis:
“I’m a strong person, and I can’t, I don’t give up that easy, but I felt bad I mean I 
couldn’t sleep that night knowing that, thinking I’m healthy all my life I’m 
not…That I’ve had something in me for the past ten or twelve years and I didn’t 
even know about.”
Connie and Isabella feared rejection from their husbands.  Connie had remarried a few 
months before diagnosis. She said, “So, first things come to my mind was, my gosh, my 
husband married me and is gonna be burdened.  That was my first reaction.  I almost feel 
like, [C laughs] I thought he must think he got tricked.”  Isabella explained, “Well first of 
all I mean, I mean my first thought was he's gonna leave me.  I mean I've got, they, a 
disease that could be sexually transmitted.”
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Fear of Imminent Death. Several respondents mentioned feeling they were going 
to die.  Liz said, 
“He said, he said I had Hepatitis C and I was moderately active cirrhosis, and I 
thought, I'm gonna die.  You know, that's it, I'm gonna die.  Ya'll just, you know, I 
guess I better go get myself in order or whatever, you know.  Ellis said, “I worry 
about it all but when the first doctor told me about it I really truly, I thought I was 
gonna, gonna die.”
Ronald said,
“Oh, I felt, um...pretty much devastated.  Emotionally pretty much devastated 
and, and I felt, you know, like, I tend to sort of, I don't know if you call it 
overreact or what to some circumstances, but I felt like I had been given a death 
sentence and that my life was basically over.”
Catherine said, “So it's like ok if I'm a die with this then let me.  And that was just my 
first reaction from it.”
Sadness.  A few respondents specifically mentioned feeling depression as their 
reaction to diagnosis.  Grant said after being diagnosed, “I'm like ooh man, it's just like 
I'm feelin' depressed--like I went into depression.” Sherri was all ready suffering from 
depression at the time of diagnosis, said, “It depressed me more.”
Ambivalence.  In contrast to respondents who felt shocked, depressed, or fearful, 
other respondents reported a lackadaisical response to their diagnosis, possibly as a 
means of denial for some. Daniel explained how he did not really follow up with medical 
care after diagnosis because of lack of insurance:
“And, and I went and seen the other man one time and he, I did some more tests 
with him and, to, to, make, you know, clarify that I did have it and I did.  And, he 
wanted to start checkin’ into it, but I didn’t have insurance…So I went, I guess I
went almost a year without doing anything about it.”
David said, “I just didn't, put a lotta seriousness into it, it's hard for me to put serious-
seriousness into it right now even, because a the fact that I feel pretty good.” Tom also 
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did not place a lot of importance on the initial diagnosis. He said, “Not really.  Like I had,
I had other stuff going on.”  Nick explained, “Uh, about the disease, I took it for 
granted.”  Sallie Anne said, “I mean when I first found out, when I found out, I was kinda 
upset, and then when I re-re found out again [she was diagnosed with non-A, non-B 
hepatitis years before], I was really upset, for about 2.5 seconds.”  Peggy was concerned 
about the inconvenience, “Just that it would be a pain in the ass though until you got well, 
you know with the costs and everything.”  Unlike respondents who cited the lack of 
information about the disease as a source of fear, Jamie’s lack of knowledge kept her 
from worrying.  Jamie said,
“Well, I mean, well, I was, I was, like I said I didn’t know anything about it, and I 
think I was thinking it was something that could be cured cause he was saying he 
could put me on this medication and it would help clear up my liver and different 
things like that.  So, I thought it was something that you know that could be 
cleared up.”
KNOWLEDGE ABOUT HCV
Previous knowledge or lack thereof about HCV may affect the initial reaction to 
diagnosis. Medical knowledge can be a response to uncertainty experienced after 
diagnosis (Bury 1982).  It is important to assess respondents’ understanding of HCV at 
the time of the interview to evaluate how current knowledge impacted coping.  
EXPERT KNOWLEDGE
Almost one third of respondents (29%) knew a great deal about HCV.30 These 
respondents understood the disease and the treatment available. For example, Meredith 
said, “They said something about the years I had in clean time, of clean time, the, when I 
was diagnosed and the fact that I was female and my age group made me a good 
30
 See Appendix 5.1 on page 188.
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candidate for this treatment.”   While there was a range of knowledge within this 
category, all of the persons accurately discussed numbers, such as viral loads and biopsy 
scores. Isabella said, “He did the viral load which, you know, shows you how many 
copies per mil--, milliliters is in your blood.”  Not all of the respondents were familiar 
with genotypes of the virus in this category but some were.  
An overwhelming trend among these respondents was their impetus to seek our 
information. Melissa said, “And, I remember leaving his office, and the first thing I did, 
although I don’t quite remember it is, I drove straight to Barnes and Nobles book 
section…And then just read, you know, devoured them, highlighted, you know.”  She 
talked about contacting one of the pharmaceutical companies:
“And spoke with the people in the research department there, and I got 
information sent to me at the time, which I can’t get now.  Um, evidently they’re 
really tight about their research, and I didn’t tell them who I was, and they didn’t 
ask.  So, they sent it to me like I was a doctor [M laughs]”
Connie, a Japanese woman, was diagnosed in the early 1980s when little information was 
available. “So, I wrote to Japan and they send me any of the news that all the information 
how you contract and how you going to be and how to do those blood tests and those 
kinda things.  There was much more information [in Japan].”  Sharon said, “I hounded 
the Internet for information.  I ordered books upon books upon books.” Catherine, the 
only African American in this category as well as the only African American who 
practices open disclosure, said, 
“I just started reading, I started going to the library, I started reading up stuff on it, 
and just picking up pamphlets everywhere, and every time I would go somewhere, 
and I would see something about hepatitis I would get it and read it and 
everything.  I just got all the knowledge that I can get off of it, cuz I wanted to 
know everything there was about it.”  
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Cece commented, “Once, once I got the literature, because I demand literature.  I wanna 
know.  And I read, and I read, and I read until I was completely satisfied with what I had.  
I had, but I had to get all points of it.”  Despite the public clinic being very busy, 
Meredith described her experiences there:
“I have no qualms about asking a million questions and clinics are a good 
atmosphere.  They always have people involved that are just so willing to answer, 
you know,— I mean it's not like they’re [indecipherable] and just seein’ me like 
cattle, no, if you're articulate and you speak to them and you have, and you have a 
legitimate question or if they see that like you're, you're writing down your 
question oh by the way, you know, oh yeah this is what I want to, you know, that 
sorta thing, they actually like that sorta thing because it's like, well my efforts 
aren't being wasted, you know. “
Meredith discussed how persons being seen at the public clinic can get extensive 
information, but that they must be proactive and engaged with the staff to do so.   
Meredith is a White woman with some college who may have the skills necessary to 
extract this knowledge in that setting.  It is unclear however, whether persons of varied 
social class and ethnic backgrounds have the same interaction skills available or whether 
medical personnel would interact with diverse persons in a similar fashion.  
Several respondents discussed researching past records as to how or when they 
were infected. Liz tried to find records from her when her child was born and she had a 
cesarean.  Connie contacted the military hospital from her childbirth experience.  David 
tried to assess when he might have been infected:
“I went back as far as possible trying to find all lab blood reports that I had, where 
I had complete blood counts, and, blood work done.  In the earliest one I 
remember was done when I was in my early twenties, twenty, twenty-one, 
twenty-two years old, and they, they didn't even have a record of it, they had to 
dig it up on microfilm.  Had to pay 'em money to do that, had to research this stuff 
to find it.  But they did locate it...and the enzymes on the, were elevated.”
Gaining knowledge about the disease was beneficial for numerous respondents. 
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Catherine said, 
“But you know, they started telling me about the medications, and you know the 
things I needed to do. And you can actually live with this thing for ten years, and 
stuff like that, and you know then got some knowledge of it, and I changed a lot 
of things you know.”
Jenn discussed her experience getting her biopsy results when she knew less about the 
disease: “Cause not having that much knowledge about the disease when I was first told 
about it, you know, then when she says it’s level two inflammation and swelling and it’s 
like ok what’s that mean, you know.”  For David, acquiring more information changed 
how he conceptualized the disease:
“But you gotta realize the first time, even though it was when I began treatment I 
still, I don’t think I was takin’ it as seriously, because it’s such a, it’s it’s so 
hidden, you can’t see it, you can’t tell, so it’s like I’m doin’ this but I don’t even 
know if I need to be doin’ this.  But since then, on up to now, I’ve read so many 
articles and I’ve heard so many things, it seem, the instances of liver cancer and 
liver cirrhosis, and, know th at this is real.  So I just I understand it a lot better and 
I understand the possible seriousness of it, where back then I didn’t take it as 
serious.”
MODERATE KNOWLEDGE
Over half of all respondents have what can be conceptualized as moderate 
knowledge of HCV.31  These respondents understand the disease for the most part, but 
few talk in numbers or are perhaps inaccurate if numbers are mentioned.  Some of these 
persons did, similar to those with expert knowledge, mention researching the disease.
Vanessa said,
“I read on the internet about, you know, the facts and that kind of stuff, but then I 
was, you know, I felt blessed because I wasn't, I guess I wasn't as bad as some of 
the people that I read about, you know [with regards to side effects from 
medication].”
31
 See Appendix 5.2 on page 189. 
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While Vanessa did not speak in specifics, her understanding of the disease and 
comparison to others helped her to feel better about her own experience.  Jeff said, “And 
she [his wife]…has got so much stuff off the computer that I mean, we just sat and talked 
about it--me and her together, you know, look, you know.”  Roxanne said, 
“Um, Dr. Cassidy kept me really informed, really, really well.  I looked it up on 
the Internet, a lot of websites and stuff.  I'd actually go in some of the chat rooms 
with, that had it.  I mean, different, different things.  Be In Charge [a program by 
a pharmaceutical company], informed me the most, I got to say.  They gave me all 
the statistics that I need, you know, to decide whether to do it [treatment] or not.”
Bob said, “I think I looked up stuff in the library, I think I actually like checked out books 
in the library.”  Not all respondents sought out information as Ronald said, 
 “I, and I'm still not well-educated.  I've been kind of in denial.  I've stayed in 
denial to some degree about it.  Now, I mean, you know, I don't study it very 
much or anything…I guess they just gave me some general--they gave me some 
literature to read, a nice booklet that looked real professional and scientifically 
based, which I haven't read.” 
Although some respondents did seek out information about HCV, respondents 
with moderate knowledge were often unfamiliar with the language used to describe the 
disease and tests or discussed results in general terms.  For example, Tari said of her 
biopsy results, which are presented in terms of grading and staging, “I can’t remember,
there was a one, which it wasn’t that, that was like the, it wasn’t like stage one.  It was 
more like a percentage.” She did mention that “---my labs you can’t tell that anything is 
wrong with me.”  Andrew said of his biopsy, “Then, there wasn't you know, there wasn't 
too much corrosion, it was lookin fine.”  Jamie said of her biopsy, “Uh…he said I had a 
lot a scar tissue.”  Ronald said, “I think they said somethin' about like B, a B.  I remember 
them mentioning, I think I remember mentioning like a B, a B amount of scarring.”  
Several respondents did seem to understand liver enzyme testing although again, 
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knowledge varied. Daisy’s husband said of her liver enzymes, “The enzymes were up, 
you know, to a a positive level, you know.  It wasn't exactly where it should be, but said 
it was up to a positive level.  She oughta be doin' little better.”  Liver enzymes are high 
when there is a problem, thus his comment is perplexing.
A few respondents seemed to almost have expert knowledge with regards to 
details such as their viral load or even the genotype of their virus but mentioned other
fairly important aspects of the disease that were inaccurate. Larry could speak about side 
effects of treatment. “And this medication, the way I understand it, it eats up red blood 
cells, and that's what carries oxygen to the muscles and the organs of your body.”  Larry, 
however, erroneously believed that there is a Hepatitis F and G. Eddy said of having 
hepatitis decades earlier, “I think that what leaves me open to Hep C where I might have 
gotten both at the same time or something like that but it’s that the liver never healed 
itself from the first infection.”  Having other kinds of hepatitis does not make one more 
vulnerable to becoming infected with HCV.  Derrick understood his liver enzymes were 
high which led to his diagnosis.  He also knew his liver staging and his genotype. But he 
added that, “So I mean I knew that there was no cure, that it was really slow, and that you 
would either need a liver transplant or you're gonna die.”  HCV is estimated to lead to 
serious liver disease in roughly 20% of those infected (Franciscus and Highleyman 
2003).  Charlie, who catalogued his liver enzyme tests in an Excel file, said of his friend, 
“He has Hepatitis, and he has it bad, like his viral count is at least 8 million.  Mine's 
825,000.”  Viral count however, is not related to prognosis per se.  Lauren knows her 
viral load and understands the medications.  She did say no one in her family had a 
history of Hepatitis C, but HCV is not a genetic disease.  She also said, “That it's always 
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fatal, and gettin' liver cancer and I think and I don't know, I forgot, 40 percent of people 
that get liver cancer or 70?”   Most research indicates that chances of HCV leading to 
liver cancer are less than 15% with most citing less than 5% chance (Franciscus and 
Highleyman 2003). 
Several people discussed a “fast” or “worst” kind of HCV which was perhaps a 
reference to genotypes although the genotype of the virus is unrelated to progression of 
the disease.  Genotype is, however, related to responsiveness to treatment and length of 
treatment which may be what confused some.  Lauren explained, 
“I haven't heard any, except the other doctor said that mine must be the very slow 
kind.  I have the worst kind….And probably been, all, all different kinds [of donor 
blood], mixed in together, that's how I wound up with the worst kind.” 
 Ronald also mentioned this:
“And that it progresses--there's a slower progressing and a faster progressing and 
that, you know, depending on your own immune system and your own lifestyle, 
you know, so what I decided to do was to, was to wait and get another liver 
biopsy and determine which if it was progressing--how fast it was progressing.”
Larry said, “I have genotype 1, which is the worst one.  Or, I forget if they call it 1 or A.”
In addition to discussing “worse” kinds of HCV, a few respondents compared 
HCV to other types of viral hepatitis.  Although their knowledge of HCV was moderately 
accurate, their awareness of other types of hepatitis was highly inaccurate.  Derrick said, 
“And they know that A and B are highly contagious and are highly aggressive and can 
kill you in a week.”  Charlie explained an interaction with his brother:
“So he fretted all weekend, he finally called me up on Sunday and says, you don't 
have Hepatitis B, do you?  I said, hell no, man, I've got C.  Don't--God.  Thank 
God…Well, he said, yah, because B's worse than C…With B you're--you've got 
one foot in the grave and the other one on a banana peel.  So he was kinda--
because you've got longevity with it, you know, people get Hepatitis C and it 
never jumps up in their face.”
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Bob said, “I mean he basically told me that it wasn’t Hepatitis B; so it wasn’t, you know, 
fatal in the immediate sense.”   These respondents may have been using other types of 
hepatitis as a deviance exemplar (Ronai and Cross 2002).  In other words, their confusion 
about the nature of hepatitis B may have allowed them to feel better that they had HCV 
which was not as severe or bad in their mind.  
Respondents with moderate knowledge understood HCV in general, but often also 
held other inaccurate beliefs regarding HCV.  Karla said, “See he hadn't put me on 
insulin yet, 'because if I go on insulin, the Hepatitis C, it'll speed up rapidly and, and I, I 
could die before Jeff.”  Karla added, “When I first got it, it wasn't really bad. I could have 
took a pill and got rid of it, you know, but now it's so bad that I have to have the 
Interferon.”  There was confusion among several respondents regarding sexual 
transmission.  Sexual transmission of HCV is regarded as rare (Franciscus and 
Highleyman 2003).  Andrew said, “…where I got this sexually transmitted disease you 
know and you got to be very careful and if you date somebody you got to be extra careful 
and this and that.”  Mark alludes that he may have got it from promiscuity. It is not 
unfeasible that persons are confused about sexual transmission, however, as sexual 
transmission is sometimes listed as a means of transmission despite the improbability. 
LITTLE/ INACCURATE KNOWLEDGE
One fifth of persons interviewed had either little to no knowledge of HCV and/or 
grossly inaccurate information.32 These respondents often did not know anything about 
various tests and had a rudimentary understanding of HCV, if any.  Ellis understood that 
his previous experience with treatment kept the virus at bay while on treatment.  He 
32
 See Appendix 5.3 on page 190.  
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talked of having a “spot on his liver”.  He was on treatment again and said, “…and all my 
blood tests showed up negative I asked them what that meant and they told me that it 
means that the medicine's workin and I think that's fine.”  Jerry did not know who 
diagnosed him with HCV or when he was diagnosed. He said the doctor told him, “And 
he got the results back and he said my liver's 95% good.” While Mack knew he had lower 
levels of the virus and that doctors did not recommend treatment for him, he did not 
know if he had had a biopsy or not. 
The main confusion for this group of respondents was with regards to modes of 
transmission.  Several respondents told me implausible modes of receiving the virus.  
While Sparky is knowledgeable with regards to treatment and tests regarding HCV, he 
told co-workers and believed he may have got it through binge drinking.  Sparky 
explained, “I think I got it from drinking…I drank, I’d buy a fifth of Wild Turkey, and 
drink straight whiskey til I’d throw up, and drink some more, and drink some more, and 
drink some more.”  Later he revealed “Uh, I did…I did IV drugs for awhile.”  He did not 
offer this as a means of transmission however. Ellis said, “And I think that's why I got the 
Hepatitis, from drinkin’ alcohol that's what started that feelin.  The other thing only thing 
I can know, we used to swim in the canal as a kid over there.  Back then we drank a lot.”  
Matthew, who talked mainly of his drug addiction during the interview, added, “And 
that's anotha thing you know they say that my Hepatitis C come from drink.”
Little Brother did not know anything about the results of his biopsy or that there 
could be side effects from the treatment which he was on.  Little Brother said about how 
he might have contracted HCV:
“Yeah, said it could be a earring, could be drinkin’ behind somebody.  She said it 
could be a couple a things.  Cause in that plant [chemical plant where he used to 
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work] you know, you just can’t say, she say, you never know, could be a couple a 
things.” 
He said of avoiding transmission  to others, “Yeah they told me.  Uh...use rubbers and 
use some other kinda liquid stuff.  Don't use, you know, straight out naked, you know 
what I'm talkin about, you give it to somebody else.” Jerry did not know how people get 
HCV or how he got it.  
A few other respondents were aware of how they probably got HCV.  Sherri knew 
that she probably got HCV through a transfusion before a surgery but she knew nothing 
about treatment or the disease except that it affected the liver.  Mack did say he might 
have gotten HCV through IV drug use, but was confused about sexual transmission and 
kept making comments about homosexual behavior.  Although Ann said she was infected 
from a transfusion, she seemed confused about how it was transmitted:
“Um...well if in a sense like wanted to know, what could people really do to 
prevent it.  What people could do, I feel sometime a lotta things have to do with 
the type of food we eat, not being clean.  You know, not using the proper utensils, 
like when you get to doin' something, I mean I just use the example, workin' out 
in your yard and cleanin’ the, the flowers or whatever and some people have a 
tendency to come in and not wash their hands, and I guess wit me workin’ with 
children, I got in the practice of always washin’ your hands.  That’s a part of 
sanitary-well if you don’t, if your hands are dirty, whatever you touch, your 
mouth, your, you know if you have a open sore, and that leaves openin’ for other 
things ta happen to your body.  So I guess that part I’ve always been kinda 
interested in hearing what I been wantin’ to know about that.”
Grant said he could have gotten it from needles, tattoos, or eating raw oysters, which is 
not a means of transmission.  Stick told me had hepatitis B, not C but then accurately 
described how HCV is transmitted. He said he told his wife.  “So, I came back and I told 
her I had Hepatitis B and ... she said somethin like that and I said, well I said you don't 
catch it, I don't mean you catch it through sex... You gotta share a needle or something 
like that.” Stick, did, however, have HCV as well as HBV.
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RAMIFICATIONS OF HCV KNOWLEDGE
Knowledge about HCV is variable for this group of respondents supporting 
findings by Heimer and colleagues (2002) as well as Davis, Rhodes, and Martin (2004).  
The majority of respondents have a moderate understanding of the disease with some 
misinformation.  A select minority has incorporated physician’s terminology into their 
parlance and can speak eloquently about their disease.  Unfortunately, another group has 
very little understanding of their disease.  The most troubling finding regarding HCV 
knowledge is the strong relationship to racial and ethnic identity whereby minorities are 
much more likely to have little or inaccurate knowledge (2= 18.38, p<.001).33
Knowledge is not related to educational obtainments, income, or gender.  The majority of 
respondents were patients of Dr. Cassidy thus suggesting that the doctor patient 
interactions may be affected by the race of the patient in terms of information discussed. 
Knowledge about HCV has both costs and benefits for individuals.  Greater 
knowledge is related to reporting felt stigma (2= 7.77, p<.05) and enacted stigma (2= 
6.85, p<.05).  Thus, understanding HCV promotes self labeling and attunement to 
negative reactions from others.  As discussed in Chapter 4, Whites reported experiencing 
felt and enacted stigma more so than racial and ethnic minorities.  Whites also disclosed 
more openly as discussed in Chapter 3.  HCV knowledge and levels of disclosure are also 
related to each other (2= 9.06, p<.01).  Persons reporting positive reactions from 
disclosure in the workplace are more likely to have accurate knowledge (2= 7.26, p<.05).  
Positive reactions from the family are also related to accurate knowledge (2= 6.58, 
p<.05).  Thus, while having an advanced understanding of HCV may lead to greater 
33
 See Appendix 5.4 on page 191 for cross tabulations for all chi-square calculations in Chapter 5.  
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feelings of stigmatization it also leads to greater levels of disclosure and accessing 
positive support in the workplace and from family. Knowledge can be empowering and 
provide hope for individuals especially as individuals struggle with a tenuous future after 
diagnosis.
Part of the process of biographical disruption according to Bury (1982) involves 
the problem of uncertainty as discussed in Chapter 1.  Numerous respondents discussed 
how uncertainty regarding their illness affected their lives.  Ronald explained, 
“I was havin' all these thoughts about death and dying and mortality and 
everything and, and it was causin' me to re-evaluate my course of action, uh, and 
what I wanted to do with the rest of my life, not knowing how much time there 
was because of this, and also, thinkin' a lot about, you know, whether to accept 
treatment or not, and stuff like that.”
Sallie Anne said,
“Well, yah, I worry about it some of course.  I might, that's what I'm saying, I 
don't, just cuz I've said I've given it to the lord I do worry about it, cuz I think 
about, there are times I’ll go and do, I was thinkin' about this the other day, geez 
I'm gonna start to cry, I thought about, you know will my grandchildren, my 
youngest ones, remember me.
Catherine also worried about her family’s future:
“I was like you know God, who's gonna raise my children? You know and I, it's 
just hard you know, I kept asking God, why me.  You know, I said God why me 
why me, you know and uh, I just you know I just kept thinking about my kids you 
know.  Leaving them here, not knowing who's gonna take care of them, because 
at that time my daughter was young, my son was younger.  And uh, that was my 
most concern.”
Yellow tearfully explained, “When I first found out I had it, I didn't know much about it.  
I didn't know how long I had to live, how long I was gonna live, uh, I didn't know 
anything about it.  And the last couple of years it got really bad I didn't know when I was 
gonna die.”
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Gaining knowledge about the disease can help alleviate some aspects of the 
uncertainty.  Samantha said, “Knowing how common it is, knowing that a lot of people 
live productive lives with it, knowing that there’s medications for it.  I guess that what 
keeps me not depressed about it. Pretty much, I guess that’s helpful.”  As mentioned 
previously, David only began to take his disease seriously as he gained more knowledge.  
Harold said, “But, I come to realize if you know the education that I’ve learned and that 
it’s not a death sentence.”  While ignorance may be bliss in terms of not engaging in felt 
stigma or recognizing enacted stigma, the risks to physical health, lack of support 
because of low levels of disclosure, misinformation provided to others by those with little 
knowledge, and possible transmission because of a lack of knowledge are deleterious and 
harmful for not only those with little or inaccurate knowledge but for society as a whole. 
HIV/AIDS DISCOURSE
As I have argued, there is little discourse available to persons diagnosed with 
HCV to understand their disease.  In the absence of ample available discourse concerning 
HCV, respondents turned to the widely available discourse about HIV and AIDS.  Over 
half of the sample made some type of unsolicited reference to HIV/AIDS during the 
interview, thus indicating that this is a powerful means of making sense of having HCV 
for individuals.  Persons relied on these cultural images regardless of their knowledge 
about HCV.    
Cultural imagery regarding HIV/AIDS is so pervasive that numerous respondents 
expressed relief that they had HCV and not HIV.  Several persons mentioned being afraid 
when the doctor called to tell them they needed to discuss some blood tests because they 
thought that they were being diagnosed with HIV.  Similar to persons comparing HCV to 
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Hepatitis B, HIV serves as a good deviance exemplar.  Derrick said, “I just felt like shit, 
you know, I was like, well it could be worse, you know they could have said I had, you 
know, AIDS.”  Larry said, “And now there's AIDS out there now.  And that's what scared 
me to death.”  Research of IDUs reveals a preoccupation with HIV and less concern or 
fear about HCV (Davis et al. 2004).  I also found this trend among respondents without a 
history of drug use.  Sharon said, “And so I was always, in the back of my mind, afraid of 
AIDS…Once I tested negative for HIV, I was so happy it took me a while to get 
frightened about the, about the hep C.”
HIV/AIDS was used as a contrast to show how HCV is different.  Jason said 
regarding disclosure of health status, “And I guess I'm lucky, you know, I don't know, as 
far as I know, I know, you know, a lot of people who have HIV, you know, that they tell 
someone I'm sure their reaction's gonna be different.”  Eddy explained the irony in his 
diagnosis, “You know it is kinda this, this big deal in San Francisco was a gay man 
getting, not having AIDS and somehow having dodged that bullet through no good work 
on my part and now all of sudden I am going be hit by this truck instead.”  David 
discussed differences in transmission: “Not even as much as, I mean, not like AIDS, you 
only receive it through blood contact, where as with AIDS it's, it could be other body 
fluids.”  Mack told me what he would like the public to know about HCV:
“I would like to understand I would like for them to understand the comparison 
between that and hepatitis, I mean...HIV.  I think it's going to be potentially the 
worst epidemic because like I say, the in hepatitis mean, in HIV, the virus once it 
hits the air is dead.  And so but this, you could have this all over your house; you 
know what I'm saying. You know it never dies.  The virus doesn't die like that in 
the air so potentially I think, does this out number HIV already?”
170
Respondents also addressed similarities to HIV/AIDS.  Isabella compared HCV to 
AIDS in terms of research and treatment.  “And, I mean, look how far we've come with 
AIDS.  Now, you can live a full life with AIDS.”  Ann compared the diseases to try to 
understand transmission:
“I mean when you think about it, I mean like AIDS, it's anotha virus, some 
people say that, the just the virus itself, you can carry it, nobody can catch it.  But 
then with, with HIV, I mean you know, one is really catchin' it and the otha one 
you just carry.  I wanna know how can you carry it and can’t give it to somebody.  
And it's the same thing with this.  They say H, I mean C, you can't give to 
nobody.”
Mark said that the public needed to know:
“That you can't catch it from talking to people.  Same thing it is with HIV.  You 
know what I mean, can't catch it by touching, just general contact with 
them…People don't know a thing about it, HIV is the same way, I mean they don't 
know.”
When I asked Lauren if she had heard of HCV, she replied, “I, I had heard of the AIDS, 
but none of the rest of them, and now there's even more.”  I asked Matthew if he knew 
anyone with HCV. He replied that he did not but, “No, they haven't told and I know a 
couple people got AIDS, I know them.”  Similarly, Emma said she only knew people 
with AIDS, not HCV.
While Jason viewed disclosing HCV as less stigmatizing than HIV, Ronald 
explained his fears about disclosing his HCV, “Because of the way they react to people 
with HIV.”  Maruf also offered that HCV is linked to HIV in people’s minds.  Meredith 
said, 
“It's like of course, you know, but, it's, it's strange because automatically when 
you say treatment, disease, anything people automatically and with drugs they 
automatically say, oh you, you're saying that you have this but you really have 
AIDS.”
Bob also linked drug usage as the connection between HIV and HCV:
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“You know, especially in this day with HIV, you know, which is, I mean 
certainly not as in the forefront as it was maybe in the 80s, late 80s and 90s when 
I, you know, found out I had Hep C but I think it still resonates with that and if 
you say you got a junkie’s disease, you got a disease from like, you know, from, 
from sharing needles that it resonates really strongly with social perceptions of 
HIV and AIDS and, and I think that plays heavily on myself in my own 
interpretation of what, what it means of what I have and what it means for me to 
have it.”
Several respondents expressed that HIV/AIDS and HCV were nearly the same 
thing.  Emma says,
“At first they thought it was AIDS, AIDS.  And then they found it was 
Hepatitis…Then I though, I really started reading more on it, and reading up on 
AIDS to see what is the difference between them… And basically, there’s no 
difference… It’s new.  Um, I wanna say it’s not, I, it’s, there is a difference.  Then 
again, I don’t know. All I know is, Hepatitis you not supposed to have no sexual 
intercourse, well, you can have sex, protected sex.”
Karla’s daughter told her having HCV is the same things as AIDS to her. Karla explains 
stigmatization towards her and Jeff because people think HCV is like AIDS. 
Roxanne said, “It's kinda like the AIDS almost, to be honest… Or if I’m cleaning the 
swimming pool or something they treat it like it's AIDS… I mean in the early nineties, 
like I said, they treated you like somebody who had AIDS.”  Derrick said, 
“You know I know I probably couldn't get a job in food services you know 
because of it.  I mean--You're touching food, and having to do knife work and 
stuff like that.  The employers don't want you, you know, cooking for them, it's 
like you having an AIDS patient working in your kitchen.  You know that's a 
blood borne illness, so you know people are gonna be scared of that kind of 
stuff.”
Samantha said, “I felt, I felt like somebody who had AIDS.”
It is not surprising that persons related HCV and HIV especially with regards to 
drugs as a means of transmission.  Relying on HIV discourse, in addition to
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misinformation regarding sexual transmission of HCV, may explain the propensity of 
quite a few respondents to discuss promiscuity as either a possible means of transmission 
or as not a viable means because they were not promiscuous. 
The most important consequence of relying on HIV discourse is the likelihood of 
engaging in felt stigma (2= 4.25, p<.05).  Roxanne repeatedly referred to AIDS in her 
interview and then said, “  … And, mean to be honest, even though I know can't catch 
AIDS by sittin' right beside somebody, if I knew somebody had AIDS, I wouldn't put my 
little boy right next to 'em.”  Thus, she is using a discourse about people she 
discriminates against to understand her own illness.    
CONCEPTIONS OF ILLNESS
While some respondents relied on HIV/AIDS discourse to attempt to make sense 
of having HCV, people also conceptualized their illness more broadly.  Illness concepts 
are individual meanings associated with illness, as discussed in Chapter 1 (Schussler 
1992).  Similar to Schussler (1992), I found that respondents reported numerous 
conceptions of their illness.  For some persons, one concept seemed most salient.  For 
others, they fluctuated throughout the interview in terms of stressing one conception 
versus another. 
ILLNESS AS PUNISHMENT
Seeing their illness as a punishment of some sort was a common theme especially 
among the respondents who contracted HCV through IV drug use.  Daniel spoke 
extensively and repeatedly about how HCV was c onsequences of his bad behavior:
“So unfortunately, I, I did it, and I had to pay for it.  Just like a venereal 
disease…It is, that’s exactly right, it is a consequence of decisions that I made 
when I was young…You know, if we live under the blessin’ of God, we’re 
blessed, if we take that and don’t and we live under the curse of the enemy, the 
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devil, that means when we don’t live under God’s blessing and we, we choose the 
other way unfortunately we have to pay for it. 
Bob echoed this sentiment:
“I think I remember like, I just, there was a, there was a feeling in me like kinda 
like an outcast sorta feeling, you know, kinda like, you know, sort of, oh paying 
for your sins now you’re an outcast kinda thing, you know.  But, you know, I 
don’t, I don’t know what to, what to really put my finger on.”
Ann described a similar conception although she did not contract HCV through IV drug 
use:
“Really, in a sense, well really truly, I looked at it as a attack of the 
enemy…Attack from Satan. I use that word.  Because a lotta things are 
generational curses.  A lotta things have been brought in from our foreparents.  
And sometimes certain people bodies are just gonna experience, and I guess ta 
me, it didn't botha me that much  because I've, I've had a lotta tragedies happen in 
my body.
Charlie exclaimed, “When I got that, that's all I could think about, now what have I 
done?” Samantha described her initial feeling that she was being punished:
“I guess at one point I said, I even blamed myself, I said you know I was like, 
you know, this is your fault, you know, this is what you know, you, you’re being 
punished for the way you lived, you know and so I guess I was a little hard on 
myself, you know, and then I was like you know, you know what you got it, you 
know how you got it and yet it’s not my fault that I did get it but it’s not that I’m 
being punished. It’s just one of those things in life that happens. I mean you 
choose a certain lifestyle, you know, you taking more risks, you know, and so I’m 
not superwoman, shit’s gonna happen and just like a lotta other things happen in 
my life. I can’t go, oh, poor me, I mean that’s the life I chose. So certain 
consequences are, you know, inevitable...I guess as many times as feel like I am 
ok with it, there’s always that thing in the back of my head, you know, that I think 
will always be there as long as I have it, you know there will always be that, that 
feeling of just like, (pause) a reminder of my past. A reminder of what I’ve done 
in my past.
ILLNESS AS CHALLENGE/ACCEPTANCE
HCV was also seen by some respondents as something to be accepted.   The 
comments above by Samantha show her transition and vacillation from seeing her illness 
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as punishment to seeing it as something to be accepted.  Acceptance can mean different 
things to different people.  Some respondents suggested that they must accept their 
disease.  However, they may still conceptualize the disease as a challenge and actively try 
treatment to eradicate it.  Andrew explained how he understood having HCV:
“But basically, you know I done accepted it, you know, I mean, it could be 
worser…Things go through my mind if I would be this different, if I lived my life 
this way or that way.  Yeah, I think about all that. But uh, I'm not lookin back I 
mean I'm still livin.”  
Jamie revealed, “Yeah, well, not really scared, but just because I knew what kind of 
lifestyle you know I had lived, and so I accepted it, but not really scared.”   She added, 
“So, I mean the way I see it, we all die of somethin.  I just take it one day at a time.  I 
mean like I said, if the medicine helps, it helps, if not I just go on.”  Jerry said, “Uh, well, 
I just put one day at a time, you know.  Just say whatever.” Daisy explained,
“And it's just one thing after another but still takin' with a grain of salt, if it’s 
meant to be, it’s meant to be.  But I, I've never been one that, well why me or 
question it.  I, I've never been that way.  In, in fact I tried to, you know after the 
initial shock of it and everything, I tried to make a joke of it, you know.”
Maruf said, “I didn’t [ask why did this happen to me] because you know I’m realistic I’m 
not a kid anymore…oh my God why did this happen to me because it happened already 
and I done it to myself.” Larry explained, “But anyway, I wouldn't change anything to be 
honest with you, with my life, it's just happened, I'm not blaming me, I'm not blaming 
society, anybody.  Catherine said, “And reality is ok, this is what you've got to deal with, 
Hepatitis C is here, so we can't really worry about what happened back then, I mean that's 
not gonna help us right now.”  Peggy added, “Probably because, you know, what are you 
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gonna do, it's done. You know all you can do is what they tell you to do and hope for the 
best.”  Jason summed up his conceptualization:
“So, I mean, if even if I don't get cured you know, I mean, I've tried--if it's the 
best I can do, you know.  I mean, I've, you know, I’ve laid off alcohol, you know, 
I've done everything that they've told me to do, you know, if God doesn't want me 
to cure--want to cure now then hey, six months, a year down the road when they 
have a better treatment, you know.”
Sharon’s increasing symptoms led to her acceptance of her illness. 
“Um, when I had to have the wheel chair, I probably don't have the words to 
articulate what it felt like.  Once that wheel, I had, I knew I had to have that wheel 
chair because of the disease I had those Eureka moments where I understood that 
this was a disease I couldn't just brush off.  And in a year say, I'm fine, I'm gonna 
go back to bein' me.  I mean I was fifty eight then, I'm sixty now.  Um and I 
understood with that wheel chair the changes my life was gonna take. And I didn't 
know how I was gonna, I still don't know how I'm gonna deal.  Uh, I mean I'm 
still in the process of learnin' to be a different person…So I have to take whatever 
happens to me and find a way to deal with it, which is what I'm tryin' to do.”
Others take a more fatalistic approach when accepting their illness.  Matthew said, 
“What’s gonna happen, I could not change you know.  I could get treated for this, 
an' treated for that...I can't change what's already been did... Like I say, gonna do 
this, gonna do that, the good lord gon' take me, he gon' take me.  I don't care how 
much treatment or whateva you gon' get. Your time for you to go, you gon' go.”
Stick held a similar sentiment. “So, just, if I die, just, maybe just the Lord just call me.”
Derrick, who was more knowledgeable than Stick or Matthew, decided to not pursue 
treatment explained:
“You know, I still drink beer every now and then.  Cuz I've always liked beer.  I 
don't drink it like I used to, I don't drink it everyday, but I know every time I open 
that beer that it's you know, it's probably one less day I'm going to be here.  And I 
just say well, it's the quality of life.  If it makes me happy then I'm going to do it.  
And if I die I die, so what everybody dies.”
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ILLNESS AS LOSS
While respondents spoke of accepting HCV, some also spoke of the various types 
of loss experienced as a result of the illness including reactions to treatment.  Most of the 
loss associated with HCV stemmed from changes experienced in the body which affected 
other aspects of life.  Several respondents spoke of negatives changes to their moods.
Lauren said,
“Oh, yeah. I’m not as outgoing as I was, I’m not, I know that.  I think my 
personality has changed for the worse.  And I’m probably grumpier than I was.  I 
don’t have as much patience with things that I used to have.  I’m tryin’ to be that 
way again, you know?  Um, I got really angry and bitter for a while and I took it 
out on my David, who bless his heart, took all that garbage and I’ve told him, you 
know, I’m sorry.”
Sherri explained, “Sometimes I feel it more then ever when I'm by myself.  Cause I know 
it's still there ‘cause all I wanna do is just lay down and just sleep.  Don't wanna go no 
where. Get irritated.”  Tom said, “It's uh made me a little more pessimistic about the 
outcome of the ending of this life you know.  Uh, I don't have the energy that I did you 
know, a lot of times I don't think I have the energy to get up today.”
Liz lamented,
“And I have been sick as a dog.  I've lost weight.  I've lost my hair. I've lost 
friends.  I was a bitch.  I couldn't handle the medicine, it was just--I hated myself 
too, I mean, God, I'm not, I'm not a mean person.  You know, I have a lot of anger 
in me, but I'm not a mean--I don't set out to be mean.”
Daniel also struggled with the medication,  “Depression, short fuse, you could go off real 
easy, uh, all these things, and I didn’t, and it’s true, you don’t have any patience at all, 
patience is the thing you can just throw that out the window, you have no patience.”
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Symptoms of HCV or side effects from treatment affected several people’s ability 
to do daily chores or tasks.  Liz discussed how her inability to perform chores affected 
her sense of self:
“You know, I'm the house wife and laundry and all that good stuff, and, you 
know, Roy come in and not have underwear and things like that and, and it's just 
like, at that period of time when I was really goin' through the worst part of the 
medicine, not only did I feel like crap because of the medicine, I felt guilty 
because I couldn't keep the house up, I couldn't take care of him like I used to.  
Even the dog, he was sufferin', he was, you know, and I was, I was just like, it 
wadn't that I didn't care about any of that it was just I physically couldn't pick 
myself up and do any more.  I just can't, it just makes me angry 'cause I'm like if I 
didn't have this stupid disease I, I would be healthy and energetic and my mind 
would be alert.”
Jamie, Lucy, Daisy and Jenn also talked of not being able to keep up with household 
chores.  Daisy added, 
“You can walk, I can walk out there and I just, it, if I have any energy it sucks it 
out of me.  You know, so I pretty much stayin’ until the sun goes down or if it's 
real cloudy and I loved, used to love to work in the yard.  And I can't even do that 
no more.” 
Daisy also spoke about how she and her husband can no longer travel.  Connie spoke of 
her loss of creativity:
“Then another thing, see I’m a potter, and I do sculpture.  Well, I can’t come up 
with any idea.  And its almost like I dry up.  So, I was telling the doctor about 
that.  I said the one thing I pride in accomplish to occupy my time, and now I 
can’t come up with any ideas.  And that’s sad, you know.”
Liz also mentioned feeling that her artwork suffered as she was not feeling creative 
anymore. 
Others discussed the impact of HCV with regards to working.  Ann said, 
“And them um, as I start takin the medication, I started keepin' kids in my house, 
and I really found out that it wadn't gonna work.  Cause the kids bein' active and I 
would wake up tired and sometimes didn't have a lot of energy.  And I had a little 
bitty baby that I was keepin' he used to holler so much I asked his mama to take 
him, cause he just start workin' on my nerves.”
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Larry and Derrick discussed how they were not able to do manual labor in the hot sun 
anymore. Rick said, “I woulda been workin this last month if I wouldn't be feelin so bad.”
Daniel described, 
“Doin’ the type a work I do, I have to, I bid jobs and I do payroll…I couldn’t 
hardly do it, I would start doin’ it, I would get so aggravated, I don’t even know 
how to explain it, and I just have to put it down, and say I can’t do this.  It’s a 
really really hard medicine, it, it is.  Uh, I dealt with anger a lot with it, it brought 
out some anger in me, and…just tough.”
Isabella discussed how not working impacted her sense of self:
“So I came from this really strong family that was oriented in work.  So, you 
know, my parents taught me, you gotta get out there and take care of yourself and 
be responsible.  And so I did, and the hardest thing for me I mean, was to give 
that up.  That, I mean, you know, due to my, my illness.  It was the hardest thing 
to give up.  To say I can't do this because I'm so sick.  I have to have somebody 
else take care of me and that was hard because I was always, you know, 
independent and on, in, in, not that I'm, well in control if I.”
HCV also impacted interactions with family and friends.  Rick said,
“I'd be doin a lot of things more socially, if I wasn't feelin bad.  I can't plan a big 
party here or nothing, like we used to have a little weekend gatherings here, the 
bonfire, and volleyball, and horseshoes, and people come by boat, bring their 
campers and shit.  Cuz I don't never know when I'm gonna feel good enough to do 
that.  And I don't wanna be feelin bad tryin to be a host.”
Donald explained, “Oh, the few things I've wanted to do before I kick on outta here and I 
know I'm not gonna get to do ‘em…Well, stuff with Chad [son] and go a few places, do a 
few things...We used to ride horses all the time, can't do that anymore.” Cece said about 
her boyfriend, 
“And he's very angry at my disease.  And bitter.  And pissed off.  He's tired he 
said.  He's tired of comin' home to a sick person.  You know, it's, it's taken a toll 
on 'em…But it's caused him to fall out of love with me.  You know, I, know this 
much.  I know he still loves me, but it's just, it's just hard right now.  Very hard.”
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Mark said treatment caused problems in his marriage because of his volatile emotions.
He expressed great concern about the future of his marriage.  Daniel confessed that, “me 
and Jill [his wife] had a big fight one time and, you know, I hit her.”  He felt that the 
medication caused his moods to be very unstable. 
ILLNESS AS VALUE
While numerous respondents experienced HCV as a loss with regards to various 
activities and relationships, people also spoke of the value of having HCV.  Several 
persons mentioned the positive impacts on their outlooks or perspectives especially with 
regards to feeling grateful about their lives.   Maruf commented, “Yeah I been, lately, I 
been more responsible, more calm.  I don’t know why…Yeah.  I been more calm.  I don’t 
get upset as easy as I used to.”  Sparky said, 
“More or less I started to change my outlook on it.  I used to dwell on it and made 
a lot of BS, it’s not worth it.  I look for all the positive, and I don’t know where it 
come from, but you see it here and there, and uh, how does it go…live everyday 
like it was your last.”
Vanessa said, “You know, it gives you something to think about and it, I mean, I tell ya, I 
think you really appreciate life and you don't take life for granted like some people.”    
Ronald said,
“And but it, it got me in touch with my mortality.  It made me definitely made me 
aware, more aware that I'm not gonna live forever here, you know.  I mean, I'm a 
believer, so I believe I'll, you know, continue on, but in, in terms of my just stayin' 
in a rut, actin' like I'm gonna live forever here, not doin' some of the things that I 
would like to do.  It's changed that. It's given me a different perspective on life
…It's also kind of given me more of a sense of freedom in terms of having these 
choices because I do feel like, you know, I mean the doctors have told me it's 
gonna shorten my life, and I don't know how much shorter.  So if I feel like doing 
something, then, you know, then I'll go ahead and do it—“
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Connie said, “Well, I’m glad uh the illness, you know, the hepatitis let me see that life 
square in the face.  Everybody’s dying its just that I had a warning, you know.  So, you 
know I appreciate it.”  Daniel explained, 
“But I did learn a lot through the treatment, learned a lot about myself, I learned a 
lot about bein’ humble, and, you know, course, I may not be practicin’ it all the 
time but I, but it will humble you.  It will teach you that there is more in life than 
you.”  
Sharon discussed, “But, had I not been knocked down with the Hepatitis C, I'm not a 
hundred percent sure that I would've taken the time to get to know my grandchildren and 
to be as good a grandmother as I am….Yeah.  I am a lot less focused on me.”  
Several respondents mentioned how having HCV made them especially grateful 
for their recovery from alcohol and drug use. Ronald commented, “And so it's helped me 
to apply my [Alcoholics Anonymous] program, and it's helped me to have more, 
appreciation and awareness of my own freedom from drugs and alcohol.  Eddy said, 
“Umm, it’s made me really grateful that I am sober. It has yeah, it’s affected my 
life.” It’s, you know, I, it’s not, I mean, it’s been a basically a positive thing for 
me. It’s made me focus in my body and do some good things for my body and 
beyond that, it hasn’t really affected me, so, but I was really lucky that I had 
stopped drinking five years before.”
Samantha said, 
“I value it [sobriety] more, you know, I value it, I value my health more, you 
know. I even value my daughter more. It made me think, made me realize that, 
Yeah, I could die of something else a lot sooner, but I mean, it ain’t the same, I 
maybe feel, I guess I really think that, I guess, I want to be with my daughter 
more in her life and see her grow up.” 
 
FAITH
Reliance on God or faith of some sort was repeatedly mentioned by persons as a 
means of dealing with their illness.  Jeff turned to prayer after being diagnosed:
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“So I'm like Ok, you know, I, so in other words, I'm gonna die.  And they said 
yeah.  So I--so it took--I mean, it, it still bothers me, but I just--I told 'em I said 
well, you know, you can tell me this, but I got right with the Lord… It was like, 
what do I do?  You know, so, I just started prayin'.  I said you know, it's, it's got to 
be a way something, some--either way, I've just got to find it.  And started prayin'.  
I still do every night, and I been here, goin' on two years now.  
Numerous respondents discussed how God could take care of them.  Ronald said, 
“It's kind of like a faith issue.  It's an issue to where you rely on your higher 
power and your high--we believe that, that my higher power has the power to 
somehow impede it or cause it to, you know, go slow enough or, you know, 
whatever.  I mean, I'm religious enough that I believe he has the power to cause it 
to actually go in remission.  And, and so that's where I'm putting my, my hope is 
in my--in his power. 
Ellis said, “Give it up for the Good Lord, I’m gonna pull through.  I’m gonna be cured 
from it.  I want him to send me up to heaven.”  Daisy expressed a similar sentiment: “I 
just put it in the Lord hands and, he's the only one that got me through all this stuff.”
Sallie Anne explained, 
“I feel, well I'm a Christian, and that right there gives me a lot of the staying 
power that I have, that right there is the fundamental rock that I'm you know 
sitting on I think, I just feel like, whatever they need to do, they'll do, and the 
Lord, it's in the Lord's hands and he’s gonna handle it, you know, he handles 
everything else.”
She told me how she read her bible when she felt down and that it made her feel better. 
Cece explained how her faith changed her response to having HCV:
“But you know it's like I was sayin', I did this to myself.  I got this way because of 
me.  Now I'm tryin' to do somethin' about it because I have God in my life today.  
And it, it's a major difference.  Phew.  Major difference.”  
David said, “I don’t believe that it bothers me as much because I feel I’m a very spiritual 
person and I feel close to, to God, to my creator, and so, I’m not afraid of death, I’m not 
afraid of it in that sense.” Vanessa also relied on God,
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“And so, I mean, you know, and I just, you know, I talk to God about it or 
whatever.  I mean, it really, that there really kinda kept me goin'… If I start to 
think about it-- I, you know I just believe, you know that the Lord will see me 
though this, you know, that it's just you know I, you know, I let myself know that 
this is just a test, it's just a trial, it's just somethin' that I have to go though for 
now, but one day it'll be over and, and I'll be victorious.”  
Two respondents, Daniel and Catherine, spoke of their faith and God through out 
the entire interview.  Their faith and religiosity was incredibly salient to their illness 
account.  Like Vanessa, Daniel saw his illness as a test:
“But you know, I told the Lord, I told God, I said look if this is what you want me 
to do, if I have to go through treatment again, as bad as I hate it, I’ll do it if you 
want me to.  But I really don’t think he does, and at this point I don’t feel like I’m 
gonna.  Uh, so, I think God wants me to trust him and I’m not sayin’ we don’t 
need doctors by any means… I believe that this is a test, I believe this is, this is a 
life that we live that’s gonna determine the outcome of where we gonna spend the 
rest of our eternity, and I think we have choices to make in, in this journey.”
Catherine also mentions that doctors are crucial but that her faith upon God is even more 
important:
“I'm first of all I'm a Christian, and I truly believe that God can do anything, and I 
have seen god do miracles, so besides what a doctor tells me, my faith relies in 
God.  Cuz I know the doctor. can tell you anything, but I know when God says 
something he's gonna do it.  So, I my faith you know, I have to keep my faith up, 
you know, and just knowing, that ok, you know God, the doctors say that I have 
this, they say I have that.  You know ok.  Now, I've seen what you've done with 
other people now, what are we gonna do with this.”
Catherine explained that God has seen her through turmoil before and would continue to 
take care of her.   Catherine relied on her faith to combat stigma.  She is the only African 
American, as mentioned previously, who practiced open disclosure.  She explained this 
because of her reliance on God:
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“But then Gods started showing me things you know, he started showing me that 
you know, his love was stronger than anybody’s love.  And you know, he was 
showing me, that no matter what people thought about me, that he loves me, and 
that he was gonna take care of that.  And he's doing that today.”
CONCLUSION
The process of diagnosis is crucial to the labeling process of having HCV.  HCV 
is according to Brown’s (1995) typology, a routinely defined condition, meaning that 
there is a biomedical definition applied and that this condition is generally accepted (41). 
While there is little conflict between doctors and patients about whether this type of 
diagnosis is accurate or real, the consequences of the diagnosis are an issue.  The manner 
in which persons came to be diagnosed, either as a surprise or individual initiated 
diagnosis, appears unrelated to the reactions to diagnosis.
The ensuing reactions of fear of the unknown, shock, fear of imminent death and 
sadness are all typical reactions to diagnosis with chronic illness (Bury 1991; Bury 2000; 
Charmaz 1991).  The scant research on HCV suggests that persons experience a severe 
and negative reaction to diagnosis (Glacken et al. 2001; Hepworth and Krug 1999; 
Hopwood and Southgate 2003).  Hepworth and Krug (1999) note, 
"The identities that people have through their relations with others are directly 
affected by a diagnosis of HCV in that histories and stories about self are 
challenged, rewritten, and forced to take on new meaning as new discourses 
intrude into people's lives" (242).  
While I also found that many respondents did have an intense reaction to diagnosis, not
all did.  As discussed, some respondents had an ambivalent reaction to their diagnosis. 
For some, the lack of symptoms associated with the diagnosis made it easy to deny the 
severity or salience of the diagnosis. Bury (2000) discusses how the impact on the body is 
crucial to understanding identity changes.  Other respondents did have symptoms, but 
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still did not describe having an emotional reaction.  For Jamie, the ambivalence was 
related to her lack of knowledge about the disease but Peggy had fairly accurate 
knowledge of the disease and was still ambivalent.  Perhaps the respondents who 
described an ambivalent response are simply organizing their illness account along these 
lines to minimize disruptions to their identities.  Yet, for most, at other points in the 
interview, they described how HCV did impact them later.  While Radley (1989) 
suggests that indifference to illness increases as social class decreases, I found no 
relationship between an ambivalent reaction and social class, race, or gender. An 
ambivalent reaction to diagnosis was linked to practicing reluctant or limited disclosure
(2= 4.39, p<.05) most likely because the illness was less salient for these individuals.   
The diagnostic process itself may affect knowledge about the disease.  Persons 
may or may not receive testing and subsequent treatment after an initial diagnosis.  Most 
of my respondents were under the care of a physician and had some diagnostic testing 
done if not also treatment.  While there was diversity in terms of previous knowledge 
about HCV before diagnosis, we might expect there to be more of a convergence in 
knowledge after diagnosis, especially for persons seeing the same physician.  Instead, I 
found various levels of knowledge about HCV at the time of the interview.  Krug (1995) 
notes "the impact of an initial positive diagnosis [of HCV] carries with it an almost 
inevitable desire for information" (312).  Krug (1995) performed discourse analysis 
including, 
“Naturalistic observation at HCV support group meetings; from casual 
conversations with HCV-positive persons, physicians, and others; from 
interviews, from cultural texts such as newspapers and television documentaries; 
and from the written texts that HCV positive people and support groups generate, 
share, and discuss” (301). 
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The racial and class makeup of Krug’s sample is unknown.  I, however, found an intense
desire for information among persons with expert levels of knowledge or moderate 
knowledge.  Among my sample, there is a connection between attending support groups 
and expert levels of knowledge.  Krug (1995) did study support groups, which may affect 
his findings.  Certainly not all of the respondents in this research described wanting more 
information which may be linked to preferring uncertainty than a stark reality (Weitz 
1989). 
Most importantly, minorities are more likely to have little or inaccurate 
knowledge about their disease.  As discussed, knowledge about the disease leads to more 
open levels of disclosure but also negative self-labeling.  Disclosure does lead to more 
experiences with stigmatization.  Yet disclosure also allows for positive reactions from 
others.  Persons with more knowledge about HCV reported positive reactions from 
family and in the workplace. Finally, gaining knowledge about one’s illness can an 
important coping mechanism (Bury 1982).  Thus, future research needs to further address 
the impact of race on illness experiences.  
While knowledge varied about HCV, many respondents turned to the more 
readily available information regarding HIV/AIDS to understand having HCV. Zickmund 
and colleagues (2003) found that persons with HCV explain stigmatization because of an 
association with HIV.  Among this sample, persons who relied on HIV discourse were 
more likely to engage in felt stigma thus indicating the negative consequences of using 
HIV imagery to understand HCV. 
Similar to some persons with HIV, several respondents conceptualized their 
illness as punishment (Weitz 1989).  Yet at the same time, some of these persons as well 
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as other respondents saw their illness as a challenge that they must accept.  Persons also 
described their illness in terms of loss and value.  Schussler (1992) found that persons 
who see their illness as a challenge or as having value tend to cope with their illness 
better.  Seeing illness as a punishment is related to poorer coping skills and increased 
levels of depression (Schussler 1992).  Yet these conceptualizations and coping 
mechanisms are related to presence and use of support. 
Faith emerged as an important means of support for numerous respondents 
including those who saw their illness as a punishment.  Seeing illness as punishment may 
not have the same deleterious effects that Schussler (1992) described for these individuals 
because they have now been redeemed in their mind in God’s eyes.  Numerous 
respondents explained that their health was in God’s hands and that their faith sustained 
them.  Research on Black women has found a similar coping mechanism regarding illness 
and encouragement within the church to define illness as sin (Abrums 2000).  
Interestingly, mentioning faith is not, however, related to gender, race, or class in this 
study.  Respondents who discussed faith as a coping mechanism were more likely to be 
Baptist or some other Christian affiliation (mostly Evangelical) versus Catholic, some 
other religion, or no religion (2= 8.75, p<.05).  Likewise, respondents who mentioned 
faith were more likely to attend services frequently (2= 12.59, p<.01).  Thus, future 
research should be cautious when linking faith solely to race and gender and instead 
focus on religiosity.    
Despite the lack of ample cultural imagery, respondents found ways to make 
sense of having HCV.  Diagnosis did give rise to trepidation for some.  The issue of 
uncertainty was a salient issue for many as seen in the discussion about fear of the 
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unknown as well as the role that knowledge plays in alleviating uncertainty.  Even
respondents who reported an ambivalent reaction to diagnosis had to deal with some 
repercussions regarding interactions with others even if minor.  HCV knowledge is quite 
variable, as mentioned, and unequally distributed by race leading to different illness 
careers for respondents.  If the trend of promoting HCV education and awareness 
continues, future research should monitor the implications for the illness career of 
persons with HCV.  Public awareness could change an individual’s reaction to diagnosis 
as well as knowledge about the disease thus alleviating some of the current inequality.  
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APPENDIX 5
5.1 EXPERT KNOWLEDGE
Name Gender Age Race/Ethnicity Education
(Years)
Household Income Reported Mode of 
Transmission
Cece Female 45 White 9 $10,000-19,999 IV drugs
Isabella Female 41 White 16 $30,000-39,999 Transfusion
Jenn Female 50 White 14 $50,000-59,999 Sex/household
Liz Female 53 White 12 $40,000-49,999 IV drugs
Melissa Female 49 White 16 $80,000-89,999 IV drugs
Meredith Female 46 White 14 $20,000-29,999 IV drugs
Sharon Female 60 White 14 $0-9,999 Transfusion
Catherine Female 41
African-
American 11 $10,000-19,999 Snorting drugs
Connie Female 70 Japanese 15 $50,000-59,999 Transfusion
David Male 48 White 14 $30,000-39,999 IV drugs
Harold Male 47 White 16 $40,000-49,999 IV drugs
Jason Male 22 White 14 $90,000 or above Transfusion
Rick Male 54 White 12 $0-9,999 IV drugs
Tom Male 51 White 15 $50,000-59,999 IV drugs
Yellow Male 50 White 13 $10,000-19,999 IV drugs
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5.2 MODERATE KNOWLEDGE
Name Gender Age Race/Ethnicity Education
(Years)
Household Income Reported Mode of 
Transmission
Daisy Female 61 White 11 $10,000-19,999 Transfusion
Karla Female 37 White 11 $0-9,999 IV/sex/household
Lauren Female 59 White 13 $10,000-19,999 Transfusion
Lucy Female 53 White 13 $60,000-69,999 Sex/household
Peggy Female 53 White 13 $70,000-79,999 Needle stick
Roxanne Female 35 Hispanic/White 13 $30,000-39,000 Transfusion
Sally Anne Female 50 White 12 $20,000-29,999 Transfusion
Samantha Female 26 White 12 $0-9,999 IV drugs
Emma Female 54
African-
American 9 $10,000-19,999 IV drugs
Jamie Female 53
African-
American 13 $20,000-29,999 IV drugs
Tari Female 39
African-
American 14 $60,000-69,999
Sex/household 
contact
Vanessa Female 41
African-
American 13 $20,000-29,999 Tattoo
Bob Male 33 White 15 $10,000-19,999 IV drugs
Charlie Male 53 White 18 $90,000 or above IV drugs
Daniel Male 46 White 9 $60,000-69,999 IV drugs
Derrick Male 36 White 12 $20,000-29,999
Snorting 
drugs/tattoo
Donald Male 70 White 5 $60,000-69,999 Transfusion
Eddy Male 47 White 20 $40,000-49,999 IV drugs
Jeff Male 40 White 6 $0-9,999 IV drugs
Joey Male 50 White 12 $10,000-19,999 Snorting drugs
Larry Male 53 White 16 $10,000-19,999 IV drugs
Mark Male 35 White 12 $30,000-39,999 Transfusion/sex
Nick Male 47 White 8 $0-9,999 IV drugs
Ronald Male 54 White 18 $40,000-49,999 IV drugs
Andrew Male 44
African-
American 12 $10,000-19,999 Drug related
Maruf Male 43 Jordanian 12 $30,000-39,999 IV drugs
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5.3 LITTLE/INACCURATE KNOWLEDGE
Name Gender Age Race/Ethnicity Education
(Years)
Household Income Reported Mode of 
Transmission
Ann Female 51
African-
American 13 $10,000-19,999 Transfusion
Sherri Female 46
African-
American 12 $0-9,999 Transfusion
Sparky Male 51 White 13 $40,000-49,999 IV drugs
Ellis Male 49
African-
American 12 $50,000-59,999 Drinking 
Grant Male 51
African-
American 10 $20,000-29,9999 IV drugs
Jerry Male 51
African-
American 10 $10,000-19,999 Unknown
Little 
Brother Male 42
African-
American 12 Missing
Earring/Drinking 
after others
Mack Male 52
African-
American 13 $10,000-19,999 IV drugs
Matthew Male 53
African-
American 12 $0-9,999 IV drugs
Stick Male 52
African-
American 9 $30,000-39,999 Tattoos
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5.4 CHI-SQUARE CROSS TABULATIONS
HCV Knowledge and Race (2= 18.38, p<.001)
Minority White Total
Little/Inaccurate 9 1 10
Moderate 6 20 26
Expert 2 13 15
17 34 51
HCV Knowledge and Felt Stigma (2= 7.77, p<.05)
No Felt Stigma Felt Stigma Total
Little/Inaccurate 8 2 10
Moderate 8 18 26
Expert 5 10 15
21 30 51
HCV Knowledge and Enacted Stigma (2= 6.85, p<.05)
No Enacted Stigma Enacted Stigma Total
Little/Inaccurate 8 2 10
Moderate 13 13 26
Expert 4 11 15
25 26 51
HCV Knowledge and Levels of Disclosure (2= 9.06, p<.01)
Limited/Reluctant Open/Activist Total
Little/Inaccurate 8 1 9
Moderate 15 11 26
Expert 4 11 15
27 23 50
HCV Knowledge and Workplace Support (2= 7.26, p<.05)
No Support Support Total
Little/Inaccurate 10 0 10
Moderate 24 2 26
Expert 10 5 15
44 7 51
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HCV Knowledge and Family Support (2= 6.58, p<.05)
No Support Support Total
Little/Inaccurate 9 1 10
Moderate 17 9 26
Expert 6 9 15
32 19 51
HIV Discourse and Felt Stigma (2= 4.25, p<.05)
No Felt Stigma Felt Stigma Total
No HIV/AIDS 15 11 26
HIV/AIDS 8 19 27
23 30 53
Ambivalent Reaction and Levels of Disclosure (2= 4.39, p<.05)
Limited/ Reluctant Open/Activist Total
Ambivalent Reaction   9 2 11
No Ambivalent 
Reaction
19 22 41
28 24 52
Faith and Religious Preference (2= 8.75, p<.05)
Baptist Catholic Other 
Christian
Other/None Total
Faith  7   1  7  1 16
No Faith 11 11  6  9 37
18 12 13 10 53
Faith and Attendance at Services (2= 12.59, p<.01)
Never Once/Twice 
per year
Once/Twice 
per month
Weekly Twice or 
more per 
week
Total
Faith   2 2   2  5 5 16
No Faith 13 7 10  6 1 37
15 9 12 11 6 53
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CHAPTER 6: CONCLUDING THOUGHTS AND FUTURE RESEARCH
PRIMARY FINDINGS
From the stories of men and women with HCV in Southern Louisiana , illness 
experiences have been shown to be fundamentally tied to individual decision making 
processes as well as larger structural factors.  Through in-depth interviews with fifty-
three persons with HCV, I found that respondents shaped disclosure patterns and 
motivations for disclosure.  Individuals reported a range of social reactions to their 
disclosures including stigmatization and support. People with HCV devised ways to give 
meaning to their experience despite the lack of cultural imagery.  This chapter 
summarizes the main findings, addresses the global theme of race and inequality that 
clearly came to the fore in their stories, and outlines the implications of the research.
Using a loose illness career framework, I trace the overarching findings from disclosures 
of HCV status, reactions to disclosures, and how individuals made sense of having HCV
all in the absence of widely available cultural discourse. 
DISCLOSURE PRACTICES
Persons with HCV reported a range of disclosure patterns, as discussed in Chapter 
3.  A small group of people, all of whom were involved in support groups, engaged in 
“activist disclosure” defined by their goal to educate others about HCV.  Those who 
practiced activist disclosure were more likely to be White.  The bulk of respondents, 
however, were either “open” or “limited” in their revelations regarding their HCV status.  
Thus, the majority of persons told some family and friends about their health status.  
Another smaller group of persons were quite secretive.  People remained silent because 
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of not wanting to burden others or remind others of their past lifestyles.  Yet, they were 
quite clear that they feared stigmatization of some sort.  Some respondents described 
waiting to disclose while others simply felt their health status was private information. 
Reasons for disclosure centered on concern for others such as protecting others, to 
explain atypical behavior, to educate others, or as a symbol of trust.  Persons also 
disclosed because of their own concerns for care, help, or sympathy.  The mode of 
transmission of HCV did not affect disclosure patterns which is not surprising 
considering the lack of cultural imagery about HCV.  While gender and social class were 
unrelated to patterns of disclosure, race had a key effect.  Minority respondents were less 
likely to be “activists” or even “open” about their HCV status.  Research needs to address 
whether this is a general pattern for minorities as this may reveal insight into racial health 
disparities as disclosure patterns had associated benefits and risks.  
REACTIONS TO DISCLOSURE
One risk of disclosure respondents reported is stigmatization, as discussed in 
Chapter 4.  Over half grappled with some type of stigma.  A quarter of respondents were
not even aware of a stigma associated with HCV.  Nearly half of the sample, however,
revealed experiences which researchers have come to call “felt stigma”, that is feeling 
shame because of imagining how others would react if they knew about the stigmatizing 
attribute (Jacoby 1994).  People had a number of fears about reactions from others 
including an association of HCV with deviance, seeing HCV as contagious, or viewing 
people with HCV as dirty.  They also reported experiences with “enacted stigma” which 
are acts of discrimination, thus confirming those fears as most incidents concerned a 
connection between HCV and deviance or fear of contamination. Racial differences 
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emerged as a whole as Whites with HCV were more likely to be aware of stigma, engage 
in felt stigma, and report experiences with enacted stigma. Several people did have 
negative experiences in the workplace or in healthcare settings.  These stigmatizing 
experiences centered on an association with HCV and deviance and/or contagion. 
Not all disclosures, however, were met with stigmatization.  Some respondents 
described little to no reaction to their disclosures or minimization of their illness.  Again, 
the lack of cultural imagery and knowledge about HCV may play a role here.  Disclosing 
health status was beneficial for some respondents who received support through family, 
friends or at work. People coped with stigmatization through information control, which 
can be seen used to avoid stigma or resist stigma.  Individuals also coped through 
condemning the condemners whereby they minimized any stigmatizing response by 
degrading the person as ignorant.  Finally, some persons participated in support groups
which facilitated “activist disclosure”.  
MAKING SENSE OF HCV
People employed numerous mechanisms to understand their experiences with 
HCV, as discussed in Chapter 5.  Over half of all respondents experienced a “surprise 
diagnosis” in the course of a medical exam or blood donation.  Others initiated the 
diagnostic process because of symptoms of some sort.  Upon diagnosis, some individuals 
experienced fear of the unknown, shock, fear of imminent death, or sadness.  The 
“uncertainty” experienced after diagnosed was exacerbated by the lack of cultural 
imagery about HCV.  Others, however, described a rather ambivalent reaction to 
diagnosis perhaps abetted again by the lack of cultural discourse concerning HCV.
Persons who described an ambivalent response were less likely to disclose their health 
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status.  Thus, not all respondents who practiced reluctant or limited disclosure did so 
because of a fear of discrimination.  For some people, having the often asymptomatic, 
culturally invisible disease of HCV is just not that important.  People may minimize the 
significance of the disease compared to other difficulties in their lives.   
Knowledge about HCV appeared to shape disclosure patterns.  Some people could 
expertly discuss the disease while others had little or incorrect information.  The majority 
of the respondents possessed moderate knowledge about HCV. Knowledge helped 
reduce uncertainty.  Those with less information were less likely to openly disclose their 
health status.  Minorities with HCV were more likely to have vague or inaccurate 
knowledge, thus perpetuating the cycle of minority health disparities. 
 In the absence of available cultural discourse, people relied on discourse about 
another disease, HIV/AIDS, to make sense of their experiences.  In this regard, modified 
labeling theory is relevant.  While some saw their illness as a punishment or loss, others 
described the challenges or value that resulted from having HCV.  Finally, a diverse 
group of respondents relied on faith to understand their illness. Relying on faith was not 
related to race/ethnicity, class, or gender but linked to attendance rates at religious 
services and religious affiliation. 
THE INDELIBLE STAMP OF RACE AND ETHNICITY 
The effects of race permeate illness experience with HCV.  Blacks represent over 
1 in 5 person with HCV in the United States (Palmer 2006).  HCV progresses more 
quickly in Blacks and they are less likely to receive treatment once diagnosed (Palmer 
2006).  Even when treated, Blacks respond less favorably to treatment than Whites
(Palmer 2006).  While hepatologists have been studying these differences from a 
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physiological approach, this research sheds light on variations from a sociological 
perspective. Persons of all racial and ethnic backgrounds had different experiences with 
diagnosis. Most people were largely unaware of HCV before diagnosis or had little 
knowledge.  Initial reactions to diagnosis were undifferentiated by race or ethnicity.  The 
ensuing behaviors were, however, influenced by race.  
Black respondents did not disclose in the same manner as White respondents.  
Blacks may have discussed their health status with some close family and friends but 
were unlikely to practice “activist” or “open” patterns of disclosure.  Surprisingly, these 
patterns did not appear to be explained through gender, education, income, or mode of 
transmission.  Some research on HIV has found a connection between disclosure rates 
and race/ethnicity (Mason et al. 1995; Simoni et al. 1995).  An explanation for the 
discrepancy in disclosure regarding HIV is the lower levels of knowledge about 
HIV/AIDS in minority communities thus discouraging open disclosure patterns (Simoni 
et al. 1995).  
Minorities in this research were more likely to have inaccurate or little knowledge 
about HCV.  Their lack of knowledge may have inhibited more open disclosure practices 
because of confusion or misunderstandings of their own about HCV.  Black respondents’ 
lack of knowledge may reflect the dearth of available information regarding HCV in the 
larger Black community.  If there is indeed less information in the Black community 
about HCV, the lack of open disclosure practices among Blacks with HCV will only 
perpetuate the problem.  This lack of knowledge represents what Link and Phelan (1995) 
discuss as a “fundamental cause” of disease as it involves access to resources, specifically 
knowledge, which can minimize the impact of a disease.  Future research must evaluate 
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public knowledge about HCV with attention to sampling various racial and ethnic groups.  
Another factor affecting disclosure patterns is cultural norms regarding discussions of 
health status.  Blacks were more likely to mention not disclosing because it is private 
information.  Being a racial or ethnic minority already potentially places persons in a 
stigmatized identity, they may be unwilling to risk further stigmatization through 
disclosing their HCV status (Goffman 1963). 
Ironically, disclosure does lead to more experiences with stigmatization.  
Correspondingly, since Blacks were less likely to disclose, they reported fewer 
experiences of stigmatization.  While Whites did mention engaging in felt stigma more 
than Blacks, kthis is likely a result of their greater understanding of the disease as a 
whole.  Thus, with greater education about HCV, Blacks may also self label.  Some 
research suggests that Blacks are more aware of discrimination because of being part of a 
stigmatized minority group (Oyserman and Swim 2001). Yet in this research, White 
respondents reported more acts of enacted stigma.  Whites may attribute discrimination to 
their HCV because they do not hold other visible stigmatized statuses.  While it may 
seem beneficial for Blacks to continue lower levels of disclosure to avoid stigmatization, 
they are missing the health benefits that can accrue from disclosure.  Research reflecting 
this tension shows that persons labeled as mentally ill do face stigma, but also receive 
necessary and beneficial services as a result of the label (Rosenfield 1997).  
Disclosure of health status does allow for support from family, friends, or in the 
workplace.  Social support has profound effects on mental and physical heath status
(Thoits 1995).  Thus, while Blacks do not experience stigma as much as Whites, they 
miss opportunities for social support.  Levels of knowledge were related to positive social 
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support thus limiting social support for Blacks.  Positive social support in the workplace 
was related to higher incomes also disenfranchising Blacks as they are more likely to 
have lower paying jobs than Whites. 
Black respondents in this research are clearly experiencing HCV in a different 
fashion than white respondents. This racial inequality reflects larger trends in health in 
the United States.  These differences in experiences with HCV are not attributable to 
social class supporting research that claims education and income do not explain racial 
discrepancies in health seeking behaviors (Schnittker et al. 2005).  Instead, racial 
differences may be an outcome of provider patient interactions and style.  
Numerous researchers have examined provider patient interactions.  Waitzkin 
(1985) found that physicians believed they spent more time giving information to patients 
than they actually did.  Physicians’ social class as well as patients’ social class affected 
the informative process (Waitzkin 1985).  Doctors tended to underestimate the amount of 
information they thought patients wanted.  There were no social class differences in 
patients’ desire for information.  Patients’ thirst for information was unrelated to the 
information actually given to them.  Length of acquaintance and a busy clinical load were 
related to less information being given to patients.  In short, sociolinguistic patterns 
affected the information received by patients (Waitzkin 1985).   
The majority of respondents in this research were patients of one physician.
However, a provider does not interact with all patients in exactly the same manner.  In 
fact, providers take on a variety of roles tailored to meet the needs of individual patients 
(Lutfey 2005).  Lutfey (2005) also found that residents interacted with patients in a 
different fashion than seasoned physicians.  Respondents in this research who were seen 
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at the public clinic were likely to see a different resident at each visit.  Thus, these 
patients do not have the benefits of establishing a long term relationship with one person 
possibly affecting information given to them as found by Waitzkin (1985).  However, the 
racial differences in experiences with HCV spanned both recruitment sites thus limiting 
the explanatory power of organizational setting.
Style is another factor that influences racial discrepancies.  Style refers to how 
people present their illness (Bury 1991).  Research has repeatedly found that social class 
affects style (Anderson 1991; Blair 1993; Bury 1991; Radley 1989).  Middle class 
persons focus on the body in a more abstract fashion and are more verbal while lower 
class persons are concerned with how symptoms affect day to day functioning.  Anderson 
(1991) states that what appeared to be racial differences in illness experience were in fact, 
class differences.  In this research, however, differences are not linked to educational 
obtainments or income.  There is some support that racial and ethnic minorities 
experience illness differently regardless of social class (Smaje 2000).  Zola (1966) noted 
differences in presentation of symptoms among Irish Americans and Italian Americans.  
These findings point to the importance of culture in how individuals experience their 
bodies and illness (Zola 1966).
Illness experiences with HCV were also cultural.  As evidenced by the length of 
the interview process, Whites in this sample talked longer about their experiences than 
minority respondents, providing a window into their interactions with providers.  While 
Blacks may desire just as much information about HCV as Whites, they do not obtain the 
same levels of knowledge.  Blacks’ lower levels of knowledge about HCV and more 
inhibited disclosure patterns are contributing factors to these racial variations in illness 
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experience.  These differences are also a result of illness style and subsequent provider 
and patient interactions. Physicians may unwittingly interact differently with Black 
patients with HCV because they are aware of racial differences in responsiveness to 
treatment, thus setting up a self-fulfilling prophecy (Lutfey 2000).  Future research 
should focus specifically on provider and patient interactions among persons with HCV 
to further explicate racial differences in illness experience. 
RESEARCH IMPLICATIONS
My research has implications for literature in the areas of medical sociology, 
sociology of deviance, race and ethnicity, and social psychology.  These findings also 
offer contributions to address the plight of persons with HCV and the lack of public 
health education in the United States.
Current models of illness experience are applicable albeit in a limited fashion to 
HCV.  Although some respondents experienced troubling symptoms before diagnosis, for 
most, diagnosis was the trigger or beginning point for their illness careers.  Biographical 
disruption, according to Bury (1982), presumes that diagnosis is the first stage of 
disruption.  Not all respondents with HCV reacted to diagnosis with feelings of shock, 
fear, or devastation.  Some respondents were rather ambivalent.  These findings question 
the presumption of a diagnosis of chronic illness necessarily leading to a biographical 
disruption.  Diagnosis does lead to different trajectories of the illness career depending on 
how stable an individual’s biography was before diagnosis.  In other words, a diagnosis 
may be fairly irrelevant for some persons in light of other life stressors.    
Nevertheless, most persons with HCV do experience some level of biographical 
disruption but not always starting with diagnosis.  Addressing disclosure practices and 
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subsequent reactions provides some insight into how disruptive illness is for individuals. 
The lack of cultural imagery about HCV provides more options for persons with HCV in 
that they are less limited by available discourse compared to other diseases.  Respondents 
themselves often had no sense of what it meant to have HCV.  The people they disclosed 
to often had even less familiarity with HCV.  Thus, respondents had much more freedom 
in terms of giving meaning to the illness experience compared to a culturally visible 
disease such as cancer.  As a consequence, we see an array of disclosure practices.  
Modified labeling theory posits that persons have expectations or understandings of what 
it means to have a particular disease (Link 1987).  Once diagnosed, individuals must now 
apply that understanding to their own situation.  Most persons with HCV did not have an 
understanding of what it meant to have HCV before diagnosis because of the lack of 
cultural imagery.  Yet, this theory is still somewhat useful in addressing HCV because in 
the absence of cultural imagery about HCV, many respondents turned to other available 
discourse: HIV/AIDS.  Persons do attempt to make sense of their situations with the 
available cultural tools.  While public education about HCV is desirable on many levels, 
it may confine individual decision making with regard to disclosure practices.
These findings also contribute to the discourse on stigma.  Unlike much of the 
research on stigma and HIV/AIDS, this research approaches the data with attention to 
structural factors (Parker and Aggleton 2003).  I find that Blacks report less experience 
with stigma than Whites.  It is unclear whether Black respondents really experienced less 
HCV related stigma or whether they attributed stigmatizing experiences to other factors.  
Future research should focus on how occupying multiple stigmatized statuses may lead to 
attributing discrimination to the most salient or visible status.           
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My findings emphasize the salience of race and ethnicity also with regards to 
style and provider patient interactions.  As discussed in the previous section, medical 
sociologists need to focus on how race and ethnicity affect illness experiences.  Most 
research on style has focused on social class (Bury 1982; Radley 1989).  Findings from 
this research instead highlight the salience of race and ethnicity for style.  Furthermore, 
the research suggests attention to the social construction of illness within the Black 
community which may shed further light on racial health disparities.  Much of the 
research on provider patient interactions has examined social class and gender  (Waitzkin 
1985).  Again, this research points to the relevance of race and ethnicity in these 
interactions.  These findings also highlight the erroneous assumption that race, class, and 
gender always affect social processes in a predictable fashion. As mentioned, to my 
surprise, gender and class did not appear to affect illness experience with HCV.  Thus 
future research should not presume an inevitable significance. 
I have continuously emphasized the lack of cultural imagery surrounding HCV.  
There is some evidence that this trend is currently changing as HCV advocates pressure 
government agencies for changes (See www.hepcadvocacy.org).  Public education may 
in some ways have detrimental affects in terms of increasing rates of felt and enacted 
stigma.  Persons with moderate or expert knowledge of the disease are more likely to 
engage in felt stigma.  Currently, many people openly disclose and are not stigmatized 
perhaps because of the lack of cultural imagery.  Unfortunately and ironically, with 
increased education, the public may associate HCV with deviance because intravenous 
drug use is currently the main mode of transmission in the United States.  Educational 
programs must tailor information to prevent blaming persons with HCV for their illness.  
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The benefits of public education, however, outweigh the potential costs.  
Increased knowledge about HCV among the public will lead to greater prevention, more 
people getting tested for the disease, increasing chances of early treatment, and prolonged 
life span.  With greater cultural discourse, people would then have some sort of 
understanding of HCV when diagnosed, thus alleviating some of the associated 
uncertainty.  Knowledge about the disease facilitates more open disclosure practices and 
subsequent support from family and in the workplace.  More public awareness would also 
diminish persons with HCV fearing others might see them as contagious as well as others 
minimizing the illness because of a lack of understanding.  Most importantly, increased 
public awareness and patient education will address the stark contrast in illness 
experience by race and make headway in alleviating racial health disparities.   
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INTERVIEW GUIDE 
INTRODUCTION
Introduce myself and explain the background of the study. 
Tell the respondent how long the interview will probably take.  Explain that I will tape 
record the interview, where the tape will be stored, and that they can refuse to answer any 
question or stop the interview at any time. 
We will go over the consent form and the respondent will sign it. 
I will ask the respondent to pick a pseudonym or explain that I will pick one if they like. 
I would like you to tell me a bit about yourself. How long have you been in this area?  
Can you tell me a bit about your time here?  
SOCIAL RELATIONSHIPS
I am interested in you telling me about your social relationships and by that I mean 
family and friends that you are close with. 
What is your marital status? 
If not married, do you date or have a romantic partner? 
How long have you been with your spouse/romantic partner? 
Do you have any children?   
If yes, how old are they? 
If minors, do they live with you? 
If not, how often do you see them/talk with them?
If adults, do they live in Baton Rouge? 
If adults, how often do you see them/talk with them?
Does anyone else live in your household (besides ___, ___, and _____)?
Do you have other family in Baton Rouge?
If yes, how often do you see them/talk with them?
Who would you say are the 3 persons you are closest to?
How often do you see/ talk with _______? (If not one of the abovementioned 
persons.)
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PRE-DIAGNOSIS
Tell me about your life before you were diagnosed.  
What activities did you participate in?
How were your relationships with family and friends?
Did you have any previous medical conditions?
What were your previous experiences with health practitioners?  
Had you ever heard of Hepatitis C?
If yes, what did you know about it? 
What was it? How did people get it?  What did it do to people?
Did you know anyone with Hepatitis C?
What did you think about Hepatitis C (or people who got Hepatitis C?)
DIAGNOSTIC EXPERIENCE
When were you diagnosed with hepatitis C and by whom/where?
How did you come to find out you had Hepatitis C?  
Were you feeling sick?  Did you have symptoms? 
What was it like when the doctor told you that you had Hepatitis C?
How did he/she tell you? 
What did they tell you about Hepatitis C?  
Did he/she explain what the disease does to your body and the 
possible consequences of the disease?
Did he/she explain possible treatments for you?
Did he/she explain how to avoid transmitting Hepatitis to others?
Were you told that you would have to make any changes in your lifestyle?
What were you told about how you may have gotten Hepatitis C, if anything?  
Do you agree that is how you probably got Hepatitis C?
Do you have any feelings about that?
Do you have any ideas about how long you have had it?
How do you think most people who have Hepatitis C get it?
What do you remember most about how you felt when you were diagnosed?  
What did you do upon finding out?  
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At that time, what did you think having this disease meant to you/for you?   How could 
you make sense of having this illness?   In other words, did you ever ask yourself, “Why 
has this happened to me?”  How did you answer?
DISCLOSURE
When you first found out, did you tell anyone right away, why or why not? 
Who did you tell?  
Why did you tell this specific person?
What did you tell them?
How did that person(s) respond?  
How would you have liked them to respond?
Who have you told about your illness?
Nowadays, who do you tell about your illness?
What specifically do you tell people about Hepatitis C, if anything?  
Can you describe a specific incident where you told someone recently? 
Why did you tell this person?
How do you explain how you got it?
What do people ask you about HCV? 
Have you had any reactions from anyone you have told that have made you feel 
uncomfortable in any way? 
What did they do or say?
How did you feel when that happened?
Did you think differently about yourself or that you have Hepatitis C?
What about telling healthcare workers, either at your doctor or the hospital?
Has anyone there asked questions about having HCV?
What did they ask you?
How did you respond?
How did you feel about this interaction?
SUPPORT
Do you feel you have people you can count on for help?  Who are they?
Of the people you have told about having Hepatitis C, who has been the most helpful or 
supportive? 
What did this person do that was helpful or supportive? 
What kind of help/ support have you or do you most need?
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What kind of advice have persons given you?
Do you feel you can rely on your family/friends for support?
Has anyone been unhelpful or not supportive?  Why, what did they do?
Have you gone to a support group?  Why or why not?
HEALTH STATUS/ TREATMENT
How would you generally describe your overall health right now?
Are you aware of symptoms of HCV?
Have you experienced active symptoms, either at the time of diagnosis or since?  
What are they?   
How do you explain these symptoms to others?   
Have these symptoms affected your day-to-day activities?  How?
Have you had to make changes to your lifestyle because of your illness?
Have you had further testing concerning your health status, why or why not? 
Have the test results been explained to you in a way that you understand?  
Have you had a liver biopsy?  
What was your experience with the procedure?  
Where the results explained to you clearly?
Were you told about treatment options?  
What were you told about the treatment, if anything? 
 Have you had treatment or are you currently undergoing treatment, why or why not?  
Tell me about your experiences with this regimen. 
Did you experience side effects?  
If yes, what were they?
Was it difficult to stick with the treatment?  Why or why not?
Did your family or friends help you with sticking to the treatment?  
If you completed treatment, was it successful?
If you did not complete treatment, do you think you will try it again?
Did you tell family or friends know about the treatment before or after you started, why 
or why not? 
What has been their reaction?
Did you have to tell your employer about your treatment?  
What was your employers’ reaction?
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Were they helpful?
INFORMATION/MEANINGS
Have you sought out information about Hepatitis C from other sources, such as the 
internet, friends, library, etc.?  
Do you feel comfortable asking for more information from your doctor about your 
illness?  
Can you tell me about an example when you have done this?
What information would you like to have about HCV?
What would you like people to know about HCV?
How do you make sense of having this illness today?
Do you ask yourself, “Why has this happened to me?” How do you answer this today?
Have your ideas about what is means to have hepatitis C changed over time?
Has having treatment/active symptoms changed what it means to you?
Have others’ reactions affected what it means to you? 
How much do you feel you can control or not control the course of your illness?
How has having HCV changed the way you see yourself?    
CONSEQUENCES
Do you think having Hepatitis C has affected your life?
Has it affected relationships with your spouse/partner, children, or other 
family members or friends?  How?
Has it affected your employment?  How?
Has it affected your day-to-day functioning?  How?
Do you still engage in ______, ______, and ________ activities that you did 
before diagnosis?
Has having Hepatitis C affected any plans for the future or goals?
Have you had to change anything about your life?
Food or beverages?
Physical activities?
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Study # 04-8802
INDIANA UNIVERSITY - BLOOMINGTON
STUDY INFORMATION SHEET 
EXPERIENCES OF PERSONS WITH HEPATITIS C VIRUS
You are invited to participate in a research study.  The purpose of this study is to learn 
about people living with hepatitis C virus (HCV).    
If you are interested in being interviewed for this study, please contact Alicia 
Suarez: (225) 247-1996. 
INFORMATION
If you choose to be interviewed for this study, you will be part of approximately 50 
persons with HCV who will be participating in this study.   The interview will take 
approximately 60 to 120 minutes and will be conducted at a location of your choice.  I 
will be asking you about: your life before you found out you had HCV, your experiences 
with diagnosis, whether you have told others, what you have told others about your 
illness, reactions from others about your illness, experiences with treatment if any, and 
general reaction to having HCV (how it affects your day to day life).  You may request a 
break at any time.  You may also request that the interview be stopped and completed 
another day.  You may refuse to answer any question during the interview. You may 
terminate the interview at any time.  
Audiotapes will be used for research purposes.  Only the principal investigator and a paid 
transcriber will have access to the audiotapes, which will be stored in a locked filing 
cabinet.  You may request a copy of the audiotape and/or transcript of your interview, 
and it will be provided to you free of charge.  You may also request a copy of any 
published paper based on this research and one will be provided free of charge.  The 
audiotape of your interview will be destroyed by September 1, 2006.
RISKS
Some persons may experience discomfort or embarrassment in discussing personal 
details of their lives in relation to their illness with the researcher.  However, you may 
refuse to answer any question that makes you uncomfortable and may stop the interview 
at any time if you wish. 
BENEFITS
Participating in this study will contribute to knowledge about personal experiences of 
those living with HCV.  Little is known about how persons with HCV deal with their 
illness and how it affects their lives. This research will help both physicians as well as the 
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general public better understand what it is like to have HCV, as well as how to better 
assist those living with this illness.  In addition to helping others with HCV, you may 
enjoy discussing your experiences and opinions, and may gain a clearer understanding of 
these issues as well.  
CONFIDENTIALITY
This study is completely confidential.  Data will be stored securely and will be made 
available only to persons conducting the study unless you specifically give permission to 
do otherwise.  No reference will be made in oral or written reports that could link you to 
the study.  Your response will be stored under a pseudonym with no identifying markers 
linking your responses to you.  These pseudonyms will be used in any reports resulting 
from this study in order to maintain your confidentiality.  Individual responses may be 
described in research reports; however, all possible precautions will be taken to disguise 
individuals’ identities so that readers of the report will be unable to link you to the study.  
After each interview, the actual contact information for you and your name will be 
destroyed so there is no way that your responses can be linked to you. Audiotapes will 
be destroyed upon the completion of this study (no later than September 2006).
CONTACT
If you have questions at any time about the study or the procedures, you may contact 
the researcher,
Alicia Suarez, Ph.D. (candidate) at the Department of Sociology, Ballantine Hall 744, 
1020 East Kirkwood Avenue, Indiana University, Bloomington, IN  47405, or at (812) 
855-2924 or at asuarez@indiana.edu.  
Local number: (225) 247-1996. 
If you feel you have not been treated according to the descriptions in this form, or your 
rights as a participant in research have not been honored during the course of this 
project, you may contact the office for the Indiana University Bloomington Human 
Subjects Committee, Carmichael Center L03, 530 E. Kirkwood Ave., Bloomington, IN 
47408, 812/855-3067, or by e-mail at iub_hsc@indiana.edu.
PARTICIPATION
Your participation in this study is voluntary, you may refuse to participate without 
penalty.  If you decide to participate, you may withdraw from the study at anytime without 
penalty and without loss of benefits to which you are otherwise entitled.  If you withdraw 
from the study before your data collection is completed your data will be returned to you 
or destroyed.
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Form date: April 21, 2004
Study # _____
INDIANA UNIVERSITY – BLOOMINGTON
Experiences of persons with Hepatitis C Virus
Contact sheet
________________________________________________________________________
I agree that Dr. Cassidy may give Alicia Suarez my name and phone number to contact 
me about an interview for her research concerning Hepatitis C virus. 
Date _______________________________________________
Signature ___________________________________________
Name _______________________________________________
Phone Number _______________________________________
(Optional) This is a good time to phone me __________________________________
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BACKGROUND INFORMATION
Please fill in or circle the answer. 
1) What is your age?   ____________
2) What is your racial/ethnic background?  
a) African-American
b) Hispanic
c) Asian-American
d) Native American
e) White
f) Other____________
3) What is your religious preference, if any? _____________________________
4) How often do you attend services? __________________________________
5) How often do you meditate and/or pray? ______________________________
6) What is the highest grade of school or level of education you have completed?
7) What is your employment status?  ___________________________________
8) If employed, what is your occupation? ________________________________
9) If married/living with someone, what is your spouse’s/partner’s employment 
status?  _________________________________________________________
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10) If employed, what is his/her 
occupation?______________________________
11) Considering all sources of income and all salaries, what range best describes 
your household’s total annual income for the last year?
a) 0-9,999
b) 10,000-19,999
c) 20,000-29,999
d) 30,000-39,999
e) 40,000-49,999
f) 50,000-59,999
g) 60,000-69,999
h) 70,000-79,000
i) 80,000-89,000
j) 90,000 or above
12) In general, would you say you/your family has?
a) More money than you need
b) Just enough money for your needs
c) Not enough to meet your needs
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HEPATITIS C SUPPORT AND INFORMATION
Support Groups:
Metairie, Louisiana. “Friends of Hep C Support Group”  East Jefferson General 
Hospital. 1st Floor Auditorium. Meets on 1st Thursday of the month. 7-9pm. 
Contact person: Bridget. (504) 737-2429. 
New Orleans, Louisiana. “Hepatitis C Support Group Meeting”  At the office of Dr. 
Ellis Williams. 3239 Bienville St.  Meets on 3rd Tuesday of the month. 7-9pm. Call 
(504) 943-6365 or toll free (866) 891-4164. 
http://www.sirentowail.org/
Lafayette, Louisiana. “Hepatitis Support Group” 1st and 3rd Wednesday nights of 
each month.  For more information, contact: Christine Pullum (337) 981-0220.
Hotline:
1-800-522-HEPC (4372) 
“The Hepatitis Help Line Call Center at Hep C Connection, located in Denver, 
Colorado, operates Monday – Friday, 7:00 a.m. – 5:00 p.m. (MST). Our trained 
phone counselors are hepatitis C-challenged individuals, themselves, or are 
caregivers for hepatitis C-challenged family members. They combine personal 
experience with on-going research and training to provide confidential, practical 
help and up-to-date information about living with the virus. Frequently, that 
includes educating callers about hepatitis A and B, and addressing co-infection 
(HCV/HIV) issues, as well.”   http://www.hepc-connection.org/
Information:
http://hepatitis-central.com/hcv/
http://www.focusonhepc.com/
http://www.epidemic.org/index2.html
http://www.hcvadvocate.org/
http://www.liverfoundation.org/
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S494: Fall 2004
Research assistantship with Alicia Suarez
This position will be to assist Alicia with the research project, “So How Did You Get 
That?”: Experiences of Individuals Living with Hepatitis C Virus (HCV).  The project 
involves in depth interviews, which will be collected in the summer of 2004.  The 
Research assistant (RA) will help with the data analysis in the fall of 2004.  The RA will 
not be expected to work any more than 10 hours a week.  Here are the requirements for 
the position:
Participate in informal training session on how to transcribe data.  
 Read research proposal and relevant background literature to become
familiar with project. (Articles will be provided to RA). 
Transcribe interviews with a high level of accuracy. 
Participate in first stage of data analysis through filling out Interview Outline 
Forms. 
Informal meetings with Alicia to discuss the first stage of data analysis.  These 
meetings will be every other week or so depending on our schedules. 
Demonstrating an understanding and dedication to the data analysis process. 
Grades will be evaluated based on completion of the above goals.  The RA will earn 3 
credit hours from the position. 
I, __________________________, agree to participate as a Research Assistant for the 
abovementioned course. I understand what is required of me and how I will be evaluated. 
Signature ________________________________           Date ______________________
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Interview Outline Form
Completed by: 
Date: 
Respondent Name: 
Gender: 
Age: 
Race: 
Class:
Employed: 
Occupation:
Spouse/Partner occupation:
Household Income:
Evaluation of income:
Education:
Religion: 
How often meditate/pray: 
Marital Status: 
Description
1) Illness concept
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2) Disclosure
3) Social Support
4) Stigmatization
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